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Respiratory syncytial virus (RSV), a ubiquitous human pathogen, infects nearly all children 
by the age of two.  It produces severe lower respiratory tract disease, including bronchiolitis, and 
is characterized by excessive mucus production and immune-mediated lung damage. Severe RSV 
bronchiolitis in infancy is strongly correlated with development of recurrent wheezing later in 
childhood, and boys are twice as likely to be affected than girls.  These findings suggest persistent 
immune system alterations well beyond the time of viral clearance, especially in boys. RSV has 
the ability to evade the type-1 immune response and prime toward a pathologic Th2/Th17 
response. Immunopathology associated with severe RSV infection is believed to be the cause of 
significant airway diseases later in life.    However, sex differences associated with these changes 
and/or if systemic alterations are occurring along with local lung alterations have not been 
previously defined. 
Our studies here show that early-life RSV infection leads to differential long-term effects 
based upon the sex of the neonate, leaving male mice prone to exacerbation upon secondary 
allergen exposure while overall protecting female mice. During initial viral infection, we observed 
better viral control in the female mice with correlative expression of interferon-β that was not 
observed in male mice. Additionally, we observed persistent immune alterations in male mice at 
4 weeks post-infection. These alterations include Th2 and Th17-skewing, innate cytokine 
expression (Tslp and Il33), and infiltration of innate immune cells (DC and ILC2). Upon exposure 






allergic exacerbation while female mice appear to be protected; knockdown of TSLP signaling 
using TSLPR-/- mice abrogated allergen exacerbation in male mice. 
We also show that long-term systemic alterations are occurring following early-life RSV-
infection. Bone marrow-derived dendritic cells (BMDC) isolated from early-life RSV-infected 
male mice at 4 weeks post-infection retained expression of maturation markers (Cd80/86, Ox40l). 
Chemokines/ cytokines associated with the inflammatory response during RSV-infection were 
also persistently expressed along with Kdm6b and Tslp.  Knockdown of TSLP signaling using 
TSLPR-/- male mice abrogated this activated phenotype and led to enhanced T cell IFN-γ 
production.  ATAC-seq data indicated differences in the chromatin landscape of WT and TSLPR-
/- BMDC, showing more open regions of chromatin near anti-viral type-1 genes, Mid1, Spp1, and 
Cxcl11 in TSLPR-/- BMDC. qPCR showed increased expression of Mid1, Ifnb and Il12a.  
Further evaluation of BMDC showed KDM6 demethylases were upregulated upon RSV-
infection.  KDM6 Chemical inhibition (GSK J4) in BMDC decreased production of chemokines 
and cytokines associated with the inflammatory response during RSV-infection and decreased 
maturation marker (CD80/86, MHCII) expression, similar to the TSLPR-/- BMDC phenotype.  
RSV-infected BMDC treated with GSK J4 altered co-activation of T cell cytokine production. 
Airway sensitization of naïve mice with RSV-infected BMDCs exacerbate a live challenge with 
RSV infection but was inhibited when BMDCs were treated with GSK J4 prior to 
sensitization.  Finally, in vivo treatment with GSK J4 during RSV-infection reduced 
immunopathology. 
Collectively, these studies highlight the importance of proper anti-viral immune responses 
to limit RSV-driven Th2 immunopathology and future disease by limiting persistent alterations of 






the neonate should be considered during RSV disease treatment.  These studies identify TSLP as 






Chapter 1:  Introduction 
1.1. Respiratory Syncytial Virus Infection 
1.1.1 Virus genome and immune evasion 
Respiratory syncytial virus (RSV) is often the first clinically relevant pathogen encountered in 
life, with nearly all children infected during the first 2 years of life1,2 .  RSV infection is the leading 
cause of childhood hospitalization and increases the risk for developing childhood asthma and 
recurrent wheezing1,3. RSV can also adversely affect the elderly and immunocompromised 
individuals, causing severe lower respiratory tract infection and pneumonia4–6. RSV is a single-
stranded RNA virus belonging to the Paramyxoviridae family.  The RSV genome consists of 10 
genes that can encode 11 different proteins:  the fusion glycoprotein (F), G glycoprotein (G), small 
hydrophobic protein (SH), a matrix protein (M) and 2 matrix protein variants (M2-1 and M2-2), a 
nucleoprotein (N), a phosphoprotein (P) and the large RNA polymerase protein (L) as well as 2 
non-structural proteins (NS1 and NS2)7,8.  The F, G and SH proteins form the viral envelope while 
the M proteins, N, P and L proteins associate with the single-stranded RNA.   
The RSV-F and G proteins are the main virulence factors which mediate airway epithelial cell 
penetration during RSV infection7–9. The G protein facilitates attachment to glycosoaminoglycans 
present on the surface of target cells, while the F protein mediates fusion of the viral envelope and 
cell plasma membrane, releasing the nucleocapsid into the cytoplasm9,10. Upon entry, the L protein 
initiates transcription of the negative-sense RNA7,11. Virion assembly then takes place at the 
plasma membrane, where the nucleocapsid localizes with viral envelope proteins expressed on the 






where they form clusters of long filaments that extend from the cell surface, which form the 
syncytia associated with RSV infection7,11. 
RSV has the ability to evade the immune response via multiple mechanisms.  The non-
structural proteins (NS1 and NS2) are able to inhibit both the innate and adaptive immune 
system12,13.  NS1 is a known inhibitor of type-1 interferon, which is required for viral clearance14–
16.  Additionally, NS1 can antagonize both dendritic cell maturation and T cell responses17,18, while 
NS2 can bind RIG-I and degrade STAT-2 to further inhibit type-1 interferon12,13.  Finally, the G 
glycoprotein has multiple methods for being immunomodulatory, such as the production of a 
secretory G form that acts as an antigen decoy to inhibit antibody-mediated viral effects11,19.   
The remarkable ability of RSV to evade and alter the immune system is likely what leads to 
the clinical relevance of this pathogen.  Despite only a single RSV serotype and 2 antigenic 
subpopulations (A and B), immunologic memory following RSV infection is often short-lived and 
sub-optimal and therefore, re-infection throughout life is common7,8,11. Additionally, early-life 
RSV infection is associated with childhood wheezing related to respiratory viral infection 
exacerbation, allergies and asthma1,3.  Currently, there is no available vaccine for RSV and 
therefore, elucidating the mechanisms and pathways involved in RSV-driven immunopathology 
and subsequent lung pathologies later in life is of critical importance.   
1.1.2. Epidemiology 
The health burden costs of RSV infection account for over 3 million hospitalizations and 
approximately 100,000 deaths per year in children under 5, worldwide20,21.  Studies have shown 
that up to 68% of infants may be infected with RSV in their first year of life and nearly all children 
will be infected by 2 years of age22.   In healthy infants, those that are 3-6 months of age during 






neutralizing antibodies; however, these antibodies appear to be insufficient, decrease as the infant 
ages and completely wane within 6 months of age22. 
RSV infection is almost always symptomatic, with most infections leading to mild upper 
respiratory tract infections or otitis media22.  However, severe lower respiratory tract infections, 
most often bronchiolitis, may also occur and may be life-threatening.  It is suggested that 15-50% 
of childhood infections involve the lower respiratory tract with ~5% requiring hospitalization22,23  
and up to 10% of those hospitalized will end up in the intensive care unit due to severe disease11,22.  
RSV is believed to be the most frequent viral cause of lower respiratory tract infection in children 
and is implicated in up to 80% of all bronchiolitis cases22,23.  Bronchiolitis is the cause of nearly 
20% of infant hospitalization in the United States22, indicating that RSV is a significant health care 
burden, even in industrialized countries.    
RSV-related death is a significant cause of mortality in developing countries and individuals 
with pre-existing conditions and is believed to be the second most likely cause of death by a single 
pathogen in children under 1 year of age, worldwide22,24.   In addition to a severe primary infection, 
RSV re-infection is common throughout life and up to 75% of infants infected by 12 months of 
age will become re-infected before they reach the age of 2.   Symptoms of the disease wane with 
re-infection; however, the elderly, immunocompromised individuals, and those with chronic 
conditions are at high risk of developing lower respiratory tract infections making RSV a 
significant cause of morbidity and mortality in these individuals22,24.  
There is currently no vaccine available or a sufficient option for anti-viral therapy, partially 
due to our incomplete understanding of how severe immunopathology is developed.  In the 1960s, 
a vaccine trial was conducted with suboptimal optimal results; vaccinated infants became severely 






There is however, a monoclonal antibody (Palivizumab) that does show success when given to 
high risk infants prophylactically, leading to decreased hospitalization compared to control groups 
as well as decreased incidence of subsequent wheezing28.  However, at least half of all children 
that are hospitalized due to severe RSV are previously healthy individuals22 that would not qualify 
for prophylactic treatment; therefore, identifying mechanisms leading to disease and furthermore, 
novel treatment options for the general population is a critical unmet need. 
1.1.3. RSV-driven immunopathology 
RSV predominantly infects ciliated epithelial cells in the airways but can also lead to infection 
in the sub-epithelium and neighboring immune cells, such as dendritic cells29,30. The major 
histopathologic characteristics of RSV infection include acute bronchiolitis, mucosal swelling of 
the airways, and airway obstruction caused by sloughed epithelial cells and mucus 
production6,22,30. Recent pre-clinical and clinical data, suggest that severe RSV disease is 
associated with an altered innate and adaptive immune response, characterized by excessive Th2 
and Th17 immune responses20,31–36.  Numerous studies have shown that RSV plays a role in 
reducing innate cytokine production that is necessary for appropriate anti-viral responses20,35,37,38.  
Both viral replication as well as RSV-associated immunopathology can lead to RSV disease 
symptoms and probing these and potentially other underlying disease mechanisms that are 
supported by clinical data will be important for therapeutically targeting the immune environment.   
Initial RSV response is driven by innate cytokines, such as IL-25, IL-33 and thymic stromal 
lymphopoietin (TSLP) that are released from the airway epithelial cells following infection.  These 
cytokines have the ability to activate the immune response through interactions with dendritic 
cells, T cells and innate lymphoid cells39–43.  During a typical viral infection, the immune response 






T cells toward distinct T helper type responses 44.  RSV can skew the immune response away from 
anti-viral and towards a Th2-type response by inhibiting the production of IFN-β and subsequently 
decreasing the Th1 response45.  This lack of an anti-viral response as well as skewing towards 
dysregulated Th2/Th17 has been correlated with severe disease20,31,35.  Additionally, studies with 
neonatal RSV infection have demonstrated that there are persistent, long-term alterations in the 
lung that include increased mucus production and increased populations of immune cells46,47.  
1.1.3.1. Th2 response  
1.1.3.1.1. T cells 
The differentiation of specific T cell subsets was discovered in mice48–50 and subsequently 
shown in humans51.  T cell-mediated immunity occurs in successive antigen-driven and cytokine-
driven steps. First, T cells are activated by specific antigens presented by peptide-MHC complexes 
on the surface of antigen presenting cells (ie. Dendritic cells). Next, these activated T cells are 
induced to clonally expand by the cytokine Interleukin-2 (IL-2), and subsequently differentiate 
into CD4+ T cells as a result of a specific subset of cytokines engaging and activating their 
respective cytokine receptors52,53. Distinct cytokine profiles reflect different T cell functions and 
include:  Th1-type, which primarily produce IFN-γ; Th2-type characterized by the production of 
the cytokines IL-4, IL-5 and IL-13, and Th17-type, which produce mainly IL-17 and IL-22.  The 
overall role of T cells differs in that Th1 are mainly involved in cell-mediated immunity54 and the 
anti-viral response55,56 whereas Th2 is responsible for humoral immunity and B cell development 
of the antibody response54.  The Th17 arm of the immune response is largely involved in 
antibacterial and mucosal immunity57.  A successful immune response requires a balance of these 
subsets and inappropriate immune response skewing has been linked to the development of 






For example, the Th2 immune response has been implicated in severe RSV disease as well as 
the development of many lung pathologies, such as allergy and asthma20,35,58. The Th2 response 
promotes the infiltration of eosinophils and neutrophils into the lungs leading to an inflammatory-
allergic cellular environment which dampens effector functions, such as the secretion of IFN-γ35,36. 
As a result, clearance of RSV is delayed and instead, viral spreading is promoted. The specific 
cytokines involved in this response include IL-4, IL-5 and IL-13 which have been shown to 
perform both independent as well as overlapping roles, leading to antibody class switching to IgE, 
eosinophil recruitment and mucin production; characteristics of both severe RSV disease as well 
as asthma that can lead to airway hyperreactivity which is associated with poor lung function35,58.   
IL-4/IL-13 
Interleukin-4 (IL-4) is a multifunctional cytokine that plays a critical role in the immune 
response and shares sequence homology, cell surface receptors, intracellular signaling, and partial 
functional effects on cells with another Th2-type cytokine, IL-1359,60.  Both IL-4 and IL-13 are 
produced by activated T cells as well as mast cells, basophils, eosinophils and innate lymphoid 
type-2 cells (ILC2)39,59,60.  IL-4 is best known for defining the Th2 phenotype as well as regulating 
cell proliferation, apoptosis, and expression of numerous genes in various cell types60.  
Additionally, IL-4/IL-13 are involved in antibody class-switching to IgE by recruiting and 
activating IgE-producing B cells that mediate diseases such as allergy and asthma60–62.  These 
cytokines are also both involved in inflammation and mucus production associated with the type-
2 immune response. 
The IL-4 alpha receptor (IL-4Rα) is a unique member of the common-gamma chain (γc) family 
of receptors59 with the ability to signal within three different receptor complexes, known as Type 






comprises IL-4Rα and γc59. Type I receptor complexes are only formed by IL-4 and are more active 
in regulating Th2 development. In non-hematopoietic stem cells, IL-4 can use the Type II complex, 
comprising IL-4Rα and IL-13Rα166. Type II receptor complex is also a functional receptor for IL-
1367 which largely explains the overlap of the biological effects of IL-4 and IL-1368. Type II 
receptor complex formed by either IL-4 or IL-13 is more active in regulating cells that mediate 
airway hypersensitivity and mucus secretion63. Interestingly, IL-13 appears to have its own distinct 
role in allergic inflammation, acting as a key regulator of allergen-induced airway inflammation, 
and goblet cell metaplasia68.  
IL-5 
The Th-2 associated cytokine IL-5 was initially identified by its ability to support the growth 
and terminal differentiation of mouse B cells in vitro; it has now been shown to exert pleiotropic 
activities on various target cells including B cells, eosinophils, and basophils. IL-5 is produced by 
both hematopoietic and non-hematopoietic cells including T cells, granulocytes, and natural helper 
cells and exerts its effects via receptors that comprise an IL-5-specific α and common β-
subunit69.  IL-5 is involved in the recruitment of eosinophils and contributes to inflammation and 
epithelial cell sloughing within the airways70.  IL-5 regulates eosinophilia within the lung as well 
as in the circulation and amplifies chemotaxis into the airways. Moreover, in the presence of 
antigen, IL-5 provides fundamental signals for eosinophil degranulation and assists in the 
induction of airway hyperreactivity (AHR) 70,71. 
In addition to inflammation, epithelial cell sloughing and AHR, the Th2 immune response is 
also involved in mucus production. Excessive secretion of mucus in the airways is an important 
cause of morbidity and mortality in diseases such as asthma, chronic obstructive pulmonary 






airway diseases, including RSV, increased numbers of goblet cells (mucus-producing cells) line 
the surface airway epithelium of the lung, defined as goblet cell metaplasia72. Mucus production 
within the lungs of mice is largely driven by the mucus genes:  Gob5 and Muc5ac.  The expression 
of Muc5ac is used as a marker for goblet cells and Gob5 expression has been shown to be increased 
in the lungs of asthmatics72.  Additionally, it has been determined that the overexpression of Gob5 
can lead to increased expression of Muc5ac72. Mucus cell metaplasia in airway diseases is 
accompanied by significant airway inflammation, therefore, inflammatory cells and their secreted 
mediators are believed to directly act on airway epithelial cells to induce goblet cell formation. In 
asthma, Th2 cytokines, such as IL-4 and IL-13 play important roles in directly causing Muc5ac 
expression in airway cells but IL-13 seems to have the more prominent role. IL-4 has also been 
shown to induce mucin expression in vitro and in vivo72, but is not critical to mucus cell 
hyperplasia. IL-13, on the other hand, has been shown to act directly on airway epithelial cells to 
increase Muc5ac expression as well as lead to goblet cell metaplasia72. 
1.1.3.1.2. Innate Lymphoid Type-2 Cells (ILC2) 
Importantly, T cells are not the only cells capable of producing Th2-type cytokines.  Some of 
the additional cell types, include mast cells, eosinophils, neutrophils and basophils.  Another 
significant producer of Th2 cytokines are the innate lymphoid 2 cells (ILC2), known to be involved 
in lung disease pathogenesis.  ILC2 are a rare population of innate cells of lymphoid origin, but 
unlike T cells or B cells do not contain an antigen receptor and are therefore, non-specific innate 
responding cells.  It has been suggested that ILC2 are far more potent than CD4+ T cells in their 
induction of type-2 cytokines; in fact, it is estimated that ILC2 produce 10 times more cytokine 






Innate lymphoid cells play key roles in lymphoid tissue development as well as the initiation 
of inflammation and more complex roles during the immune response, including the transition 
from innate to adaptive immunity and chronic inflammation39,74.  Remarkably, dysregulation of 
this rare population has been linked with chronic pathologies, including asthma and 
autoimmunity39. The early expression of ILC2 leads to eosinophilia (IL5), mucus production (IL-
13) and lung repair (amphiregulin)74,75. ILC2 are the main source of IL-13 during helminth 
expulsion but are also known to expand during allergic lung inflammation74.   
Innate cytokines, including thymic stromal lymphopoietin (TSLP), IL-25 and IL-33 are known 
inducers of ILC2 differentiation39,40,76. ILC2 are increased in RSV infected lungs and these cells 
produce IL-5 and IL-13, cytokines important in the development of airway inflammation and 
mucus production as described above46,47.  The secretion of these innate cytokines following 
infection of airway epithelial cells by RSV leads to the initial activation of the immune response, 
including the activation of dendritic cells (DC, described below) as well as ILC243.  Stier et al73, 
link the early induction of effector ILC2 to the development of airway hyperreactivity and mucus 
production associated with RSV through TSLP-driven induction of IL-13 producing ILC273.  Age-
related IL-33 production was shown to be necessary to induce ILC2 and lead to Th2-driven 
immunopathology following neonatal RSV infection47. In addition to the RSV-driven 
immunopathology, this innate cytokine/ILC2 mechanism has also been implicated in pathologies 
related to early-life rhinovirus infection77.   
Furthermore, ILC2 have also been linked to adaptive immunity78.  For example, ILC2 response 
is required for DC polarization of CD4+ Th2 memory during allergic responses79. ILC2s were 
found to act upstream of DCs, making them essential for DC production of CCL-17, a 






efficient localized memory Th2 cell response in collaboration with tissue-resident DC79.  During 
allergic lung inflammation following papain exposure, ILC2 are necessary for CD4+ T cell 
polarization80.  Here, IL-33 mediated ILC2 development was required for IL-13 driven migration 
of DC to the lung draining lymph nodes where they primed T cells towards Th2. 
1.1.3.2. Th17 response  
 In addition to Th2-type immunity, RSV also leads to a pathogenic Th-17 response.  The Th17 
immune response is involved in regulating inflammation but also modulates lung and airway 
structural cells during the pathogenesis of asthma and COPD81.  During anti-bacterial immunity, 
Th17 immunity is crucial for neutrophil recruitment to limit bacterial infection82.  Th17 responses 
are also involved in the development of mucus production and goblet cell hyperplasia by leading 
to the upregulation of Muc5ac83,84. Signaling through STAT-3, activated by IL-6 and IL-23 as well 
as IL-1β and TGFβ are required for induction of Th17 cells81.  Cell types capable of producing 
IL17-associated cytokines include CD4+ T cells, γδ T cells, ILC3, and neutrophils81.   
The IL-17 family of cytokines consists of 6 family members IL-17A-F85,86; IL-17A and IL-
17F show the strongest proinflammatory role and are involved in many diseases of autoimmunity 
as well as asthma86.  The percentage of Th17 cells as well as the plasma concentrations of IL-17 
increase with disease severity and elevated IL-17A levels correlate with increased AHR in patients 
with asthma81. Additionally, IL-17 has also been reported to modulate airway structural cells, 
leading to tissue remodeling81. IL-17A induces the expression of two mucin genes (Muc5ac and 
Muc5b) in bronchial human and murine epithelial cells and overexpression of IL-17F in mice 
results in goblet cell hyperplasia and mucin gene expression. Moreover, IL-17A and IL-17F 






In the case of RSV infection, IL-17A was determined to be upregulated during human infection 
with RSV as well as in mouse models of disease31.  Mouse modeling showed that IL-17A was 
pathogenic through its role in driving mucus production and inflammation as well as inhibition of 
CD8+ cytotoxic T cells during RSV infection and inhibition of IL-17A led to increased viral 
clearance and decreased pathology.  Additionally, this study showed that IL-17 is involved in 
exacerbated allergic responses following RSV infection through mucus production, inflammation 
and increased Th2 responses.  These data indicated that Th-17 is involved in both pathologic 
responses following RSV infection as well as exacerbations later in life, including allergy and 
asthma31.   
1.1.3.3. Dendritic Cell Role During RSV  
Dendritic cells (DC) play a crucial role in the development of the immune response and link 
innate and adaptive immunity by instructing T cells toward a Th1 (anti-viral), Th2 (anti-parasitic 
or allergy-associated) or Th17 (anti-bacterial or autoimmunity) type response.  DC are sentinel 
cells present in the lung during steady-state conditions that constantly monitor the lungs for foreign 
pathogens or antigens. Upon RSV infection, DCs acquire viral antigen either through direct 
infection or indirectly from dying infected cells. They then undergo maturation and migrate to the 
lung-draining lymph nodes (LDLN) where they present antigen to naive T cells.  Mouse DC are 
divided into conventional DC (cDC) which are CD11c+/MHCII+ and plasmacytoid DC (pDC) 
which are CD11cint/B220+87.  Plasmacytoid DC show a protective role during RSV infection 
largely through the production of Type-1 IFN29,88.  Conventional DC within the lung are further 
divided into CD11b+ and CD103+ both of which have been implicated in pathogenic 
inflammatory responses during RSV infection29; with CD103+ shown to drive very strong Th2 






production of Type-1 interferon (IFN), such as IFN-β, which leads to the production of IFN-γ and 
proper viral clearance15.  However, RSV has the ability to dampen type-1 immunity as described 
previously through multiple mechanisms, including direct inhibition of type-1 interferon as well 
as the use of an antigen decoy to evade the immune system7,12,19.  In the absence of type-1 
immunity, the DC produce cytokines and chemokines that skew the response towards 
Th2/Th177,11,36.  
It has been shown that the numbers of cDC and pDC increase in the lung following RSV 
infection in both human and mouse11,29.   Analysis of nasal washes collected from children during 
an RSV infection determined that DC were increased in the lung and furthermore, levels of cDC 
in the blood were decreased, correlating with recruitment to sights of infection29.  Interestingly, 
correlations have been shown between absolute number of cDC and increased levels of 
inflammatory cytokines (i.e. IL6, CCL2) supporting cDC as a source of inflammation within the 
nasal cavity during RSV infection29.  In addition, mouse studies indicate an increase in mature DC 
that contain RSV RNA within the lung draining lymph nodes (LDLN); evidence that DC have the 
ability to acquire DC, mature and navigate to the LDLN to activate naïve T cells.   
RSV infection of DC leads to maturation of the infected cell as well as neighboring DC along 
with the upregulation of MHC and co-stimulatory molecules, such as CD80 and CD8629,90.  RSV-
infected DC produce pro-inflammatory cytokines such as IL-1β, IL-6, IL-12, type-1 IFN and TNFα 
as well as chemokines such as CCL2, CCL3 and CCL5.  However, despite maturation and this 
pro-inflammatory milieu, these DC lack an ability to properly activate and polarize naïve T 
cells29,90.  Two different models have been described to support this phenomenon, including RSV-
secretion of an immunosuppressive factor and disruption of synapsis formation between DC and 






cell activation which leads to a decrease in T cell production of important anti-viral cytokines, 
such as IL-2 and IFN-γ, leading to an imbalanced immune response, skewing away from Th1 anti-
viral immunity toward a predominantly Th2/Th17 pathogenic response. 
The different DC subsets (pDC and cDC) have been shown to play differential roles in the 
RSV immune response.  The pDC population has a protective role through production of IFN-α 
for viral clearance as well as regulation of the Th2 response, limiting airway hyperreactivity and 
mucus production29,88,91.  On the other hand, cDC have been implicated in promoting the Th2 
response by upregulation of CCR6 and CCL20 secretion leading to the recruitment of Th2 cells to 
the lung29,92.  Furthermore, while cDC are necessary for a proper inflammatory response against 
pathogens, sheer absolute numbers of cDC have been proven to lead to a pathogenic response 
during RSV infection92.  These data suggest that a critical balance is required between pDC and 
cDC for proper inflammatory and viral responses within the lungs.   
In summary, RSV infects airway epithelial cells leading to secretion of innate cytokines such 
as IL-25, IL-33 and TSLP, which promotes induction of the immune response by activating 
dendritic cells, the main link to the adaptive immune response. Dendritic cells then instruct the T 
cells toward a skewed Th2/Th17 response, through the secretion of immunopathology-linked 
cytokines and a lack of type-1 IFN production.  In addition, the innate cytokines (IL-33, IL-25 
and TSLP) are also able to directly act on T cells as well as the innate lymphoid cells to further 
enhance a Th2 response. Together, this leads to the immunopathology associated with RSV, 








Figure 1- 1. Overview of RSV-infection.  
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1.2. Early-life RSV and asthma 
Along with the initial disease complications associated with the primary RSV infection, RSV-
driven Th2/Th17 skewing has also been implicated in leading to airway restructuring linked to 
exacerbated allergic responses later in life93.  Up to 48% of infants who were hospitalized for 
severe RSV-associated bronchiolitis and/or lower respiratory tract infection go on to develop 
asthma during their childhood94,95.  Asthma is the most common chronic childhood illness, 
affecting approximately 5 million children under 18 years of age, including 1.3 million children 
under 596. During childhood, males have higher occurrences of asthma and wheezing than do 
females at a 2:1 ratio97.  Additionally, males are approximately twice as likely to become 
hospitalized than females due to severe RSV infection23.  Thus, the risk for severe RSV infection 






1.3. TSLP in RSV and asthma pathogenesis 
As indicated above, innate cytokines such as IL-25, IL-33 and TSLP are implicated in lung 
pathologies such as those associated with RSV infection and asthma. Many studies have indicated 
a role for these innate cytokines in respiratory viral complications, asthma development, as well 
as viral exacerbations of existing asthma99–101. Allergen challenge, following neonatal rhinovirus 
infection identified that both IL-33 and TSLP are required for IL-25-induced ILC2 production of 
IL-13 leading to mucus metaplasia but TSLP was necessary for maximal ILC2 gene expression 
even in the presence of IL-25 and IL-3376.  Additionally, experimental asthma pathogenesis was 
shown to persist in IL-33R knockout mice (ST2-/-) due to increased expression of TSLP that 
enhanced ILC2 production of IL-13; abrogation of this response was only possible with the 
addition of an anti-TSLP antibody102.  Finally, in an allergen challenge model conducted on adult 
human subjects with allergic asthma, administration of an anti-TSLP monoclonal antibody (AMG 
157) reduced allergen-induced bronchoconstriction and airway inflammation, suggesting a key 
role for TSLP in allergen-induced airway responses in asthmatics103. Collectively, these studies 
make it plausible that TSLP, IL-25 and IL-33 cooperate and regulate each other during initial 
disease progression but TSLP may be more significant in the development of subsequent diseases 
later in life. Furthermore, it has been shown that increased TSLP mRNA in bronchial epithelial 
cells of asthmatics directly correlates with degree of airflow obstruction104 and GWAS studies 
show a strong association between TSLP and severe asthma105,106. Therefore, here, we have 
focused on the cytokine TSLP.   
TSLP is an early responding innate cytokine that plays a critical role in the regulation of 
immune responses and in the differentiation of hematopoietic cells.  TSLP was originally identified 






lymphopoiesis107,108. TSLP signals through a heterodimeric receptor complex consisting of an 
interleukin-7 (IL-7) receptor α chain and TSLP receptor (TSLPR) (also known as cytokine 
receptor-like factor 2 (CRLF2)). The TSLP/TSLPR axis can activate multiple signal transduction 
pathways including JAK/STAT and PI-3 kinase108. Aberrant TSLP/TSLPR signaling has been 
associated with a variety of human diseases including asthma, atopic dermatitis, nasal polyposis, 
inflammatory bowel disease, eosinophilic esophagitis and leukemia108–110. Factors such as toll-like 
receptor ligands, viruses, microbes, allergens, helminths, and chemicals trigger TSLP 
production111. Proinflammatory cytokines, Th2-related cytokines, and IgE also induce or enhance 
TSLP production, indicating multiple feedback loops108,111. The transcription factors NF-ΚB and 
AP-1 (BATF) are critical for TSLP regulation108,111.  
Stimulation by TSLP induces the phosphorylation and activation of JAKs, which then regulate 
the activity of STAT factors, including STAT1, STAT3, STAT4, STAT5a, STAT5b and 
STAT6108,112. The activation of these signaling pathways, leads to multiple TSLP-driven immune 
responses.  For example, pro-inflammatory cytokines such as IL-6 are induced through 
IRF4/STAT3 that can lead to cell proliferation, dendritic cell migration and subsequently airway 
inflammatory responses112.  Additionally, the activation through NFKBIA leads to upregulation of 
the OX-40L on dendritic cells to drive Th2 responses and airway inflammation upon interaction 
with OX-40 on Th2 cells41,112. 
TSLP has a wide range of immune cell targets, including ILC2, DC and T cells.  The initial 
biologic function of TSLP demonstrated that it interacted with DC to promote Th2 cell 
differentiation and thus promoted allergic disease113,114.  TSLP can also act directly on Th2 cells 
as well as ILC2, causing them to produce Th2-type cytokines, such as IL-5 and IL-13 to enhance 






17 and CCL-2241, chemokines that recruit Th2 cells through interaction with the CCR4 receptor.  
Finally, in response to TSLP, cDCs will themselves produce TSLP that further interacts with DCs 
and ILC2, creating a feedback loop that is independent of epithelial cell-derived TSLP115,116. 
TSLP is upregulated following RSV infection of lung epithelial cells117. During neonatal 
RSV-infection, TSLP mediates immunopathology through OX-40/Th2 signaling118, as well as 
exerts direct effects upon ILC2 cells to enhance inflammation and mucus production73. When 
TSLP was neutralized during neonatal RSV infection, the severity of a later exacerbated RSV 
infection was mitigated118, indicating that TSLP may be creating a broadly altered immune 
environment. 
1.4. Dendritic Cell Alteration Following Early-life RSV and Long-Term Alterations 
Many studies over the years have identified several DC-linked chemokines (CCL2, CCL3, 
CCL5, CxCL1, CxCL2) that contribute to the pathogenesis of asthmatic disease, the RSV-induced 
exacerbation, and the clearance and resolution of the ongoing pathology7,92,119.  In addition, 
chemokine receptors (CCR6, CCR7) have been identified that regulate recruitment of specific 
immune cells involved in the response to RSV and/or allergen-induced asthma-like 
responses92,120,121. Furthermore, RSV predisposes animals to more severe allergen responses58,89. 
The most prominent cell that appears to be involved in chronic disease that is 
enhanced/exacerbated by RSV is the inflammatory/myeloid dendritic cell (mDC). In contrast, as 
described above, the pDC is a protective subset that promotes a more appropriate anti-viral 
response.  It has previously been identified that RSV-exposed mDC are sufficient to promote a 
more severe and accelerated disease environment when exposed to allergens37,89 .  Understanding 
how RSV infection influences DC function to alter the immune environment is critical to 






in life. It is likely that RSV and other viral infections, including rhinovirus, uncover an underlying 
phenotype and reinforce the immune environment by further altering pathogenic immune 
responses, possibly through the phenomenon of trained immunity.     
Immunologic memory is a powerful tool for host defense against pathogens. In the case of 
classical adaptive immunity, T and B cells develop a highly diverse repertoire of antigen-specific 
receptors by somatic gene rearrangement. However, the general view that only adaptive immunity 
can build immunologic memory has recently been challenged by a phenomenon termed trained 
immunity or innate immune memory122,123. Trained immunity involves innate cells such as myeloid 
cells (including dendritic cells), natural killer (NK) cells, and innate lymphoid cells (ILCs) and 
their interactions with pattern recognition receptors (PRRs) and effector cytokines. In contrast to 
classical adaptive memory, the increased responsiveness to secondary stimuli during trained 
immunity is not specific for a particular pathogen and it is mediated through signals involving 
transcription factors and epigenetic reprogramming. Finally, trained immunity relies on an altered 
functional state of innate immune cells that persists for weeks-to-months after the elimination of 
the initial stimulus122,123.  
Unlike lymphocytes, innate immune cells do not express rearranging antigen receptor 
genes, but they do express PRRs and other receptors that allow them to recognize and respond to 
pathogens (pathogen-associated molecular patterns, PAMPs) and endogenous danger signals 
(damage-associated molecular patterns, DAMPs)124,125. Although these responses are not as 
specific as antigen receptors, there is evidence that expression of distinct members of PRR families 
(Toll-like receptors, NOD-like receptors, C-type lectin receptors, RIG-I-like receptors) on 
macrophages and dendritic cells may trigger specific immune responses based on the pathogen 






studies of LPS-induced tolerance where gene-specific chromatin modifications were associated 
with silencing of genes coding for inflammatory molecules, while priming other genes coding for 
antimicrobial molecules126. These findings suggested that macrophages could be primed by LPS 
to become more or less responsive to subsequent activation signals. This observation was 
expanded by studies that demonstrated that exposure of monocytes/macrophages to C. albicans or 
β-glucan enhanced their subsequent response to stimulation with unrelated pathogens or PAMPs, 
leading to the term trained immunity122,127. Training was demonstrated to be accompanied by 
significant reprogramming of chromatin marks. 
A distinguishing feature of trained innate immunity is the ability to mount a qualitatively 
different and often much stronger transcriptional response when challenged with pathogen or 
danger signals. In myeloid cells, many loci encoding inflammatory genes are in a repressed 
configuration128,129 and upon primary stimulation, massive changes are observed in these loci 
with alterations driven by the recruitment of transcription factors (i.e. NF-κB, AP-1, and STAT 
family members) to enhancers and gene promoters, which are usually pre-marked by myeloid 
lineage-determining transcription factors such as PU.1122. Transcriptions factors then recruit 
coactivators (i.e. histone chromatin remodelers) that locally modify chromatin to make it more 
accessible to transcriptional machinery128,129. 
Maintenance of this enhanced accessibility may lead to a more efficient induction of 
genes primed by the initial stimulation126. The persistence of histone modifications deposited at 
promoters or enhancers after the initial stimulus may impact the secondary response122,127. 
Therefore, the observed long-term persistence of some histone modifications in myeloid cells 






sustained activation of the upstream signaling pathways and transcription factors that control 
their deposition (i.e. PU.1, STAT, IRF). 
1.5. Epigenetics Following RSV Infection 
The concept that our immune responses are influenced by environmental factors including 
microorganisms, pollution, diet and pathogen exposure is important for understanding disease 
progression. Epigenetic modifications can directly target DNA or target the histone proteins that 
comprise the nucleosomes that the DNA is wrapped around.  Chromatin that is wound around 
histones is regulated by the nature of the modifications to the protein tails of the histone core 
components, including H2A, H2B, H3, and H4.  These modifications (methylation, acetylation, 
ubiquitination, phosphorylation, etc) determine the transcriptional status of the gene loci by 
exposing or sequestering the gene promoter region. Approximately 100 enzymes have been 
identified that modify histone proteins and subsequently control whether genes are in a 
transcriptionally active (open) or transcriptionally silenced (closed) configuration.  A group of 
epigenetic enzymes ("writers") add distinct chemical groups (methyl, acetyl, or phosphate) to 
histones to determine whether the chromatin is "open" or "closed".   In addition to the enzymes 
that add these groups, studies have identified that there are also enzymes the take these same 
groups away ("erasers").  While epigenetic modifications to histones can have long-term effects 
on the gene expression profile of a cell, these writers and erasers can provide modifications that 
allow for greater plasticity during cell activation. The amino acid that is most often modified in 
histones is lysine and its position in the histone tail can determine if the added modification allows 
an active (open) or silenced (closed) configuration of the gene.  For example, the addition of methyl 
groups on lysine (K) 4 of histone (H) 3 (i.e. H3K4) leads to activation of gene transcription, 






methyltransferases (writers) that add methyl groups and demethylases (erasers) that remove them. 
There is already evidence that epigenetic modulation directs the differentiation and maturation of 
immune cells. For example, the cytokines typically produced by Th2 cells (IL-4, IL-5 and IL-13) 
are suppressed in Th1 cells through histone modification131,132. In addition, Th17 cells have 
increased H3K4 methylation at the IL-17 promoter132. In DCs, IL-12 production is decreased 
following severe sepsis due to decreased H3K4 methylation133. KDM5B, an H3K4 demethylase, 
is upregulated following RSV infection of DCs37. Since H3K4me3 is an activating mark, this 
demethylase acts as a transcriptional repressor to specific gene targets. RSV infection induces 
KDM5B expression, which in turn induces changes in DCs that create a pathogenic T cell mediated 
immune response due to the regulation of critical innate cytokines, especially Type I IFN. Together 
these studies have characterized how a single epigenetic modification can alter an ongoing immune 
response that has significant impact on subsequent allergic airway responses.   
Another key epigenetic gene modifier is H3K27 tri-methylation, which represses gene 
transcription and removal of this mark by KDM6 demethylases leads to active gene transcription.  
H3K4 methylation is crucial for active gene transcription, while H3K27 methylation appears to 
fine tune gene transcription 130,134. In addition to the canonical role of H3K27 demethylation, 
KDM6 also contributes to gene activation by modulation of H3K4 methylation through 
stabilization of the MLL complex 135,136 and guides gene transcription by binding POLII to enhance 
its movement along genes 137,138.  Many studies have linked KDM6 demethylation of H3K27 and 
immune cell regulation.  For instance, KDM6b has been strongly implicated in macrophage M2 
polarization134.  Additionally, inhibition of KDM6a/b enzymatic activity has been shown to lead 
to decreased inflammation during experimental autoimmune encephalitis by creating a tolerogenic 






several chromatin modifying enzymes that alter the ability of the immune response to function 
appropriately. 
1.6. Summary and Specific Aims 
Respiratory syncytial virus (RSV) is often the first clinically relevant pathogen encountered in 
life, with nearly all infants infected within the first 2 years of life2,23.  RSV infection is the leading 
cause of childhood hospitalization, and increases the risk for developing childhood asthma and 
recurrent wheezing1,3.   In addition to causing this exacerbated lung disease, RSV is also directly 
associated with a significant amount of health burden costs and mortality, accounting for over 3 
million hospitalizations and 66,000-199,000 deaths per year, in children under 5, worldwide20,21. 
Recent data, including that from our laboratory, suggest that severe RSV disease is associated with 
an altered innate and adaptive immune response, characterized by excessive Th2 and Th17 
immune responses .  Numerous studies have shown that RSV has a role in reducing innate cytokine 
production necessary for appropriate anti-viral responses20,35,37,38. 
Both direct viral replication as well as indirect immunopathology can lead to RSV disease 
symptoms.  RSV can skew the immune response away from anti-viral and towards a Th2 type 
response by inhibiting the production of IFN-β and subsequently decreasing Th145 (Figure 1-1). 
This lack of anti-viral response as well as skewing towards dysregulated Th2/Th17 has been 
correlated with severe disease20,31,35, possibly leading to airway restructuring and this restructuring 
has been linked to exacerbated allergic responses later in life93.  How RSV alters the immune 
system to influence these responses is currently unknown.  Determining what factors are altered 
upon initial infection may lead to a greater understanding of how the immune response is affected 






It has been suggested that up to 48% of infants who were hospitalized for severe RSV-
associated bronchiolitis and/or lower respiratory tract infection may go on to develop asthma 
during their childhood94.  Asthma is the most common chronic childhood illness and during 
childhood, males have higher occurrences of asthma and wheezing97.  Additionally, males are 
approximately twice as likely to become hospitalized than females due to severe RSV infection23.  
Therefore, the risk for both severe RSV infection as well as RSV-associated asthma development 
may be higher in males than in females. 
How RSV alters the immune system to influence immune responses later in life and why 
males are more susceptible to both severe infection as well as childhood asthma is currently 
unknown.  Previous studies with neonatal RSV infection have demonstrated that there are 
persistent changes in the lung that include mucus production and increased immune cell 
populations that persist in the lung, including type 2 innate lymphoid cells (ILC2) that produce IL-
5 and IL-13, known to contribute to the immunopathologic Th2 responses that are associated with 
severe RSV infection and asthma46,47.  Epithelial cell-derived cytokines, including thymic stromal 
lymphopoietin (TSLP), IL-25 and IL-33 are known inducers of ILC2 differentiation39,40,76. TSLP 
drives Th2-type responses via its influence on DCs, T cells, and ILC2s 41,42,140 and in some cases, 
may be required for CD4+ Th2 memory42.  RSV infection has been shown to lead to increased 
expression of TSLP117,118, which has also been implicated in asthma pathogenesis141–143 .  In fact, 
TSLP has been suggested as a possible biomarker in pediatric asthmatics144.  Additionally, it has 
been shown that RSV infection leads to activated IL-13 producing ILC2s that are dependent on 
TSLP73. The studies described here will examine the modulated immune responses during neonatal 
RSV infection that include alteration of immune cell phenotypes and subsequent persistent 






RSV infection alters local and systemic immune cell populations in neonates through TSLP 
production. These studies will utilize the human chimeric RSV A2 strain with Line 19 F fusion 
protein which has been shown to enhance viral load, mucus hypersecretion and airway 
hyperreactivity in mouse models145.  A neonatal mouse model was developed to evaluate early-
life RSV infection as well as secondary allergic disease (Figure 2-5). Determining what factors 
are altered during early-life exposure and how to control RSV infection to limit these changes, 
may lead to possible interventions to decrease the incidence of childhood asthma.    
We first examined the role of TSLP following early-life RSV infection and subsequent 
allergic responses later in life to determine if differences exist between male and female mice.  
We hypothesized that males will be more susceptible to RSV infection and have a stronger immune 
response to allergen upon subsequent challenge and that exacerbation will be dependent on TSLP.  
Our results show that male mice have decreased viral control with increased viral gene expression 
over the course of primary infection whereas females clear the virus much quicker.  Correlating 
with increased viral clearance in female mice, IFN-β is expressed only in female mice but not male 
mice.  Upon allergen challenge later in life, male mice show an exacerbated allergic response to 
cockroach allergen (CRA) while female mice are protected.  Furthermore, testing in TSLPR-/- 
mice abrogated the exacerbated response in male mice, supporting a role for TSLP in male-specific 
allergic exacerbation following early-life RSV infection. 
We next examined how early-life RSV infection leads to systemic changes of the 
immune system, specifically in the bone-marrow-derived dendritic cell (BMDC) population.  
We hypothesized that RSV will lead to phenotypic alterations of BMDC that will cause changes 
in pro-inflammatory cytokine production and more highly reactive BMDC that migrate into the 






early-life RSV infected mice show differential pro-inflammatory responses compared to naïve 
mice, producing higher levels of pro-inflammatory cytokines and chemokines, such as IL-6 and 
CCL3 and male mice retain signs of activation, including upregulation of CD80/86 and MHC II 
as far out as 4 weeks post-infection.  Interestingly, BMDC from early-life RSV-infected female 
WT mice and TSLPRKO-/- male mice do not show this phenotype and appear more like BMDC 
from naïve mice.  These data indicate that the BMDC from early-life RSV-infected male mice 
remain in a persistently activated/inflammatory state and knockdown of TSLP signaling abrogates 
this phenotype.  Furthermore, ATAC-seq data indicated that changes in the BMDC were linked to 
accessibility of the chromatin landscape in WT vs TSLPR-/- mice and showed links to genes within 
the Type-1 IFN pathway, such as Mid1 as well as transcription factors involved in Th2 
pathogenesis, specifically IRF4.  In addition, we observe that RSV-infected BMDC from TSLPR-
/- mice are capable of driving strong T cell production of IFN-γ upon co-culture with T cells 
isolated from RSV-infected animals.  These data indicate that early-life RSV-infection leads to 
systemic alterations in the bone marrow related to TSLP signaling and inhibition of type-1 
interferon which may be linked to persistent transcriptional modifications. 
Finally, we examined epigenetic regulation of BMDC following RSV infection and the 
role of lysine demethylases, KDM6A/B.  Data from our previous BMDC studies, indicated that 
BMDC isolated at 4 weeks post-early-life RSV-infection retain upregulation of the epigenetic 
enzyme, Kdm6b, even at baseline; therefore, we further examined the role of the Kdm6 family of 
enzymes during RSV infection.  We hypothesized that RSV infection will lead to the upregulation 
of the H3K27 demethylases, KDM6A and KDM6B that will alter BMDC phenotype leading to 
RSV-driven immunopathology.  These data show that following RSV infection in vivo, KDM6A/B 






BMDC are also capable of upregulating these enzymes following RSV infection.  The inhibition 
of KDM6 enzymatic activity by GSK J4 leads to a decrease in pro-inflammatory cytokine and 
chemokine expression in BMDC and a shift in T cell response, partially through alteration of APC 
function (decreased expression of CD86 and MHCII).  Airway sensitization of naïve mice with 
RSV-infected BMDCs exacerbated a live challenge with RSV infection but this exacerbation was 
inhibited when BMDCs were treated with GSK J4 prior to sensitization.  Finally, in vivo treatment 
with GSK J4 during RSV infection reduced inflammatory CD11c+ DC (CD11b+/MHCII+ and 
CD11b+/CD86+) in the lungs along with IL-13 levels and overall inflammation. These results 
suggest that KDM6 expression in DC enhances pro-inflammatory innate cytokine production to 







Chapter 2:  Sex-Associated TSLP-Induced Immune Alterations Following 
Early-Life RSV Infection Leads to Enhanced Allergic Disease 
2.1. Abstract  
Many studies have linked severe RSV infection during early-life with an enhanced likelihood of 
developing childhood asthma, showing a greater susceptibility in boys. Our studies show that 
early-life RSV infection leads to differential long-term effects based upon the sex of the neonate; 
leaving male mice prone to exacerbation upon secondary allergen exposure while overall 
protecting female mice. During initial viral infection, we observed better viral control in the female 
mice with correlative expression of interferon-β that was not observed in male mice. Additionally, 
we observed persistent immune alterations in male mice at 4 weeks post infection. These 
alterations include Th2 and Th17-skewing, innate cytokine expression (Tslp and Il33), and 
infiltration of innate immune cells (DC and ILC2). Upon exposure to allergen, beginning at 4 
weeks following early-life RSV-infection, male mice show severe allergic exacerbation while 
female mice appear to be protected. Due to persistent expression of TSLP following early-life RSV 
infection in male mice, genetically modified TSLPR-/- mice were evaluated and demonstrated an 
abrogation of allergen exacerbation in male mice. These data indicate that TSLP is involved in the 
altered immune environment following neonatal RSV-infection that leads to more severe 
responses in males during allergy exposure, later in life. Thus, TSLP may be a clinically relevant 








Respiratory syncytial virus (RSV) is often the first clinically relevant pathogen 
encountered, with nearly all children infected during the first 2 years of life1,2.  This viral infection 
is the leading cause of childhood hospitalization and increases the risk for developing childhood 
asthma and recurrent wheezing1,3. The health burden costs of RSV infection account for over 3 
million hospitalizations and approximately 100,000 deaths per year in children under 5, 
worldwide20,21. Recent pre-clinical and clinical data, including data from our laboratory, suggest 
that severe RSV disease is associated with an altered innate and adaptive immune response, 
characterized by excessive Th2 and Th17 immune responses20,31–36.  Numerous studies have shown 
that RSV plays a role in reducing innate cytokine production that is necessary for appropriate anti-
viral responses20,35,37,38.  Both viral replication as well as immunopathology can lead to RSV 
disease symptoms and probing these and potentially other underlying disease mechanisms that are 
supported by clinical data will be important for therapeutically targeting the immune environment.   
During a viral infection, the immune response is strongly dictated by dendritic cells (DC) 
because they activate the immune system and instruct T cells toward distinct T helper type 
responses 44.  RSV can skew the immune response away from anti-viral and towards a Th2-type 
response by inhibiting the production of IFN-β and subsequently decreasing the Th1 pro-
inflammatory response45.  This lack of an anti-viral response as well as skewing towards 
dysregulated Th2/Th17 has been correlated with severe disease20,31,35, leading to airway 
restructuring linked to exacerbated allergic responses later in life93.  Up to 48% of infants who 
were hospitalized for severe RSV-associated bronchiolitis and/or lower respiratory tract infection 
go on to develop asthma during their childhood94,95.  Asthma is the most common chronic 






million children under 596. During childhood, males have higher occurrences of asthma and 
wheezing than do females at a 2:1 ratio97.  Additionally, males are approximately twice as likely 
to become hospitalized than females due to severe RSV infection23.  Thus, the risk for severe RSV 
infection and RSV-associated asthma development is higher in males than in females98. 
 How RSV alters the immune system to influence these observed responses is currently not 
well defined.  Previous studies with neonatal RSV infection have demonstrated that there are 
persistent changes in the lung that include increased mucus production and increased populations 
of immune cells. Specifically, type 2 innate lymphoid cells (ILC2) are increased in RSV infected 
lungs and these cells produce IL-5 and IL-13, cytokines important in the development of 
inflammation and mucus production46,47.  Innate cytokines, including thymic stromal 
lymphopoietin (TSLP), IL-25 and IL-33 are known inducers of ILC2 differentiation39,40,76. TSLP 
is a known driver of Th2-type responses through its influence on DCs, T cells, and ILC2s 41,42,140 
and may be required for CD4+ Th2 memory42.  RSV infection has been shown to lead to increased 
expression of TSLP117,118, which has also been implicated in asthma pathogenesis141–143.  In fact, 
TSLP has been suggested as a possible biomarker in pediatric asthmatics144.  Additionally, it has 
been directly shown that RSV infection leads to activated IL-13 producing ILC2s that are 
dependent on TSLP73. However, the mechanisms by which early life RSV infection alters immune 
responses related to allergen sensitization have yet to be elucidated.   
In the present study, we examined the modulated immune responses due to neonatal RSV 
infection that include alteration of immune cell phenotypes and subsequent persistent changes 
leading to the altered development of allergic responses.  Specifically, we demonstrate for the first 
time that early-life RSV infection alters immune cell populations in neonates in a sex dependent 






resulting in enhanced allergic responses later in life. These results suggest that clinically targeting 
TSLP during early-life RSV exposure may prevent RSV-induced immune environment changes 
and thus may decrease the incidence of childhood asthma. 
2.3. Materials and Methods  
2.3.1. Animals 
All experiments involving the use of animals were approved by the University of Michigan animal 
care and use committee. Male and female BALB/c mice, 6 to 8 weeks of age, were purchased from 
The Jackson Laboratory (Bar Harbor, ME) and used as breeders for experimental animals. TSLPR-
/- mice were kindly provided by Dr. Steven Ziegler and adult mice bred in-house were used as 
breeders. Male and female mice (WT and TSLPR-/-), born in-house were used for all experiments. 
All mice were maintained under standard pathogen-free conditions. 
2.3.2. RSV-infection 
A chimeric RSV A2 strain with recombinant Line19 fusion protein was used for all experiments 
as previously described145. Male and female Balb/c and TSLPR-/- mice were infected intranasally  
(5 µL/animal) with 1.5 x 105 pfu of RSV A2/L19-F at 7 days of age.   
Analysis of the viral response was performed at 2-8 days and 14 days post-infection to determine 
primary response and resolution, respectively.  Long-term analysis was performed at 4 weeks post-
infection (Figure 2-1). 
 







2.3.3. Mouse Cockroach Allergen (CRA) Asthma Model 
The allergen used was a clinical grade, skin test cockroach allergen (CRA) (Hollister-Stier, 
Spokane, WA) as previously described146,147. Mice were sensitized intratracheally with 500 protein 
nitrogen units (pnu) of CRA, over 3 consecutive days. Next, mice were challenged intratracheally 
with 500 pnu of CRA on days 14, 20, 22, and 23 after initial CRA sensitization. On day 24, one 
day after the last allergen challenge, animals were sacrificed, and samples were taken. The same 
model was used in the TSLPR-/- mice.   
2.3.4. Quantitative RT-PCR  
Lung tissue was homogenized in TRIzol reagent and RNA was extracted using TRIzol reagent 
(Invitrogen, Carlsbad, CA). cDNA was synthesized using murine leukemia virus reverse 
transcriptase (Applied Biosystems, Foster City, CA) and incubated at 37 ̊C for one hour, followed 
by incubation at 95 ̊C for 10 min to stop the reaction. Real-time quantitative PCR (qPCR) was 
multiplexed using Taqman primers, with a FAM-conjugated probe to measure transcription of 
Gob5, Muc5ac, Il4, Il5, Il13, Il17a, Ifng, Tslp, Il25, Il33. Fold change was quantified using 2-ΔΔ 
cycle threshold (CT) method. Custom primers were designed to measure Muc5ac and Gob5 
mRNA levels as described120.  All reactions were run on a 7500 Real-Time PCR System (Applied 
Biosystems). 
2.3.5. Lung Histology 
The 2 middle lobes of the right lung were perfused with 10% formalin for fixation and embedded 
in paraffin. Five-micrometer lung sections were stained with periodic acid-Schiff (PAS) to detect 
mucus production, and inflammatory infiltrates. Photomicrographs were captured using a Zeiss 






2.3.6. Flow Cytometry  
The lungs were removed, and single cells were isolated by enzymatic digestion with 2.5 mg/ml 
LiberaseTM (Roche) and 20 U/ml DNaseI (Sigma, St. Louis, MO) in RPMI 1640 for 45 min at 
37°C or 1 mg/mL collagenase (Roche) and 20 U/ml DNaseI (Sigma, St. Louis, MO) in RPMI 1640 
+ 10% FCS for 60 min at 37°C. Tissues were further dispersed through an 18-gauge needle (5-ml 
syringe), RBCs were lysed and samples were filtered twice through 100-µm nylon mesh. Cells 
were resuspended in PBS.  Live cells were identified using LIVE/DEAD Fixable Yellow Dead 
Cell Stain kit (Thermo Fisher Scientific, Waltham, MA), then washed and resuspended in PBS 
with 1% FCS.  Fc receptors were blocked with purified anti-CD16/ 32 (clone 93; BioLegend, San 
Diego, CA). Surface markers were identified using Abs (clones) against the following antigens, 
all from BioLegend: anti-Cd11c (N418), MHC II (M5/114.15.2), Cd11b (M1/70), OX-40L 
(RM134L), Cd3 (145-2C11), Cd4 (GK1.5), Cd8 (53-6.7), Cd25 (3C7), Cd90 (53-2.1), cKit (2B8), 
ST2 (D1H9), Gr-1 (RB6- 8C5), B220 (RA3-6B2), Ter119 (Ter-119). For innate lymphoid cell 
staining, lineage markers were anti-CD3, CD11b, B220, Gr-1, and TER119. ILC2: CD45+/Lin-/ 
CD90+/ ST2+. Data was collected using a NovoCyte flow cytometer (ACEA Bioscience, Inc. San 
Diego, California). Data analysis was performed using FlowJo software (Tree Star, Oregon, USA).    
2.3.7. Mediastinal lymph nodes in vitro restimulation and cytokine production assay 
Mediastinal lymph nodes (mLN) were enzymatically digested using 1 mg/ml collagenase A 
(Roche) and 20 U/ml DNaseI (Sigma-Aldrich) in RPMI 1640 with 10% FCS for 45 min at 37°C. 
Tissues were further dispersed through an 18-gauge needle (1-ml syringe). RBCs were lysed, and 
samples were filtered through 100-µm nylon mesh. Cells (5 × 105) from mLN cells were plated in 






IL-4, IL-5, IL-13, Il-17a and IFN-γ levels in supernatants were measured with a Bio-Plex cytokine 
assay (Bio-Rad Laboratories). 
2.3.8 RNAscope for formalin fixed paraffin embedded (FFPE) tissue 
Lungs were perfused with 10% formalin for fixation and embedded in paraffin (FFPE). RNAscope 
2.5 duplex detection kit for FFPE samples (ACDbio, Newark, CA) was used to perform RNAscope 
as previously described148.  Probes to detect Tslp (target region 10-1149) and Il33 (target region 
2-947) were used with green chromogen detection.   
2.3.9. Measurement of airway hyperreactivity 
Airway hyperreactivity was measured using mouse plethysmography, that is specially designed 
for the low tidal volumes (Buxco Research Systems), as previously described121,146. Briefly, the 
mouse to be tested is anesthetized with sodium pentobarbital and intubated via cannulation of the 
trachea with an 18-gauge metal tube. The intubated mouse was ventilated at a volume of 200 µL 
at a rate of 120 breaths/min. The airway resistance was measured in the closed plethysmograph by 
directly assessing tracheal pressure and comparing the level to corresponding box pressure 
changes. These values were monitored and immediately transformed into resistance measurements 
using computer-assisted calculations. Once baseline levels had stabilized and initial readings were 
taken, a methacholine challenge was given via iv tail vein injection (375 µg/kg of methacholine) 
as previously described121,146. After the methacholine challenge, the response was monitored, and 
the peak airway resistance was recorded as a measure of airway hyperreactivity.  
2.3.10. Mucus Scoring Analysis 
Slides from PAS-stained lungs were blind-coded and scored by an individual observer to quantify 






airways with goblet cell hyperplasia and mucus; 3 = Moderate:  Multiple airways with significant 
mucus and some plugging; 4 = Severe: significant Mucus plugging. 
2.3.11. Statistical analysis 
Data were analyzed by Prism 7 (GraphPad Software). Data presented are mean values ± SEM. 
Comparison of two groups was performed with an unpaired, two-tailed Student t-test. 
Comparison of three or more groups was analyzed by one-way ANOVA, followed by two-tailed 
Student t-test for individual comparisons. A p-value <0.05 was considered significant. 
2.4. Results 
2.4.1. Neonatal RSV infection of male and female mice leads to a strong Th2/Th17-type 
immune response with delayed resolution in male mice  
To evaluate the immune response to early-life RSV infection, male and female neonatal mice were 
infected intranasally with RSV (A2/L19-F (1.5 x105 pfu)) at 7 days of age (Figure 2-1).  Following 
infection, both males and females had mucus and inflammation present within their lungs peaking 
around 4-8 days post-infection with decreased mucus observed by 14 days post-infection (Figure 
2-2A,B). Age-matched male and female control mice show little to no signs of mucus production 
within the lungs at these time points (Appendix 1; Figure A1-1A,B), indicating viral induction of 
mucus. Additionally, at 14 days post-infection, lymphoid aggregates or bronchus associated 
lymphoid tissue (BALT) was observed in male mice, but not female mice (Figure 2-2A).  An 
increase in viral gene expression was observed in male compared to female mice on day 4 of 
infection (Figure 2-2C) with female but not male mice having an increase in interferon-β gene 
expression (Figure 2-2D), a critical cytokine required for viral clearance15.  Lung draining lymph 
nodes, harvested from neonatally-infected mice at 8 days post RSV-infection, showed a strong 






(Figure 2-2E).  However, upon analysis at 14 days post-infection, males showed higher cytokine 
responses in restimulated lymph nodes compared to females (Figure 2-2F).  These data indicate 
that both male and female neonatal mice elicit an RSV-driven Th2/Th17-type immune response 
but male mice displayed a lack of viral control with a delay in immune contraction compared to 
female mice.   
 
Figure 2- 2. Neonatal RSV infection of male and female mice leads to a strong Th2/Th17-type immune response with 
delayed resolution in male mice.   
Male and Female mice were infected with RSV at 7 days of age and tissues collected at 2, 4, 8 or 14 days post-infection to evaluate 
primary response and resolution of Th2/Th17 response.  A, B.  Lungs were embedded in paraffin and Periodic acid-Schiff stain 
(PAS) was performed to visualize mucus (bright pink staining) Representative photos shown. C, D.  Lungs were homogenized and 
A
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Figure 2
Male RSV 2 dpi Male RSV 4 dpi





















































































































mRNA extracted to determine RSV F and interferon-β gene expression, respectively (N ≥ 3) E, F. Lung draining lymph nodes 
were processed into single cell suspension and re-stimulated with RSV in vitro for 48 hours to determine cytokine protein levels 
(N ≥ 4). Data represent Mean ± SEM (Representative of at least 2 individual experiments). * = p < 0.05 
 
2.4.2. Male mice infected with RSV during early-life show signs of lung immunopathology 
that persists for up to 4 weeks post-infection  
Further evaluation of persistent immune alterations was performed at later time points after 
neonatal RSV infection in male and female mice (Figure 2-1).  Uninfected, age-matched (5-week 
old) mice were used as controls and no differences were observed between the sexes (Appendix 
1; Figure A1-2).  However, significant differences were observed at 4 weeks post-early-life RSV-
infection, with persistent lung immunopathology, including visible signs of mucus still present in 
the lungs of male mice (Figure 2-3A) but not female mice (Figure 2-3B). In correlation with lung 
pathology, males had increased expression of the mucus gene, muc5ac, compared to neonatally 
RSV-infected females (Figure 2-3C).  The number of mice that displayed visible mucus and 
overexpressed muc5ac compared to naïve at 4 weeks post-infection was 78% of early-life infected 
male mice (7/9) and 15% of female mice (2/13) (Figure 2-3C).  In addition, the results showed 
persistent gene expression of Th2-type and Il17a in males compared to females (Figure 2-3D). 
Innate cytokines TSLP, IL-25 and IL-33, which are all strong drivers of Th2-type 
responses113,149,150 were also evaluated and indicated that early life RSV infected male mice 
showed persistent gene expression of Tslp and Il33 compared to female mice (Figure 2-3E). To 
determine the location of the Tslp and Il33 within the male lungs, as these cytokines are strongly 
linked to asthma pathogenesis, studies were performed using RNAscope technology. Tslp 
expression was observed within the bronchial airway epithelial cells, while Il33 was limited to the 
alveolar epithelial cell areas (Figure 2-3F-K). Thus, early-life RSV infection in male mice leads 
to persistent Th2/Th17 skewing within the local lung environment, while females resolve this 







Figure 2- 3. Male mice infected with RSV during early-life show signs of lung immunopathology that persists for up to 4 
weeks post-infection.   
Male and Female mice were infected with RSV at 7 days of age and tissues collected at 4 weeks post-infection to evaluate long-
term alterations. A,B. Lungs were embedded in paraffin and Periodic acid-Schiff stain (PAS) was performed to visualize mucus 
(bright pink staining).  Representative photos shown C-E. Lungs were homogenized and mRNA extracted to determine gene 
expression compared to age/sex-matched uninfected controls (N = ≥ 9) F-K.  RNAscope was performed to determine location of 
Tslp and Il33 within male lungs (stained in green). Representative photos shown. Data represent Mean ± SEM (Representative of 












































































































2.4.3. Differential immune cell populations in the lungs of male and female mice with early-
life RSV infection 
Due to the persistent immunopathology observed in the lungs from early-life RSV-infected male 
mice, we next examined immune cell populations that may lead to these alterations at 4 weeks 
post-infection.  Age-matched (5-week old) naïve animals were used as controls.  Naïve male and 
female animals showed similar immune cell populations at 5 weeks of age, indicating no inherent 
differences between the sexes. In contrast, lungs from male mice at 4 weeks post-neonatal RSV 
infection contained increased Cd11c+/Cd11b+ and Cd103+ DC populations (Figure 2-4A,B).  
Interestingly, female mice at 4 weeks post-neonatal RSV infection also have decreased Cd103+ 
DC compared to naïve female mice (Figure 2-4B). Additionally, early-life RSV infected males 
contain significantly more OX-40L+ cells than early-life infected females (Figure 2-4A-C), which 
have been implicated in severe neonatal RSV responses as well as asthma118,151,152. We also 
observed that males had significantly more ILC2, which can produce Th2-type cytokines (Figure 
2-4D,E).  However, no differences were observed in CD4+ or CD8+ T cells (Figure 2-4F,G). This 
phenotypic immune alteration in males may allow for the continued production of potentially 







Figure 2- 4. Differential immune cell populations in the lungs of male and female mice with early-life RSV infection.   
Male and Female mice were infected with RSV at 7 days of age and lungs collected at 4 weeks post-infection to evaluate cell 
populations.  Lungs were processed into single-cell suspension and stained for flow cytometry analysis. A. Gating strategy for 
dendritic cells B.  CD11c+ dendritic cell types (N ≥ 9) C. OX-40L+ cells (N ≥ 9) D. Gating strategy for innate lymphoid cells E. 
Innate lymphoid cell populations (N = 5) F.  Gating strategy for T cells G.  T cell populations (N ≥ 9). Data represent Mean ± SEM 
(Representative of or pooled from 2 individual experiments). * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. 
 
2.4.4. Early-life RSV infection leads to exacerbated allergic response in male mice  
Five-week old mice that were previously infected with RSV at 7 days of age were sensitized and 






immune response to allergens later in life (RSV/CRA).  CRA was administered via intratracheal 
instillation into the lungs over 3 consecutive days, starting at 4 weeks post-infection, followed by 
4 challenges 2 weeks later to elicit an allergic response (Figure 2-5A).  Naïve age-matched animals 
were used as controls and administered CRA in the same manner.  Lung histology showed that 
RSV/CRA males have severe pathology and increased mucus compared both to mice given only 
CRA and female mice given RSV/CRA (Figure 2-5B).  Airway hyperreactivity (AHR) was 
significantly higher in the males given RSV/CRA (Figure 2-5C) compared to all other groups 
indicating more severe lung physiology responses. A correlative increase in mucus score was also 
observed in the RSV/CRA male mice (Figure 2-5D) and interestingly, a decreased mucus score 
was observed in RSV/CRA female mice compared to both RSV/CRA male mice as well as CRA 
only female mice (Figure 2-5D). Additionally, mucus-associated genes, gob5 and muc5ac, as well 
as gene expression of Il13 were significantly increased in lungs from male mice given RSV/CRA, 
compared to female mice (Figure 2-5E).  Increased infiltration of inflammatory myeloid-type cells 
as well as ILC2 were observed in male mice given RSV/CRA compared to females given 
RSV/CRA, with no differences in T cell numbers (Figure 2-5F-G). However, analysis of the 
CRA-specific response analyzed by cytokine production from isolated lymph node cells showed 
that male mice infected with RSV during early life had significantly more Th2 and IL-17A 
cytokine production upon CRA re-challenge when compared to females, suggestive of a shift in T 
cell responsiveness to the allergen (Figure 2-5H). No differences were observed between 
uninfected males and females tested (Appendix 1; Figure A1-3), indicating that the baseline 
allergic response is equivalent between male and female mice.  Altogether, these data indicate that 








Figure 2- 5. Early-life RSV infection leads to exacerbated allergic response in male mice.  
Male and Female mice were infected with RSV at 7 days of age and secondary allergen challenge initiated at 4 weeks post-infection.   
A.  Experimental Design B. Lungs were embedded in paraffin and Periodic acid-Schiff stain (PAS) was performed to visualize 
mucus (bright pink staining).  Representative photos shown C.  AHR was determined using full-body plethysmography and 
methacholine challenge (N ≥ 3) D. Subjective mucus scoring was performed on blinded histological slides on a scale of 1-4 for 
mucus production (N ≥ 8) E.   Lungs were homogenized and mRNA extracted to determine mucus and cytokine gene expression 
compared to age/sex-matched naïve controls (N ≥ 3) F,G. Lungs were processed into single-cell suspension and stained for flow 
cytometry analysis. (N ≥ 4) H.  Lung draining lymph nodes were processed into single cell suspension and re-stimulated with CRA 
in vitro for 48 hours to determine cytokine protein levels (N ≥ 3). Data represent Mean ± SEM (Representative of or pooled from 






2.4.5. Deletion of TSLP receptor leads to decreased immune responses following CRA 
exposure in male mice with early-life RSV infection 
Based on our observed correlative evidence of TSLP expression with persistent Th2/Th17-
skewing, we evaluated the sex-associated role of TSLP in the immune exacerbation observed 
following CRA exposure in mice.  Male and female TSLP receptor knockout (TSLPR-/-) mice 
were RSV infected during early-life, followed by a CRA challenge initiated 4 weeks later (Figure 
2-5A). Histologic evaluation showed decreased mucus in the lungs of TSLPR-/- male mice 
compared to WT male mice given early RSV followed by the CRA challenge (Figure 2-6A). 
Furthermore, AHR was decreased in TSLPR-/- male mice with a previous neonatal RSV infection 
(Figure 2-6B), indicating improved lung function compared to WT male mice. Consistent with 
histology, a decrease in mucus score (Figure 2-6C) as well as mucus gene expression (Figure 2-
6D) was observed in TSLPR-/- male mice compared to WT male mice given RSV/CRA.  The 
results also demonstrated a decrease in Il13 cytokine gene expression levels within the lungs of 
TSLPR-/- compared to WT male mice given RSV/CRA (Figure 2-6E). Correlating with the 
decreased Il13 expression, a decrease in ILC2 was observed in the TSLPR-/- male mice given 
RSV/CRA (Figure 2-6F) with no changes in CD4+ T cell numbers (Figure 2-6G,H).  
Additionally, male TSLPR-/- RSV-infected/CRA challenged mice had decreased CRA-specific 
Th2 cytokine production in the lung draining lymph nodes compared to WT mice (Figure 2-6I). 
Of interest, similar to previous studies153, we found no difference in the male or female mice given 
only CRA when TSLPR-/- mice were compared to WT mice (Appendix 1; Figure A1-3), 
suggesting that the TSLP-induced environment created by an early life RSV infection was critical. 
Importantly, unlike male mice, females were not exacerbated following RSV-infection alone and 







Figure 2- 6. Deletion of TSLP receptor leads to decreased immune responses following CRA exposure in male mice with 
early-life RSV infection.   
Male and Female TSLPR-/- mice were infected with RSV at 7 days of age and secondary allergen challenge initiated at 4 weeks 
post-infection. A. Lungs were embedded in paraffin and Periodic acid-Schiff stain (PAS) was performed to visualize mucus (bright 
pink staining).  Representative photos shown B.  AHR was determined using full-body plethysmography and methacholine 
challenge (N ≥ 3) C. Subjective mucus scoring was performed on blinded histological slides on a scale of 1-4 for mucus production 
(N ≥ 6) D, E. Lungs were homogenized and mRNA extracted to determine mucus and cytokine gene expression compared to 
age/sex-matched naïve controls (N ≥ 3) F-H. Lungs were processed into single-cell suspension and stained for flow cytometry 
analysis (N ≥ 3) I.  Lung draining lymph nodes in single cell suspension were re-stimulated with CRA in vitro for 48 hours to 
determine cytokine protein levels (N≥ 3). Data represent Mean ± SEM (Representative of or pooled from 2-3 individual 








Clinically, data suggest that severe RSV infection during early-life enhances the likelihood 
of developing childhood asthma by 3-5 fold1,154.  Most children are infected with RSV within the 
first 2 years of life and up to 3-5% of children become hospitalized due to complications from 
severe disease23. Studies suggest that ~50% of children hospitalized during severe RSV infection 
go on to develop childhood asthma94,95. Additionally, clinical data show that boys are more 
susceptible to RSV, hospitalized at a 2:1 ratio compared to girls, and are more than twice as likely 
to develop childhood asthma2,23,155. Here we show that male mice infected neonatally with RSV 
have poorer viral control than female mice of the same age and that at 4 weeks post-early-life 
RSV-infection, male mice show a persistent signature of RSV-driven Th2/Th17 
immunopathology, mucus and an altered immune environment that leads to an exacerbated allergic 
phenotype associated with TSLP driven mechanisms.  Thus, these studies outline 2 important 
concepts; 1) early RSV infection results in an altered immune phenotype in the lung that is 
dependent upon sex; and 2) the persistence of the early innate cytokine, TSLP, has a role in the 
altered immune environment and may be a clinically relevant target early in life. 
TSLP is an early responding, innate cytokine, that can drive Th2-type responses and is 
upregulated following RSV infection of lung epithelial cells117. During neonatal RSV-infection, 
TSLP mediates immunopathology through OX-40/Th2 signaling118, as well as having direct 
effects upon ILC2 cells, causing them to produce Th2-type cytokines, IL-5 and IL-13 to enhance 
inflammation and mucus production73. When TSLP was neutralized during neonatal RSV 
infection, the severity of a later exacerbated RSV infection was mitigated118, indicating that TSLP 
may be creating a broadly altered immune environment. Additionally, TSLP has been implicated 






directly correlates with degree of airflow obstruction104 and GWAS studies show a strong 
association between TSLP and severe asthma105,106. The TSLP SNP, rs1837253 on the T allele, 
which leads to decreased epithelial cell production of TSLP, has been identified in boys to reduce 
the risk of developing atopic asthma and airway hyperresponsiveness as well as protection from 
allergic rhinitis156–158. This same TSLP mutation shows no protective effect in girls, suggesting 
that the role of TSLP in asthma may be more significant in boys than girls. Our data expands on 
these clinical findings, showing a significant correlation between RSV-induced TSLP and the 
subsequent development of viral-associated allergic asthma later in life in male mice, following 
early-life RSV-infection.  
TSLP has a wide range of immune cell targets, including ILC2, DC and T cells.  The initial 
biologic function of TSLP demonstrated that it interacted with DC to promote Th2 cell 
differentiation and thus promoted allergic disease113,114. TSLP stimulation of CD11b+ DC 
upregulates OX-40L that interacts with OX-40 on CD4 T cells to promote a Th2 response151,152. 
The survival and maintenance of ILC2 that produce Th2-type cytokines, depends on the presence 
of TSLP159,160. In addition, TSLP signaling instructs DCs to produce CCL-2241, a chemokine that 
recruits Th2 cells through its interaction with the CCR4 receptor.  Finally, in response to TSLP, 
DCs will themselves produce TSLP that further interacts with DCs and ILC2, creating a feedback 
loop that is independent of epithelial cell-derived TSLP115,116. The data provided in our studies, 
using TSLPR-/- mice, indicated that TSLP signaling is responsible for the increased presence of 
innate immune cells in the lungs of male mice conditioned with a neonatal RSV infection. 
Interestingly, the TSLPR-/- mice had a similar allergen response in the lungs compared to WT 
male and female mice when no neonatal RSV infection was given. These data recapitulate previous 






allergen responses are not altered in its absence153. Similarly, TSLP was not necessary to develop 
chronic Th2 driven parasitic helminth granulomatous responses161. Thus, TSLP may be central to 
the development of chronic type 2 immune responses when a stimulus, such as RSV infection, 
promotes an altered immune environment that predisposes tissue to development of allergic 
responses. This is likely more significant in neonates that have an immature immune environment 
that can be more easily skewed to an altered immune phenotype.  
The upregulation of another innate cytokine, IL-33, was also associated with the early RSV 
infection in male mice.  While we have not further explored the role of IL-33 in the sex difference 
in the altered immune environment, it may also contribute. Interesting, the expression of TSLP 
mRNA was more highly evident and associated with bronchial epithelial cell area in male mice at 
4-weeks post-infection, whereas IL-33 appeared to be more contained and associated with alveolar 
areas as assessed by RNAscope.  Many studies have indicated a role for these innate cytokines in 
respiratory viral complications, asthma development, as well as viral exacerbations of existing 
asthma99–101. It is evident that these cytokines have distinctive as well as additive effects on ILC2 
responses76,102,159.  Allergen challenge, following neonatal rhinovirus infection identified that both 
IL-33 and TSLP are required for IL-25-induced ILC2 production of IL-13 leading to mucus 
metaplasia but TSLP was necessary for maximal ILC2 gene expression even in the presence of IL-
25 and IL-3376.  Additionally, experimental asthma pathogenesis was shown to persist in IL-33R 
knockout mice (ST2-/-) due to increased expression of TSLP that enhanced ILC2 production of 
IL-13; abrogation of this response was only possible with the addition of an anti-TSLP antibody102.  
Finally, in an allergen challenge model conducted on adult human subjects with allergic asthma, 
administration of an anti-TSLP monoclonal antibody (AMG 157) reduced allergen-induced 






airway responses in asthmatics103. Collectively, these studies as well as our data presented here 
make it plausible that TSLP, IL-25 and IL-33 cooperate and regulate each other during initial 
disease progression but TSLP may be more significant in the development of subsequent diseases 
later in life.  Given the availability of anti-TSLP in human trials, a therapeutic intervention in 
infants with severe RSV may be highly beneficial, especially for boys. 
These novel data recapitulate the clinical observations where males are more likely to 
develop severe respiratory complications and childhood asthma than are girls.  This suggests that 
early-life RSV-infection in males leads to persistent TSLP-associated Th2/Th17 immune-driven 
pathology within the lungs, while the same early-life infection in females allows for appropriate 
Th2/Th17 resolution thereby protecting females from later asthma pathogenesis. This phenomenon 
may be due to poorly controlled viral replication and decreased viral clearance in males following 
the initial infection, possibly due to lack of type-1 interferon production, which is critical for viral 
clearance as well as resolution of Th2/Th17 immune responses15,162,163. Correlating with our 
findings, it has previously been shown that female plasmacytoid dendritic cells (pDC) isolated 
from human peripheral mononuclear cells express higher levels of type-1 interferons (IFNa/b) 
compared to male pDC following TLR7 stimulation164.  While another study has shown that type-
3 interferon (IFNl) has the ability to upregulate TSLP expression165, the role of type-1 interferons 
and TSLP has not been fully elucidated. Furthermore, previous studies with bronchial epithelial 
cells from asthmatics have shown that TSLP and interferon-β have an inverse relationship, 
showing a bias towards low interferon- β but high TSLP, while the reverse is true for healthy 
individuals166.  These results may suggest that targeting TSLP during early-life RSV infection, 
especially in male infants hospitalized with severe disease, may limit these changes and may 






Chapter 3:  Early-Life RSV Infection Leads to Long-Term Systemic 
Alterations of BMDC Through Persistent Expression of TSLP 
3.1. Abstract  
Many studies have linked severe RSV infection during early-life with enhanced immune responses 
upon secondary exposures, such as during RSV re-infection and childhood asthma.  Innate immune 
cell populations (i.e. antigen presenting cells) have been shown to be capable of immune memory 
following pathogen exposure that leads to alterations of the immune response later in life. Here we 
show that long-term systemic alterations are occurring following early-life RSV-infection. Bone 
marrow-derived dendritic cells (BMDC) isolated from early-life RSV-infected male mice at 4 
weeks post-infection retained expression of maturation markers, such as Cd80/86 and Ox40l.  
Chemokines and cytokines associated with the inflammatory response during RSV infection were 
also persistently expressed (i.e. Ccl3, Ccl5, Il6) along with Kdm6b and Tslp, previously shown to 
lead to enhanced inflammatory responses as well as secondary responses following RSV-infection, 
respectively.  The addition of recombinant TSLP to naïve BMDC cultures showed a similar 
response to BMDC isolated from early-life RSV mice, indicating a role for TSLP in the persistent 
BMDC phenotype.  Furthermore, knockdown of TSLP signaling using TSLPR-/- male mice 
abrogated this activated phenotype and led to enhanced Th1 responses.  Finally, ATAC-seq data 
indicated differences in the chromatin landscape of WT and TSLPR-/- BMDC, showing more 
“open” regions of chromatin near anti-viral type-1 genes (Mid1, Spp1, Cxcl11) in TSLPR-/- 
BMDC while more accessibility was observed near genes linked to RSV disease (Cxcl1, Cxcl2, 






type response and TSLP signaling.  These data indicate that TSLP is involved in persistently 
altering the immune system in the bone marrow following early-life RSV-infection, leading to 
altered immune responses later in life.  Thus, targeting TSLP during early-life may be clinically 
relevant. 
3.2. Introduction 
Respiratory syncytial virus (RSV) is a ubiquitous pathogen that infects nearly all infants by age 
two, is the leading cause of bronchiolitis in children worldwide1,2 and is the second most likely 
cause of death in children under the age of one by a single pathogen24.  According to the CDC, 
approximately 60,000 pediatric hospitalizations in children under the age of 5 in the United States 
each year are due to RSV, estimating an annual cost of over $300,000,0002,20,167 making RSV a 
significant source of morbidity and health care burden. Currently, no vaccine against RSV is 
available and research in this area has been slow and cumbersome due to a lack of significant 
understanding of the virus as well as previous vaccine trial failure.  In the late 1960s, attempts to 
vaccinate children with formalin-inactivated RSV vaccine caused severe exacerbated disease upon 
re-infection with live RSV due to enhanced inflammatory disease and mucus production25–27. 
Furthermore, several epidemiological studies link severe RSV infection with the later development 
of hyper-reactive airway disease, including asthma, that persists even years after the initial viral 
infection has resolved1,3,20.  The inability to properly respond to RSV infection in these patients 
may be due to altered innate immune responses that can determine the subsequent pathogenic 
responses. 
RSV can skew the immune response away from anti-viral and towards a Th2-type response 
by inhibiting dendritic cell production of IFN-β and subsequently decreasing the less pathogenic 






dysregulated Th2/Th17 has been correlated with severe disease20,31,168, leading to airway 
alterations linked to exacerbated allergic responses later in life 93. Many studies over the years 
have identified several DC-linked chemokines (CCL2, CCL3, CCL5, CxCL1, CxCL2) that 
contribute to the pathogenesis of asthmatic disease, the RSV-induced exacerbation, and the 
clearance and resolution of the ongoing pathology7,92,119.  It has previously been identified that 
RSV-exposed mDC are sufficient to promote a more severe and accelerated disease environment 
when exposed to allergens37,89.  Understanding how RSV infection influences DC function to alter 
the immune environment is critical to understanding how these responses impact pulmonary 
pathogenesis, leading to exacerbations later in life. It is likely that RSV uncovers an underlying 
phenotype to reinforce the immune environment by further altering pathogenic immune responses, 
possibly through the phenomenon of trained immunity.   
How RSV alters the immune system to influence these observed responses is currently not 
well-defined.  Previous studies with neonatal RSV infection, including those from our laboratory, 
have demonstrated that there are persistent changes in the lung that include increased mucus 
production, increased populations of immune cells and persistent expression of inflammatory 
cytokines47,91,169. Specifically, the innate cytokine, thymic stromal lymphopoietin (TSLP), a 
known driver of Th2-type responses through its influence on DCs, T cells, and ILC2s 41,42,140 is 
persistently expressed169.  RSV infection has been shown to lead to increased expression of 
TSLP117,118, which has also been implicated in asthma pathogenesis141–143.  Our lab has previously 
shown that male mice infected neonatally with RSV have poorer viral control than female mice of 
the same age and that at 4 weeks post-early-life RSV-infection, male mice show a persistent 
signature of RSV-driven Th2/Th17 immunopathology, mucus and an altered local immune 






driven mechanisms169.  Additionally, it has been directly shown that TSLP interacts with the 
transcription factor IRF4 to drive DC-specific Th2 responses170,171  as well as ILC2-linked Th2 
lung repair and disease140,172. However, whether early life RSV infection has the ability to 
persistently alter the systemic immune system has yet to be elucidated.     
In the studies in this chapter, we examined TSLP-driven modulated systemic immune 
responses due to neonatal RSV infection that include persistent alteration of BMDC cell 
populations.  Specifically, we demonstrate that RSV infection leads to persistent upregulation of 
TSLP in BMDC, leading to a persistently “activated” phenotype, including upregulation of 
maturation markers (CD80/86 and OX-40L) and the continued expression of inflammatory 
cytokines and chemokines.  Knockdown of TSLP signaling abrogates this activated phenotype, 
leaving the BMDC population in a similar activation state as naïve BMDC and allowing for T cell 
production of IFN-γ.  Furthermore, ATAC-seq analysis determined that WT BMDC have less 
accessibility in promoter regions near type-1 immune genes, suggesting decreased ability of these 
BMDC to mount the appropriate anti-viral response in the presence of TSLP. These data indicate 
that TSLP is involved in inhibition of the anti-RSV response as well as persistently altering the 
immune system at a systemic level in the bone marrow following early-life RSV-infection leading 
to trained immunity.  Thus, targeting TSLP and overall DC function may be crucial for limiting 
long-term RSV-driven disease pathologies. 
3.3. Materials and Methods  
3.3.1. Animals 
All experiments involving the use of animals were approved by the University of Michigan animal 
care and use committee (protocol PRO0000888, exp. 02/14/2022). Male and female BALB/c mice, 






breeders for experimental animals and for collection of adult BMDC. TSLPR-/- mice on BALB/c 
background were kindly provided by Dr. Steven Ziegler and adult mice bred in-house were used 
as breeders and for collection of adult BMDC. Male neonatal mice (WT and TSLPR-/-), born in-
house were used for all early-life experiments. All mice were maintained under standard pathogen-
free conditions. 
3.3.2. RSV-infection 
A chimeric RSV A2 strain with recombinant Line19 fusion protein was used for all experiments 
as previously described145. Male and female Balb/c and TSLPR-/- mice were infected intranasally  
(5 µL/animal) with 3 x 105 pfu of RSV A2/L19-F at 7 days of age.   
Long-term analysis of BMDC was performed at 4 weeks post-infection. 
Viral stocks were grown in Hep-2 cells and concentrations determined by plaque assay. Virus was 
ultra-centrifuged (100,000xg for 30 minutes at 4°C) and re-suspended in fresh cell culture media 
(RPMI 1640 supplemented with 10% fetal calf serum (FCS), L-glutamine, penicillin/streptomycin, 
non-essential amino acids, sodium pyruvate, 2-mercaptoethanol (ME)) or saline prior to use.  
3.3.3.  Bone Marrow-Derived Dendritic Cells and Co-culture with CD4+ T cells   
Bone marrow was collected by flushing the femur and tibia of hind legs with RPMI 1640 
supplemented with 10% fetal calf serum (FCS), L-glutamine, penicillin/streptomycin, non-
essential amino acids, sodium pyruvate, 2-mercaptoethanol (ME). BMDCs were grown in RPMI 
1640 supplemented with 10% FCS, L-glutamine, penicillin/streptomycin, non-essential amino 
acids, sodium pyruvate, 2-mercaptoethanol (ME) and 10 ng/ml of recombinant murine granulocyte 
macrophage-colony stimulating factor (GM-CSF; R&D Systems, Minneapolis, MN, USA). For 
studies using recombinant TSLP (rTSLP), 20 ng/mL of rTSLP (R&D Systems, Minneapolis, MN, 






GM-CSF. On Day 6, cells were cultured with RSV (MOI = 1). At 24 hours, cells were collected 
in TRIzol reagent and mRNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) for 
quantitative RT-PCR. For some experiments, CD4+ T cells were isolated from the lymph nodes of 
RSV-infected Balb/c mice or spleens from naïve DO-11 mice using the T cell isolation II kit 
(Miltenyi Biotec). Cells were then cultured with the treated BMDCs. For DO-11 cells, co-culture 
was performed in the presence of ovalbumin peptide 323-339 (10 µg/mL; Invivo Gen, San Diego, 
CA).  At 48 hours, the supernatant was collected and protein levels were measured with a Bio-
Plex cytokine assay (Bio-Rad Laboratories, Hercules, CA). 
3.3.4. Quantitative RT-PCR  
cDNA from BMDC mRNA (described above) was synthesized using murine leukemia virus 
reverse transcriptase (Applied Biosystems, Foster City, CA) by incubation at 37 ̊C for one hour, 
followed by incubation at 95 ̊C for 10 min to stop the reaction. Real-time quantitative PCR (qPCR) 
was measured using Taqman primers, with a FAM-conjugated probe to measure transcription of 
Cd80, Cd86, Ox40l, Il6, Ccl2, Ccl3, Ccl5, Kdm5b, Kdm6a, Kdm6b, Tslp, Ccl17, Mid1, Cxcl1, 
Cxcl2, Irf4, Irf8, Rela, Relb, Stat3, 18s. Fold change was quantified using the 2-ΔΔ cycle threshold 
(CT) method. All reactions were run on a 7500 Real-Time PCR System (Applied Biosystems, 
Foster City, CA). 
3.3.5. ATAC-seq 
ATAC-seq was performed as previously described173. In brief, 25,000 primary bone-marrow 
derived dendritic cells were washed in cold PBS and resuspended in cytoplasmic lysis buffer 
(CER-I from the NE-PER kit, Invitrogen, cat. no. 78833 + 0.1mg/ml digitonin + protease and 
phosphatase inhibitor, Cat no. 78440). This single-cell suspension was incubated on ice for 15 






min at 4 °C. Nuclei were resuspended in 2× TD buffer, then incubated with Tn5 enzyme (0.5ul) 
for 30 min at 37 °C (Nextera DNA Library Preparation Kit; cat. no. FC-121-1031). Samples 
were immediately purified by Qiagen minElute column and PCR-amplified for 12 cycles with 
the NEBNext High-Fidelity 2X PCR Master Mix (NEB; cat. no. M0541L). qPCR was used to 
determine the optimal PCR cycles to prevent over-amplification. The amplified library was 
further purified by Qiagen minElute column and SPRI beads (Beckman Coulter; cat. no. 
A63881). ATAC-seq libraries were sequenced on the Illumina HiSeq 2500 (125-nucleotide read 
length). 
Paired-end.fastq files were uniquely aligned to the mm10 mouse genome assembly using 
Novoalign (Novocraft) (with the parameters -r None -k -q 13 -k -t 60 -o sam –a 
CTGTCTCTTATACACATCT), and converted to .bam files using SAMtools (version 1.3.1). 
Reads mapped to mitochondrial or duplicated reads were removed by SAMtools and PICARD 
MarkDuplicates (version 2.9.0), respectively. Filtered .bam files from replicates were merged for 
downstream analysis. MACS2 (2.1.1.20160309) was used to call ATAC-seq peaks. The 
coverage tracks were generated using the program bam2wig (http://search.cpan.org/dist/Bio-
ToolBox/) with the following parameters:–pe–rpm–span–bw. Bigwig files were then visualized 
using the IGV (Broad Institute) open source genome browser. 
DiffBind analysis was used to identify significant Differentially Accessible Regions (DARs) at an 
FDR of < 0.1 for all pairwise comparisons between conditions. Finally, BART analysis was used 
to identify transcription factors associated with the DAR regions174.   
3.3.6. Statistical analysis 
Data were analyzed by Prism 7 (GraphPad Software). Data presented are mean values ± SEM. 






of three or more groups was analyzed by one-way ANOVA, followed by two-tailed Student t-test 
for individual comparisons. A p-value <0.05 was considered significant. 
3.4. Results 
3.4.1. Early-life RSV infection leads to long-term systemic immune alterations in BMDC of 
male mice 
To evaluate long-term immune system alterations following early-life RSV infection, male and 
female neonatal mice were infected intranasally with RSV (A2/L19-F (3 x105 pfu)) at 7 days of 
age.  Bone marrow was collected at 4 weeks post-infection and cultured for 6 days in the presence 
of GM-SCF to differentiate myeloid-type inflammatory bone-marrow-derived dendritic cells 
(BMDC). Phenotypic characteristics were then compared to naïve age/sex-matched control mice.  
BMDC isolated from early-life RSV-infected male mice showed differences in upregulation of 
maturation/co-stimulatory markers, such as Cd80/86 as well as Ox40l (Tnfsf4), a co-stimulatory 
molecule that is critical for DC-driven Th2 responses41,175 (Figure 3-1A).  Differences in gene 
expression of cytokines related to the pro-inflammatory immune response, specifically Il6 and 
inflammatory chemokines Ccl3 and Ccl5 were observed in BMDC from both male and female 
early-life RSV-infected mice compared to naïve mice (Figure 3-1B).  Studies from our lab have 
previously shown that epigenetic enzyme demethylases, Kdm5b and Kdm6b are upregulated 
following RSV-infection of BMDC and that KDM5B leads to RSV-induced immunopathology37. 
Furthermore, KDM6 family of enzymes have been strongly linked to the inflammatory 
response134,137. We evaluated if these enzymes remain upregulated in BMDC following early-life 
RSV infection and found that Kdm6b continues to be expressed as far out as 4 weeks post-infection 
in BMDC isolated from male mice but not female mice (Figure 3-1C).  Additional studies from 






mice following early-life RSV-infection169 and TSLP has been linked to OX-40L upregulation on 
DC, leading to Th2 responses41.  Interestingly, we also see increased expression of Tslp and its 
related chemokine, Ccl17 in BMDC isolated from early-life RSV-infected male mice only (Figure 
3-1D). Upon in vitro RSV infection, significant differences were observed between BMDC 
isolated from early-life RSV-infected male mice (RSV/Male) and naive mice as well as early-life 
RSV-infected female mice (RSV/Female), with RSV/Male mice showing significantly increased 
activation and pro-inflammatory cytokine production compared to the other groups (Figure 3-
1E,F).  Interestingly, the RSV/Female BMDC response is similar to naïve BMDC following in 
vitro RSV infection (Figure 3-1E,F).  These results indicate differential long-term alterations of 
BMDC from early-life RSV infected mice, dependent upon sex.  Specifically, early-life RSV 
infected male mice have BMDC that retain signs of activation (upregulation of maturation 
markers), show differential pro-inflammatory responses compared to naïve mice, and continue to 
express the epigenetic enzyme, Kdm6b as well as Tslp that may predispose them to exacerbated 








Figure 3- 1. Early-life RSV infection leads to long-term systemic immune alterations in BMDC of male mice.  
Male and female Balb/c mice were infected neonatally with RSV (3 x 105 pfu) at 7 days of age and bone marrow collected 4 weeks 
post-infection. BMDC were cultured in the presence of GM-CSF for 6 days.  Naïve age/sex-matched animals were used as controls. 
BMDC were then plated on cell culture plates overnight, cells collected in trizol and mRNA extracted for qPCR analysis. A. 
Maturation marker expression B. Cytokine/chemokine gene expression C. Epigenetic enzyme expression D. Innate cytokine 
expression. E,F. BMDC were infected with RSV (MOI = 1) overnight, cells collected in trizol and mRNA extracted for qPCR 
analysis. Data represent Mean ± SEM (N ≥ 3; Representative of at least 2 individual experiments). * = p < 0.05; ** = p < 0.01; *** 







3.4.2. TSLP during BMDC differentiation leads to Activated DC phenotype 
Since we observed persistent expression of Tslp at 4 weeks post-infection in BMDC isolated from 
early-life RSV-infected male mice, we next sought to determine if the presence of TSLP during 
differentiation into myeloid-type DC is capable of driving the activated DC as shown above.   
BMDC were isolated from early-life RSV-infected male mice at 4 weeks post-infection as well as 
naïve age-matched controls and cultured for 6 days in the presence of GM-CSF.  Additionally, 
separate age-matched naïve BMDC cultures were exposed to recombinant TSLP starting on Day 
0, along with GM-CSF.  BMDC were then infected with RSV (MOI = 1) for 24 hours.  The addition 
of recombinant TSLP to naïve WT BMDC culture (TSLP/WT) lead to increased gene expression 
of maturation markers, such as Cd80/86 and Ox40l (Figure 3-2A) as well as increased Il6, Ccl2, 
Ccl3 and Ccl5 at the mRNA level compared to naïve WT BMDC (Figure 3-2B,C).  Furthermore, 
TSLP/WT DC expressed these activation markers and cytokines to a similar extent as BMDC 
isolated from early-life RSV-infected mice (Figure 3-2A-C).  Finally, the addition of recombinant 
TSLP also increased gene expression of key epigenetic enzymes, Kdm6a/b (Figure 3-2D).  These 
data suggest that the presence of TSLP during differentiation, such as that seen in BMDC following 
early-life RSV-infection of male mice, directly leads to enhanced/persistent activation and pro-







Figure 3- 2. TSLP during BMDC differentiation leads to activated DC phenotype. 
Male WT Balb/c mice were infected neonatally with RSV (3 x 105 pfu) at 7 days of age and bone marrow collected 4 weeks post-
infection and BMDC cultured in the presence of GM-CSF for 6 days.  Naïve age-matched animals were used as controls.  BMDC 
were then infected in vitro with RSV (MOI = 1) overnight, cells collected in trizol and mRNA extracted for qPCR analysis. A. 
Maturation marker expression B. Il6 expression C. Chemokine gene expression D. Epigenetic enzyme expression. Data represent 
Mean ± SEM (N ≥ 3; Representative of at least 2 individual experiments). * = p < 0.05; ** = p < 0.01. Naïve M + rTSLP = BMDC 
collected from age-matched naïve male animals cultured in the presence of GM-CSF + rTSLP. 
 
3.4.3. Knockdown of TSLP signaling abrogates inflammatory phenotype of BMDC from 
early-life RSV-infected male mice 
Due to correlation of TSLP with the persistent phenotypic alterations of BMDC from early-life 
RSV-infected mice shown above, we further evaluated the role of TSLP using TSLPR knockout 
(TSLPR-/-) mice.  Since a more severe phenotype was observed in BMDC from early-life RSV-
infected male mice (Figure 3-1) and it has previously been shown that male mice infected 






response169, we focused the remaining studies on male mice only. We sought to determine if 
BMDC isolated from TSLPR-/- male mice have a decreased inflammatory phenotype compared 
to WT mice following early-life RSV-infection.  Male Balb/c WT or TSLPR-/- mice were infected 
neonatally with RSV at 7 days of age and BMDC were collected at 4 weeks post-infection as 
described above.  Here we show that the expression of the co-stimulatory marker, Cd80 is 
decreased in BMDC isolated from TSLPR-/- early-life RSV-infected mice compared to WT mice 
and while not significant, a trend towards a decrease in Cd86 and Ox40l (Figure 3-3A).  
Additionally, pro-inflammatory cytokines and chemokines associated with RSV-driven 
immunopathology are decreased in BMDC from TSLPR-/- mice (Figure 3-3B) with no significant 
differences in epigenetic enzymes (Figure 3-3C).  These results indicate that loss of TSLP 
signaling protects the BMDC population from a sustained pro-inflammatory phenotype, associated 
with immunopathology following early-life RSV-infection. 
 
Figure 3- 3. Knockdown of TSLP signaling abrogates inflammatory phenotype of BMDC from early-life RSV-infected 
male mice.  
Male WT Balb/c or TSLPR-/- mice were infected neonatally with RSV (3 x 105 pfu) at 7 days of age and bone marrow collected 4 
weeks post-infection and BMDC cultured in the presence of GM-CSF for 6 days.  BMDC were then plated on cell culture plates 
overnight, cells collected in trizol and mRNA extracted for qPCR analysis. A. Maturation marker expression B. 
Cytokine/chemokine gene expression C. Epigenetic enzyme expression. Data represent Mean ± SEM (N ≥ 3; Representative of at 







3.4.4. Lack of TSLP signaling in BMDC alters cytokine response of CD4+ T-helper cells 
Since significant phenotypic differences were observed between WT and TSLPR-/- BMDC, we 
examined if the activity in these DC resulted in an altered ability to activate T cells. Previous 
studies have shown that in vitro infection of DC followed by co-culture with T cells leads to altered 
T cell cytokine production 37,176.  WT BMDC or TSLPR-/- BMDC were infected with RSV (MOI 
= 1.0) for 24 hours and then co-cultured with T cells (1:10) for 48 hours and cytokine production 
examined.  Co-culture of RSV infected TSLPR-/- BMDC with T cells isolated from RSV-infected 
animals led to significantly increased IFN-γ production compared to WT BMDC (Appendix 2; 
Figure A2-1) as well as a significant shift in the ratio of Th1:Th2 cytokine production (Figure 3-
4A).  A similar trend was observed when naïve TSLPR-/- BMDC were co-cultured with T cells 
isolated from RSV-infected animals (Figure 3-4B), indicating an inherent difference in the ability 
to activate T cells between WT and TSLPR-/-. Finally, an increase in IFN-γ production was also 
observed when TSLPR-/- BMDC infected with RSV were co-cultured with ovalbumin peptide 
specific DO-11 T cells177,178, following exposure to ova peptide (Figure 3-4C). These data indicate 
that DC-specific TSLP expression has a role in skewing the development of the T cell response 







Figure 3- 4. Lack of TSLP signaling in BMDC alters cytokine response of CD4+ T-helper cells.  
A. RSV-infected DC co-cultured with CD4+ T cells isolated from the lymph nodes of RSV-infected mice at 8 days post-infection.  
Supernatant collected and protein concentration analyzed using Bio-Plex assay and Th1:Th2 ratio calculated from these data B. 
Naive DC co-cultured with CD4+ T cells isolated from the lymph nodes of RSV-infected mice at 8 days post-infection.  Supernatant 
collected and protein concentration analyzed using Bio-Plex assay; followed by Th1:Th2 ratio calculation C. RSV-infected DC co-
cultured with CD4+ T cells isolated from the spleens of naïve DO-11 mice exposed to ovalbumin peptide.  Supernatant collected 
and protein concentration analyzed using Bio-Plex assay.   Data represent Mean ± SEM (N = 3). * = p < 0.05; ** = p < 0.01. 
 
3.4.5. Differential chromatin landscape between wild-type and TSLPR-/- BMDC 
Since BMDC appeared to have differential activation profiles, we next sought to determine if 
differences could be observed between WT and TSLPR-/- BMDC at the chromatin level using 
ATAC-seq evaluation to assess the transcription accessibility.  BMDC were isolated from WT and 
TSLPR-/- early-life RSV-infected male mice at 4 weeks post-infection. BMDC were also isolated 
from uninfected naïve age-matched WT and TSLPR-/- male mice to be used as controls.  Here, 
using hierarchical, unbiased clustering, we observed no differences between uninfected and 
infected animals within each group (Figure 3-5A). However, significant differences were 
observed between the WT and TSLPR-/- BMDC (Figure 3-5A), indicating an inherent difference 
in chromatin accessibility at baseline between WT BMDC and those isolated from BMDC lacking 
TSLP signaling.  Next, focusing on BMDC from RSV-infected groups only, due to striking 
phenotypic differences shown above at the mRNA level compared to naïve BMDC, we performed 
DiffBind analysis (differential read density analysis) to identify if there are sites that are 
differentially accessible between WT and TSLPR-/- at 4 weeks post-early-life RSV infection.  
Here, we found approximately 1000 differentially accessible regions (DARs) between WT and 
TSLPR-/- BMDC following early-life RSV-infection (Figure 3-5B and Appendix 2; Table A1).  
To verify these regions, we performed additional hierarchical clustering using only the ~1000 
DARs and observed very distinct clustering between the WT and TSLPR-/- groups (Figure 3-5C).  
Gene ontology (GO) cluster analysis which overlaps predicted genes with genes within GO 






these differences corresponded to toll-like receptor pathways (Figure 3-5D), crucial for anti-viral 
and inflammatory responses.  It is of interest to note that many of the genes predicted in this 
pathway include those linked to activated TLR4 and IL-1β (i.e. PIK3, IRAK4, Ly96 (MD-2), IKB) 
(Figure 3-5D); known to lead to persistent immune responses and enhanced inflammatory 
diseases179–181182,183.  Further evaluation of genes linked to the DAR regions (Appendix 2; Table 
A1), showed that more open chromatin in TSLPR-/- BMDC were associated with type-1 IFN 
pathway, in regions such as those near the Mid1 gene, which may be crucial for viral clearance184–
187 as well as Spp1 and Cxcl11, both strong enhancers of type-1 immunity188–190 (Figure 3-5E).  In 
contrast, more open regions of chromatin in WT BMDC were demonstrated near genes related to 
RSV-driven immunopathology, such as Irf4, Cxcl1 (KC), Cxcl2, and Areg120,191–193 (Figure 3-5F).  
These data indicate striking differences in the chromatin landscape between WT and TSLPR-/- 
male mice, with WT BMDC showing more accessible regions near genes linked with Th2 
immunity whereas TSLPR-/- BMDC show more accessibility near genes linked with type-1 







Figure 3- 5. Differential chromatin landscape between wild-type and TSLPR-/- BMDC.  
Male WT Balb/c or TSLPR-/- mice were infected neonatally with RSV (3 x 105 pfu) at 7 days of age and bone marrow collected 4 
weeks post-infection. BMDC were cultured in the presence of GM-CSF for 6 days and collected for ATAC-seq evaluation. Naïve 
age-matched animals were used as controls. A. Hierarchical, unbiased clustering was performed to evaluate the overall chromatin 
landscape of WT vs TSLPR-/- BMDC +/- early-life RSV infection. B. DiffBind analysis or differential read analysis was performed 
to determine differentially accessibly regions (DARs) between WT and TSLPR-/- BMDC at 4 weeks post-early-life RSV-infection. 
Samples were analyzed in duplicate (N = 8 WT; N = 6 TSLPR-/-); Representative plots of each biological replicate shown. Regions 
indicated in orange represent those regions more accessible in WT; top 250 predictions shown; Regions indicated in blue represent 
those regions more accessible in TSLPR-/-; all predictions shown. C. Biased clustering was performed focusing on only the regions 
associated with the DARs discovered during DiffBind analysis. D. Top 10 pathways associated with DARs using GO Term 
Analysis. E,F. Selected DARs related to RSV immune response. WT = Wild Type; KO = TSLPR-/-; Uni = Uninfected age-matched 







3.4.6. Differential chromatin landscape between wild-type and TSLPR-/- BMDC is related 
to TSLP-linked transcription factors 
We next performed BART analysis which examines a compendia of ChIP data to determine which 
transcription factors have the highest physical overlap with the predicted DARs and gives an odds 
ratio of prevalence for binding in order to identify possible transcription factors associated with 
the specific DARs between WT and TSLPR-/-.  Here, we identified IRF4 and STAT3 which have 
been linked to development of type 2 conventional DC (cDC2) populations, TSLP signaling, and 
Th2 immunity170,171,194–196 as well as IRF8, a strong driver of type-1 immunity that has been shown 
to be inhibited by TSLP113 (Figure 3-6A,B).  The probability of an involvement of these 
transcription factors is corroborated by the data presented in Figures 3-1-3-3 showing persistent 
expression of key genes following early-life RSV infection of WT male mice:  Il6, ccl3, and ccl5 
are known targets of IRF4 and STAT3; Kdm6b is a known target of STAT3 and Irf4 is a target 
gene of KDM6B137 and RELA leads to transcriptional activation of Ox40l112. Interestingly, IRF4 
binding sites were also predicted through DAR to have more accessibility in WT BMDC chromatin 
(Figure 3-5F).  Expression analysis by qPCR correlated with this prediction, showing that Irf4 is 
persistently expressed at 4 weeks post-infection in BMDC isolated from WT but not TSLPR-/- 
mice (Figure 3-6C). TSLP has previously been shown to lead to the expression of Irf4170; 
therefore, this increase is likely due to the persistence of TSLP in the WT BMDC and suggests 
that along with IRF4-related target genes being more accessible at the chromatin level, more IRF4 
is available to bind to these regions.   We also performed qPCR analysis of Irf8, Rela/b and Stat3 
and show that their expression is not significantly altered at 4 weeks post-infection (Figure 3-6C).  
However, while not significant, there does appear to be persistent expression of IRF8 in the WT 






which has known shared functions with IRF4, including upregulation of chemokines (i.e. Ccl3, 
Ccl5)197,198. These data indicate that TSLP is able to persistently alter the systemic BMDC 
population through alteration of transcriptional programs related to Th2 immunity, especially 
IRF4, that is further enhanced by chromatin accessibility. 
 
Figure 3- 6. Differential chromatin landscape between wild-type and TSLPR-/- BMDC is related to TSLP-linked 
transcription factors.  
A. BART analysis determined transcription factors likely to bind to DAR predicted genes B. Schematic of TSLP linked pathways 
C. Male WT Balb/c or TSLPR-/- mice were infected neonatally with RSV (3 x 105 pfu) at 7 days of age and bone marrow collected 
4 weeks post-infection and BMDC cultured in the presence of GM-CSF for 6 days.  BMDC were then plated on cell culture plates 
overnight, cells collected in trizol and mRNA extracted for qPCR analysis for gene expression. Data represent Mean ± SEM (N ≥ 







3.4.7. BMDC isolated from TSLPR-/- male mice have a more appropriate Th1-type anti-viral 
phenotype  
Next, we focused on Mid1, a gene associated with type-1 interferon pathway and viral 
clearance185,186,199 as it was one of the top predicted genes in the DAR analysis (Figure 3-5E), 
Upon visualization of the DAR plot for this gene, there appears to be a de novo accessible region 
in Mid1 of the TSLPR-/- that is not present in WT BMDC (Figure 3-7A).  This is in direct 
opposition to the DAR plot of the chromatin region associated with the TSLP receptor gene (Crlf2), 
which clearly shows a loss of accessibility in the TSLPR-/- BMDC (Figure 3-7B), supporting 
visual identification of accessible vs non-accessible regions of chromatin. To further explore this 
target, BMDC were isolated from early-life RSV-infected WT and TSLPR-/- male mice at 4 weeks 
post-infection as well as naïve age-matched controls and cultured for 6 days in the presence of 
GM-CSF.  We first performed qPCR to correlate the DAR prediction and verified that Mid1 is 
increased in BMDC isolated from early-life RSV-infected TSLPR-/- mice at 4 weeks post-
infection (Figure 3-7C). To further characterize the role of TSLP in the BMDC response, we 
evaluated baseline levels of Ifnb, which functions downstream of MID1 and is crucial for viral 
clearance15, as well as Il12a, another type-1 cytokine200,201.  Here, we see that at baseline, TSLPR-
/- BMDC express increased levels of Mid1, Ifnb, and Il12a compared to WT (Figure 3-7D) 
suggesting an improved type-1 response.  Next, we performed in vitro RSV infection of WT and 
TSLPR-/- BMDC to determine kinetics of the anti-viral/immune response.  Interestingly, both 
Mid1 and Ifnb increased very rapidly upon infection in TSLPR-/- BMDC (Figure 3-7E,F) and 
Il12a was increased over WT by 24 hours post-infection (Figure 3-7G).  Overall, these data 
indicate that TSLPR-/- BMDC have an accelerated more appropriate type-1 immune response 






increased expression of IFN-γ shown above in Figure 3-4.  These results indicate that loss of TSLP 
signaling enhances the production of protective type-1 cytokines, possibly allowing for better viral 
protection and faster resolution of the inflammatory response to decrease the persistent production 
of cytokines associated with immunopathology. 
 
 






A,B. ATAC-seq DAR plots C. Male WT Balb/c or TSLPR-/- mice were infected neonatally with RSV (3 x 105 pfu) at 7 days of 
age and bone marrow collected 4 weeks post-infection and BMDC cultured in the presence of GM-CSF for 6 days.  BMDC were 
then plated on cell culture plates overnight, cells collected in trizol and mRNA extracted for qPCR analysis for gene expression. 
D. BMDC from naïve age-matched control mice were analyzed for mRNA expression of type-1 cytokines. E-G.  BMDC from 
naïve age-matched control mice were cultured for 6 days in the presence of GM-CSF and then infected with RSV (MOI = 1) 
overnight and cells collected in trizol for mRNA analysis. Data represent Mean ± SEM (N ≥ 3; Representative of at least 2 individual 
experiments). * = p < 0.05; ** = p  < 0.01; *** = p < 0.001; **** = p < 0.0001.  
 
3.5. Discussion 
RSV is a significant health care burden and cause of pediatric morbidity and mortality.  
Approximately 50% of all children will become infected with RSV in the first year of life and 
almost all children by the age of two, with 3-5% of infections resulting in hospitalization due to 
severe disease24.  RSV is characterized by a dysregulated immune response that leads to poor 
immunologic recall that allows re-infection throughout life as well as enhanced likelihood of 
asthma development7,20,22,93,154. Therefore, elucidation of mechanisms that drive disease is crucial 
for protection from both primary infection and exacerbated diseases later in life. To expand our 
observations that TSLP is involved in persistently altering the local lung environment following 
early-life RSV infection in male mice169, we sought to examine the role of TSLP on DC-specific 
systemic immune alterations following early-life RSV-infection. Here we show that male mice 
infected neonatally with RSV have persistently activated BMDC populations at 4 weeks post-
early-life RSV-infection compared to both naïve age-matched mice as well as females infected 
with RSV at the same age.  A lack of TSLP signaling in TSLPR-/- BMDC abrogates this phenotype 
and interestingly, the genomic profile of WT vs TSLPR-/- BMDC are significantly different, 
specifically in regions associated with anti-viral response.  These studies outline 2 important 
concepts: 1) early-life RSV-infection results in a persistently altered systemic immune phenotype 
that can be elucidated in the BMDC and 2) the persistence of the early innate cytokine, TSLP, has 
a role in the altered immune environment by inhibiting Th1 immunity, favoring a Th2 response. 






immune cells leading to long-term phenotypes, indicating TSLP as a clinically relevant target early 
in life. 
TSLP has a wide range of immune cell targets, including ILC2, DC and T cells.  The initial 
biologic function of TSLP demonstrated that it interacted with DC to promote Th2 cell 
differentiation and thus promoted allergic disease113,114. TSLP stimulation of CD11b+ DC 
upregulates OX-40L that interacts with OX-40 on CD4+ T cells to promote a Th2 response151,152. 
In response to TSLP, DCs will themselves produce TSLP that further interacts with DCs and ILC2, 
creating a feedback loop that is independent of epithelial cell-derived TSLP115,116. TSLP interacts 
with the transcription factor, IRF4, to lead to strong Th2-type responses and the production of 
cDC2-type cytokines and chemokines112,170,194. The TSLP/IRF4 pathway has been implicated in 
ILC2-driven Th2-immunity through Th9 cells172.  Additionally, TSLP is responsible for 
maturation of DC and upregulation of CD80/86 as well as OX-40L41,202,202.  The data provided in 
our current studies using BMDC isolated from WT or TSLPR-/- male mice corroborate these 
findings, indicating TSLP signaling is responsible for the increased activation state of BMDC 
long-term following early-life RSV-infection related to IRF4 signaling, including upregulation of 
maturation markers and persistent expression of pro-inflammatory cytokines and chemokines. 
Thus, TSLP may be central to the development of chronic type-2 immune responses following an 
early-life RSV-infection by promoting an altered systemic immune environment that trains innate 
immune cells toward the development of allergic disease.  
The reduction of anti-viral responses as well as skewing towards dysregulated Th2/Th17 
has been correlated with severe RSV-related disease20,31,168 as well as exacerbated allergic 
responses later in life93. An important feature of anti-viral immunity is the ability to upregulate 






inhibit/reduce Th2 responses.  Additionally, IFN-γ has been shown to protect against asthma 
pathogenesis203,204.  Studies presented here show a novel role for TSLP in the regulation of Type-
1 immunity leading to the inhibition of IFN-γ.  ATAC-seq data indicated more accessibility in 
regions associated with type-1 IFN activation, specifically Midline 1 (Mid1).  Mid1 is a member 
of the TRIM (tripartite motif-containing) family of proteins, which are important anti-viral 
mediators, involved directly in viral clearance as well as stimulation of IFN-related downstream 
targets184–186,199.  While Mid1 has not previously been directly linked with RSV disease, the TRIM 
family of proteins has been shown to be protective against RSV pathogenesis13,205.  Furthermore, 
MID1 is a known inhibitor of PP2A, which downregulates type-1 IFN production, a pathway many 
viruses, including RNA viruses, highjack to evade the anti-viral immune response206–208.  
Correlating with the ATAC-seq data, qPCR data showed that following early-life RSV-infection, 
TSLPR-/- BMDC were able to persistently express Mid1. Additionally, increased baseline levels 
of Mid1 and Ifnb were observed in naïve TSLPR-/- BMDC that may enhance Th1 responses in the 
absence of TSLP-signaling.  In support of this finding, when TSLPR-/- BMDC were infected with 
RSV in vitro followed by co-culture with RSV-responsive T cells, enhanced T cell production of 
IFN-γ was observed. These data collectively show that BMDC-derived TSLP is capable of 
inhibiting the anti-viral response by downregulating type-1 signaling to limit T cell production of 
IFN-γ.  
Previous studies have shown long-term alteration of innate immune cells, such as 
monocytes and macrophages following pathogenic stimuli.  For example, LPS-induced tolerance 
is observed in macrophages where gene-specific chromatin modifications are associated with 
silencing of genes related to inflammatory molecules while priming for antimicrobial genes 






subsequent activation signals126. Additional studies demonstrate that exposure of 
monocytes/macrophages to C. albicans or β-glucan enhanced their subsequent response to 
stimulation with unrelated pathogens, leading to the term trained immunity122,127. Trained 
immunity was demonstrated to be accompanied by significant reprogramming of chromatin marks. 
Long-term persistence of altered responses in myeloid cells after removal of the initial stimulus 
may reflect either stability of these marks or the sustained activation of the upstream signaling 
pathways and transcription factors that control their deposition. Our data showing persistent 
expression of the epigenetic enzyme, Kdm6b, an H3K27 histone demethylase known to enhance 
the inflammatory response134,137, reinforces the idea that upstream signaling pathways may lead to 
persistent alteration of systemic innate immune cell populations, such as BMDC.  Furthermore, 
ATAC-seq studies showing links to many transcription factors associated with Th2 immune 
responses, especially IRF4, in WT BMDC as well as a persistent increase in IRF4 expression 
following early-life RSV-infection compared to TSLPR-/- BMDC, supports the concept of 
epigenetic alterations post-RSV-infection. 
These studies demonstrate a novel pathway whereby RSV infection leads to upregulation 
of TSLP as well as the epigenetic enzyme KDM6B and a transcription factor, IRF4, in BMDC that 
together can modify multiple DC functions (Figure 3-8). These include costimulatory molecule 
expression as well as activation of defined chemokines and cytokines responsible for RSV-driven 
immunopathology, which may lead to an enhanced response upon secondary exposures.  
Knockdown of TSLP signaling leads to abrogation of this activated phenotype and restoration of 
an appropriately responding BMDC population able to drive Th1 T cell responses. These are the 
first studies, to our knowledge, that indicate a direct link to TSLP-inhibition of IFN-β as well 






could alter the progression of pathogenic immune responses of the BMDC following early-life 
RSV-infection and modify the long-term systemic immune environment.   
 
Figure 3- 8. Proposed mechanism of TSLP interactions with KDM6B and IRF4 to persistently activate BMDC.  







Chapter 4:  Upregulation of H3K27 Demethylase KDM6 During RSV 
Infection Enhances Pro-Inflammatory Responses and Immunopathology 
4.1. Abstract  
Severe disease following RSV infection has been linked to enhanced pro-inflammatory cytokine 
production that promotes a Th2-type immune environment.  Epigenetic regulation in immune cells 
following viral infection plays a role in the inflammatory response and may result from 
upregulation of key epigenetic modifiers. Here we show that RSV-infected bone marrow-derived 
dendritic cells (BMDC) as well as pulmonary DC from RSV-infected mice upregulated expression 
of Kdm6b/Jmjd3 and Kdm6a/Utx, H3K27 demethylases.  KDM6-specific chemical inhibition 
(GSK J4) in BMDC led to decreased production of chemokines and cytokines associated with the 
inflammatory response during RSV infection (i.e. CCL-2, CCL-3, CCL-5, IL-6) as well as 
decreased MHC II and co-stimulatory marker (CD80/86) expression.  RSV-infected BMDC 
treated with GSK J4 altered co-activation of T cell cytokine production to RSV as well as a primary 
ovalbumin response.  Airway sensitization of naïve mice with RSV-infected BMDCs exacerbate 
a live challenge with RSV infection but was inhibited when BMDCs were treated with GSK J4 
prior to sensitization.  Finally, in vivo treatment with the KDM6 inhibitor, GSK J4, during RSV 
infection reduced inflammatory DC in the lungs along with IL-13 levels and overall inflammation. 
These results suggest that KDM6 expression in DC enhances pro-inflammatory innate cytokine 








Respiratory syncytial virus (RSV) infects nearly all infants by age two and is the leading 
cause of bronchiolitis in children worldwide1,2.  The CDC estimates that up to 125,000 pediatric 
hospitalizations in the United States each year are due to RSV, at an annual cost of over 
$300,000,0002,20,167. In the late 1960s, attempts to vaccinate children with formalin-inactivated 
RSV vaccine caused severe exacerbated disease upon re-infection with live RSV due to enhanced 
inflammatory disease and mucus production25–27. Furthermore, several epidemiological studies 
link severe RSV infection with the later development of hyper-reactive airway disease, including 
asthma, that persists even years after the initial viral infection has resolved1,3,20.  RSV likely 
initiates and reinforces the immune environment by further altering pathogenic immune responses.   
During a viral infection, the immune response is regulated by dendritic cells (DC) as they 
instruct T cells toward distinct T helper type responses44.  RSV can skew the immune response 
away from anti-viral and towards a Th2-type response by inhibiting the production of IFN-β and 
subsequently decreasing the less pathogenic anti-viral Th1 response45.  The reduction of anti-viral 
responses as well as skewing towards dysregulated Th2/Th17 has been correlated with severe 
disease20,31,168, leading to airway alterations linked to exacerbated allergic responses later in life93. 
RSV-exposed DC are sufficient to promote a more severe and accelerated disease environment 
when exposed to secondary RSV challenge89,176 or allergens89.  Understanding whether and how 
RSV infection influences DC function to alter the immune environment leading to exacerbation or 
initiation of a pathogenic environment will be crucial for modifying pulmonary pathologies.   
Immune regulation by epigenetic mechanisms, an intense area of research, alters DNA 
transcription via histone proteins that comprise nucleosomes209,210.  Lysine residues in the histone 






example, the addition of methyl groups on lysine (K) 4 of histone (H) 3 (i.e. H3K4) leads to 
activation of gene transcription, whereas H3K27 methylation is a repressive mark130,211,212. H3K4 
methylation is crucial for active gene transcription, while H3K27 methylation appears to regulate 
and fine-tune gene transcription130,134. This process is controlled by methyltransferases that add 
methyl groups and demethylases that remove them, such as the lysine demethylase family of 
enzymes, including KDM5 and KDM6. Removal of the H3K4 methylation mark by KDM5 leads 
to repressed gene transcription while KDM6, an H3K27 demethylase that removes the methylation 
mark from H3K27, leads to more active gene transcription.  In addition to the canonical role of 
H3K27 demethylation, KDM6 also contributes to gene activation by modulation of H3K4 
methylation through stabilization of the MLL complex135,136 and guides gene transcription by 
binding POLII to enhance its movement along genes137,138.  There is already evidence that KDM6 
is involved in the inflammatory response134,137,213. Additionally, our lab has previously shown that 
KDM5B and KDM6B are upregulated during RSV infection and identified that KDM5B enhances 
RSV-driven immunopathology by inhibiting key cytokines, especially IFN-β37.  The specific role 
of KDM6 during RSV infection has not previously been explored. 
In the present study, we examined the KDM6 family of histone lysine demethylases 
(KDM6A/B).  Specifically, we demonstrate that RSV infection leads to upregulation of KDM6A/B 
in BMDC and that inhibition of its enzymatic activity depresses multiple cytokines and 
chemokines associated with RSV-driven inflammatory responses as well as antigen 
presentation/co-stimulation of DC.  Furthermore, in vivo inhibition of KDM6 activity leads to 
decreased inflammatory DC infiltration into the lungs, reduced immunopathology and decreased 
Th2-skewing, indicating that KDM6 upregulation during RSV-infection enhances 






targeting epigenetic pathways and overall DC function may be crucial for limiting long-term RSV-
driven disease pathologies. 
4.3. Materials and Methods  
4.3.1. Animals 
All experiments involving the use of animals were approved by the University of Michigan animal 
care and use committee (protocol PRO0000888, exp. 02/14/2022). Male/female C57BL/6, female 
OT-II and male/female BALB/c mice, 6 to 8 weeks of age, were purchased from The Jackson 
Laboratory (Bar Harbor, ME). 
4.3.2. RSV-infection and in vivo GSK J4 Treatment 
A chimeric RSV A2 strain with recombinant Line19 fusion protein (A2/L19-F) was used for all 
experiments as previously described145. This strain was used due to its ability to enhance viral 
infection, mucus hypersecretion and airway hyperreactivity in mouse models due to Line 19-
derived F protein, including pathogenic IL-13 and IL-17 responses31,145. Male Balb/c mice were 
infected intratracheally with 2.0 x 105 pfu of RSV A2/L19-F and tissues harvested at 8 days post-
infection.  Viral stocks were grown in Hep-2 cells and concentrations determined by plaque assay. 
Virus was ultra-centrifuged (100,000xg for 30 minutes at 4°C) and re-suspended in fresh cell 
culture media (RPMI 1640 supplemented with 10% fetal calf serum (FCS), L-glutamine, 
penicillin/streptomycin, non-essential amino acids, sodium pyruvate, 2-mercaptoethanol (ME)) or 
1X DPBS prior to use. In some experiments, cultured dendritic cells were infected with RSV for 
24 hours, thoroughly washed, and 2.5 x 105 cells were transferred intratracheally into naïve male 
mice. Ultraviolet (UV)-inactivated virus was prepared by exposure to UV light to inactivate RSV 
as previously described 120,214.  For in vivo GSK J4 treatment, GSK J4 (Millipore-Sigma, St. Louis, 






concentration 2 mg/mL; 2.5% DMSO); 200 µL was given intraperitoneally per animal for a final 
dosing concentration of 20 mg/kg per animal per dose, given once daily over 7 days. 
4.3.3. Bone Marrow-Derived Dendritic Cells and Co-culture with CD4+ T cells   
Bone marrow from C57BL/6 or Balb/c mice was collected by flushing the femur and tibia of hind 
legs with RPMI 1640 supplemented with 10% fetal calf serum (FCS), L-glutamine, 
penicillin/streptomycin, non-essential amino acids, sodium pyruvate, 2-mercaptoethanol (ME). 
BMDCs were grown in RPMI 1640 supplemented with 10% FCS, L-glutamine, 
penicillin/streptomycin, non-essential amino acids, sodium pyruvate, 2-mercaptoethanol (ME) and 
10 ng/ml of recombinant murine granulocyte macrophage-colony stimulating factor (GM-CSF; 
R&D Systems, Minneapolis, MN, USA). Cells were fed on Days 3 and 5 with fresh GM-CSF. On 
Day 6, cells were cultured with RSV (MOI = 2.5). For some experiments, cells were concurrently 
treated with 10 µM GSK J4 (Sigma, St. Louis, MO, USA), a chemical inhibitor of KDM6A/B 215, 
10 µM inactive isomer control, GSK J5 (abcam), or with ethanol (0.1%) as a control.  At 24 hours, 
supernatant was collected for protein analysis using Bio-Plex cytokine assay (Bio-Rad 
Laboratories, Hercules, CA). Cells were collected in TRIzol reagent and mRNA was extracted 
using TRIzol reagent (Invitrogen, Carlsbad, CA) for quantitative RT-PCR or resuspended in PBS 
for flow cytometry. For some experiments, CD4+ T cells were isolated from the lymph nodes of 
RSV-infected Balb/c mice or spleens from naïve OT-II mice using the T cell isolation II kit 
(Miltenyi Biotec). Cells were then cultured with the treated BMDCs. For OT-II cells, co-culture 
was performed in the presence of ovalbumin peptide 323-339 (10 µg/mL; Invivo Gen, San Diego, 
CA).  At 48 hours, the supernatant was collected and protein levels were measured with a Bio-






4.3.4. Quantitative RT-PCR  
Lung tissue was homogenized in TRIzol reagent, and mRNA was subsequently extracted using 
TRIzol reagent (Invitrogen, Carlsbad, CA). cDNA from lung or BMDC mRNA (described above) 
was synthesized using murine leukemia virus reverse transcriptase (Applied Biosystems, Foster 
City, CA) by incubation at 37 ̊C for one hour, followed by incubation at 95 ̊C for 10 min to stop 
the reaction. Real-time quantitative PCR (qPCR) was measured using Taqman primers, with a 
FAM-conjugated probe to measure transcription of Kdm6a, Kdm6b, Il4, Il5, Il13, 18s. Fold change 
was quantified using the 2-ΔΔ cycle threshold (CT) method. All reactions were run on a 7500 Real-
Time PCR System (Applied Biosystems, Foster City, CA). 
4.3.5. Flow Cytometry  
BMDC were collected and resuspended in PBS.  Live cells were identified using LIVE/DEAD 
Fixable Yellow Dead Cell Stain kit (Thermo Fisher Scientific, Waltham, MA), incubated at 4°C 
for 20 minutes then washed and resuspended in PBS with 1% FCS.  Fc receptors were blocked 
with purified anti-CD16/ 32 (clone 93; BioLegend, San Diego, CA). Surface markers were 
identified using Abs (clones) against the following antigens, all from BioLegend: anti-CD11c 
(N418), MHC II (M5/114.15.2), CD11b (M1/70), CD80 (16-10/A1), CD86 (GL-1).  The lungs 
were removed, and single cells were isolated by enzymatic digestion with 1 mg/mL collagenase 
(Roche) and 20 U/mL DNaseI (Sigma, St. Louis, MO) in RPMI 1640 + 10% FCS for 60 min at 
37°C. Tissues were further dispersed through an 18-gauge needle (5-mL syringe), red blood cells 
(RBCs) were lysed and samples were filtered twice through 100-µm nylon mesh. Cells were 
resuspended in PBS.  Live cells were identified using LIVE/DEAD Fixable Yellow Dead Cell 
Stain kit (Thermo Fisher Scientific, Waltham, MA), then washed and resuspended in PBS with 






Diego, CA). Surface markers were identified using Abs (clones) against the following antigens, 
all from BioLegend: anti-CD11c (N418), MHC II (M5/114.15.2), CD11b (M1/70), CD80 (16-
10/A1), CD86 (GL-1), F4/80 (BM8), Ly6C (HK1.4), CD3 (145-2C11), CD4 (GK1.5), CD8 (53-
6.7), CD69 (H1.2F3). Data were collected using a NovoCyte flow cytometer (ACEA Bioscience, 
Inc. San Diego, California). Data analysis was performed using FlowJo software (Tree Star, 
Oregon, USA).  All populations were gated as:  cells/singlets (doublet discrimination)/live cells.  
Distinct populations were then gated as follows: CD11c+ dendritic cells:  CD11b+/CD80+; 
CD11b+/CD86+; CD11b+/MHCII+; F4/80 macrophages:  CD11c-/CD11b+/F4/80+; 
inflammatory monocytes:  CD11c-/CD11b+/Ly6C+; inflammatory dendritic cells:  
CD11c+/CD11b+/Ly6C+; T cells:  CD3+/CD4+, CD3+/CD8+; activated CD4+ T cells:  
CD3+/CD4+/CD69+; eosinophils:  CD11b+/side scatter (SS)hi/SiglecF+; neutrophils:  
CD11b+/SShi/Gr-1+. 
4.3.6. Chromatin immunoprecipitation 
Chromatin immunoprecipitation (ChIP) was performed as previously described216. Briefly, cells 
(1 x 106 total cells) were fixed in 18.5% paraformaldehyde (PFA).  Glycine (10X) was added to 
quench extra PFA. Cells were washed using ice-cold PBS and lysed in SDS buffer. Cells were 
then sonicated using a Branson Digital Sonifier 450 (VWR, West Chester, PA, USA) to create 
200–1000 bp fragments. The lysate was clarified by centrifugation, and 5% of the supernatant was 
saved to measure the input DNA. The remaining chromatin was incubated with 1 µg of anti-
H3K27me3 antibody (Active Motif), H3K4me3 antibody (Abcam) or control IgG (Millipore) and 
incubated at 4°C with rotation overnight. Immune complexes were precipitated with salmon sperm 
DNA/protein A agarose beads. The bead complexes were washed with a series of buffers (low-salt 






Tris/EDTA buffer). Protein-DNA complexes and input DNA were eluted using elution buffer. 
Crosslinking was reversed by incubation at 65°C, and samples were treated with proteinase K. 
DNA was purified by phenol:chloroform:isoamyl alcohol separation and ethanol precipitation. 
Primers for the promoter regions of CD80 (Forward: CACCCCCGCAAGCAGAATCC; Reverse: 
GGCAACTCAAAGGTCCCCAGAAC) and CD86 (Forward1: 
AAGAAAAAGTCAACCACCAGGG; Reverse1: TTCAAGTCCGTGCTGCCTAC; Forward1: 
AAGAAAAAGTCAACCACCAGGG; Reverse2: CGTGGGTGCTTCCGTAAGTT) were 
designed using Lasergene software and DNA was amplified by qPCR using SYBR Green buffer 
(Applied Biosystems, Foster City, CA). 
4.3.7. Lung Histology 
The middle and inferior lobes of the right lung were perfused with 10% formalin for fixation and 
embedded in paraffin. Five-micrometer lung sections were stained with periodic acid-Schiff (PAS) 
to detect mucus production, and inflammatory infiltrates. Photomicrographs were captured using 
a Zeiss Axio Imager Z1 and AxioVision 4.8 software (Zeiss, Munich, Germany). 
4.3.8. Lung draining lymph node in vitro re-infection and cytokine production assay 
Lung draining lymph nodes (LDLN) were enzymatically digested using 1 mg/mL collagenase A 
(Roche) and 20 U/mL DNaseI (Sigma-Aldrich) in RPMI 1640 with 10% FCS for 45 min at 37°C. 
Tissues were further dispersed through an 18-gauge needle (1-mL syringe). RBCs were lysed, and 
samples were filtered through 100-µm nylon mesh. Cells (5 × 105) from LDLN were plated in 96-
well plates and re-infected with 1.5-3.0 x 105 pfu of RSV. IL-4, IL-5, IL-13, Il-17A and IFN-γ 







4.3.9. Statistical analysis 
Data were analyzed by Prism 7 (GraphPad Software). Data presented are mean values ± SEM. 
Comparison of two groups was performed with an unpaired, two-tailed Student t-test. Comparison 
of three or more groups was analyzed by one-way ANOVA, followed by two-tailed Student t-test 
for individual comparisons. A p-value <0.05 was considered significant. 
4.4. Results 
4.4.1. Histone lysine demethylases Kdm6a and Kdm6b are upregulated following RSV 
infection  
Epigenetic enzymes have been implicated in regulating immune gene transcription during 
inflammatory responses217–219. Previous studies have shown that histone lysine demethylases are 
upregulated during RSV infection, especially in CD11c+ populations that control the immune 
response to RSV37. In the current studies, male C57BL/6 and Balb/c mice were infected 
intratracheally with RSV and at 8 days post-infection, we collected the CD11c+ cell population 
from the lungs and verified RSV infection by evaluation of viral gene expression (Appendix 3; 
Figure A3-1A,B).  We then evaluated the epigenetic enzyme expression in the CD11c+ cell 
population and showed upregulated gene expression of Kdm6a and Kdm6b H3K27 demethylases 
in both strains of mice (Figure 4-1A,B).  Next, we evaluated the upregulation of Kdm6 
demethylases in CD11c+ bone marrow-derived dendritic cells (BMDC) since a significant source 
of inflammatory CD11c+ cells recruited to the lungs during infection are bone marrow-derived 
and furthermore, epigenetic alteration of inflammatory DC regulates RSV-driven 
immunopathology37. BMDC were infected with live RSV (MOI = 2.5) for 4, 8, 12, or 24 hours 
and infection verified by RSV gene expression (Appendix 3; Figure A3-1C) and cells were then 






and Kdm6b was observed at 4-12 hours post-infection in the BMDC (Figure 4-1D,E).  The use of 
UV-inactivated RSV did not lead to upregulation of Kdm6a or Kdm6b (Appendix 3; Figure A3-
1D), demonstrating a direct effect of RSV on the expression of these gene regulatory chromatin 
modifiers.   
 
Figure 4- 1.  Histone lysine demethylases Kdm6a and Kdm6b are upregulated following RSV infection.  
A, B. Male C57BL/6 or Balb/c mice were infected with RSV (2 x 105 pfu) and lungs collected 8 days post-infection and compared 
to naïve control animals.  Lungs were harvested and the CD11c+ cell population isolated using MACS bead separation, mRNA 
extracted and qPCR performed to determine epigenetic enzyme expression (N ≥ 3). C. Experimental design for BMDC culture D, 
E. BMDC isolated from C57BL/6 or Balb/c mice were infected in vitro with RSV and cells collected at the indicated timepoints, 
mRNA extracted and qPCR performed to determine epigenetic enzyme expression (N = 3). Data represent Mean ± SEM 







4.4.2. Inhibition of KDM6 reduces DC cytokine and co-stimulatory molecule expression 
To examine the role of KDM6 enzymes, GSK J4 (10 µM), a competitive inhibitor that blocks 
KDM6 demethylase activity was used215. Based on time-course studies, to determine optimal 
cytokine and chemokine gene expression, (Appendix 3; Figure A3-2A) and to allow for 
epigenetic modification of these genes following epigenetic enzyme upregulation, BMDC were 
treated with GSK J4 or vehicle and concurrently infected with RSV for 24 hours. RSV infectivity 
of BMDC treated with vehicle or GSK J4 was similar, as indicated by the levels of RSV gene 
expression (Figure 4-2A).  Additionally, we analyzed the live cell populations using flow 
cytometry and observed no difference in cell viability compared to vehicle-treated controls 
(Figure 4-2B). Treatment with GSK J4 during RSV-infection led to a significant reduction in 
CCL-2, CCL-3, CCL-5, and IL-6 (Figure 4-2C) indicating a decrease in inflammatory chemokines 
and cytokines in response to RSV-infection.  An inactive isomer of GSK J4 (GSK J5) was also 
used as a control and showed no reduction in these specific cytokines (Appendix 3; Figure A3-
2B), confirming specificity of this response to GSK J4.   Additionally, correlating with previous 
studies from our laboratory120,214, no upregulation of the inflammatory response (i.e. Il6 or 
chemokines) was observed using UV-inactivated RSV (Appendix 3; Figure A3-2C,D), indicating 
that active viral infection is necessary for this response.  In order to examine DC activation, co-
stimulatory and maturation markers were examined and indicated a reduction in CD80 and CD86 
as well as MHC II expression (Figure 4-2D) and this reduction was confirmed using siRNA to 
knockdown gene expression of Kdm6b (Appendix 3; Figure A3-2E). Treatment with GSK J4 
demonstrated increased H3K27 methylation status (Figure 4-2E), as well as a significant reduction 
in H3K4 methylation (Figure 4-2F), correlating with the reduced expression of key APC 






of cytokines and chemokines associated with RSV-driven inflammation and the activation of 
molecules necessary for optimal APC function. 
 
Figure 4- 2. Inhibition of KDM6 reduces DC cytokine and co-stimulatory molecule expression.  
BMDC were isolated from C57BL/6 mice, cultured for 6 days in the presence of GM-CSF and infected with RSV + GSK J4 or 
vehicle control in vitro for 24 hours. A. mRNA was extracted and qPCR performed to determine RSV F gene expression (N = 3). 
B. Cells were collected, processed and stained for flow cytometry analysis of live cell populations (N = 3). C. Supernatant was 
collected and protein evaluated using Bio-Plex assay (N = 3). D. Cells were collected, processed and stained for flow cytometry 
analysis of APC markers (N = 3).  E, F. Cells were collected and DNA extracted for ChIP analysis (N ≥ 3).  Data represent Mean 
± SEM (Representative of at least 2 individual experiments). * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. 
 
4.4.3. Inhibition of KDM6 in BMDC alters cytokine response of CD4+ T-helper cells 
Since both cytokine and co-stimulatory molecules were altered by KDM6 inhibition, we examined 






have shown that in vitro infection of DC, followed by co-culture with T cells leads to altered T 
cell cytokine production37,176.  BMDC were infected with RSV (MOI = 2.5) and treated with GSK 
J4 (10 µM) for 24 hours and then co-cultured with T cells (1:10) for 48 hours and cytokine 
production examined (Figure 4-3A).  Co-culture of RSV infected BMDC with T cells isolated 
from the lymph nodes of RSV-infected Balb/c mice led to significantly reduced IL-17A and IFN-
γ production upon inhibition of KDM6 in BMDC (Figure 4-3B). Additionally, when BMDC from 
C57BL/6 mice were infected with RSV +/- GSK J4 and co-cultured with ovalbumin peptide 
specific OT-II CD4+ T cells177,178, decreased production of IL-5 and IL-13 following exposure to 
ova peptide was observed (Figure 4-3C). These data indicate that DC-specific KDM6 expression 
has a role in regulating the development of the T cell response following RSV infection as well as 
to unrelated primary immune responses linked to Th cell mediated disease. 
 
Figure 4- 3. Inhibition of KDM6 in BMDC alters cytokine response of CD4+ T-helper cells.  
A. DC/T cell co-culture experimental design B. RSV-infected DC (Balb/c) co-cultured with CD4+ T cells isolated from the lymph 
nodes of RSV-infected female Balb/c mice at 8 days post-infection.  Supernatant collected and protein concentration analyzed 
using Bio-Plex assay (N ≥ 4). C. RSV-infected DC (C57BL/6) co-cultured with CD4+ T cells isolated from the spleens of naïve 
female OT-II mice exposed to ovalbumin peptide.  Supernatant collected and protein concentration analyzed using Bio-Plex assay 







4.4.4. BMDC-induced RSV sensitization is altered by KDM6 inhibition in RSV challenge 
To further examine the role of KDM6 enzymatic function, RSV infected BMDC (24 hour) with or 
without inhibition of KDM6 were transferred intratracheally into naïve Balb/c mice and at 7 days 
post-DC transfer, BMDC sensitized mice were challenged with RSV (Figure 4-4A).  Our lab has 
previously demonstrated that this sensitization protocol with DC elicits a pathogenic immune 
environment upon RSV re-infection37,89. Instillation of RSV-infected BMDC led to enhanced 
inflammation and mucus within the lungs compared to RSV only (Figure 4-4B) at 8 days post-
infection. However, KDM6-inhibited BMDC sensitization resulted in reduced inflammation and 
mucus production compared to vehicle control (Figure 4-4B) with a correlative decrease in the 
expression of pathologic Th2 genes (Il4, Il5, Il13) (Figure 4-4C). We also observed a decrease in 
inflammatory innate immune cells (Figure 4-4D) as well as neutrophils (Figure 4-4E) and 
activated CD8+ T cells (Figure 4-4F) within the lungs of animals given KDM6-inhibited BMDC, 
correlating with the decreased production of chemokines shown above. These data indicate that 
BMDC-specific KDM6 activity leads to RSV-driven immunopathology within the lungs 







Figure 4- 4. BMDC-induced RSV sensitization is altered by KDM6 inhibition in RSV challenge.  
A. DC transfer experimental design  B. Lungs were embedded in paraffin and Periodic acid-Schiff stain (PAS) was performed to 
visualize inflammation and mucus (bright pink staining).  Representative photos shown. C.   Lungs were homogenized and mRNA 
extracted to determine cytokine gene expression compared to naïve controls (N = 5). D-F. Lungs were processed into single-cell 
suspension and stained for flow cytometry analysis. (N = 5). Data represent Mean ± SEM (N = 5 male Balb/c mice/group). * = p < 
0.05; ** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. 
 
4.4.5. In vivo inhibition of KDM6 alters the immune response to RSV infection 
To determine if KDM6 has an immunopathologic role during a primary RSV infection in vivo, 
Balb/c mice were treated systemically (IP) with GSK J4 (20 mg/kg) daily for 7 days to inhibit 
KDM6 enzymatic activity (Figure 4-5A).  Tissues were collected at 8 days post-infection and 
evaluated for RSV-driven immunopathology. This time point has previously been described in 
mouse models comparing live viral infection to UV-inactivated RSV control, showing that live 






days post-infection120,214.  Lung histology showed that KDM6 inhibition resulted in decreased 
mucus production and inflammation as well as a reduction of bronchus-associated lymphoid tissue 
(BALT) in the lungs (Figure 4-5B,C) with a correlative decrease in mucus score (Figure 4-5D) 
and mucus genes, gob5 and muc5ac (Figure 4-5E).  Additionally, we observed a decrease in 
inflammatory CD11c+ DC (CD11b+/MHCII+ and CD11b+/CD86+) and F4/80+ macrophages in 
the lungs of KDM6-inhibited animals (Figure 4-5F,G) with no alteration in eosinophil or 
neutrophil cell infiltration (Figure 4-5H). Furthermore, in vivo treatment with GSK J4 led to fewer 
activated CD4+ T cells within the lungs (Figure 4-5I), suggesting a role for KDM6 in the adaptive 
immune response, likely through altered APC function.  Analysis of the cytokine production from 
RSV re-infected isolated lymph node cells showed reduced IL-13 and IFN-γ in GSK J4-treated 
mice compared to vehicle control mice (Figure 4-5J).  Overall, these data show decreased 
inflammatory responses by inhibiting KDM6 activity, demonstrating a direct link between KDM6 







Figure 4- 5. In vivo inhibition of KDM6 alters the immune response to RSV infection.   
Male Balb/c mice were infected with RSV (2 x 105 pfu) and concurrently treated with GSK J4 to inhibit KDM6 enzymatic activity 
and tissues were harvested at 8 days post-infection. A. Experimental design B,C. Lungs were embedded in paraffin and Periodic 
acid-Schiff stain (PAS) was performed to visualize mucus (bright pink staining) and inflammatory infiltrates (blue).  Representative 
photos shown. D. Subjective mucus scoring was performed on blinded histological slides on a scale of 1-4 for mucus production 
(N = 5) E. Lungs were homogenized and mRNA extracted to determine mucus gene expression compared to naïve controls (N = 
5) F-I. Lungs were processed into single-cell suspension and stained for flow cytometry analysis. (N = 5). J.  Lung draining lymph 
nodes (LDLN) were processed into single cell suspension and re-infected with RSV in vitro for 48 hours to determine cytokine 
protein levels (N = 5). Data represent Mean ± SEM. Representative of at least 2 independent experiments. * = p < 0.05; 
** = p < 0.01; *** = p < 0.001; **** = p < 0.0001. 
 
4.5. Discussion 
 RSV is an ubiquitous pathogen, infecting nearly all children by the age of two1,2 and is the 
second most likely cause of death by a pathogen in infants under the age of one24.  RSV is 






re-infection throughout life.  Additionally, clinical data support a link between early life severe 
RSV infection and the development of airway disease later in life, including asthma1,3,58,94. 
Therefore, elucidation of mechanisms that drive disease is crucial for protection from both primary 
infection and exacerbated diseases later in life. While epigenetic alterations of DC have been 
described that change their overall function, including DNA methylation and chromatin 
modifications, the specific changes during different diseases will require individual investigation.  
To extend our earlier observations in DC37,89, we sought to examine the role of specific epigenetic 
effects on DC-driven mechanisms following RSV infection. These altered innate immune 
responses are impactful as in vivo inhibition of KDM6 enzymes leads to decreased RSV-driven 
immunopathology. These studies indicate the following novel findings:  1) Upregulation of key 
epigenetic enzymes, such as KDM6 demethylases, following RSV infection leads to altered APC 
function, increased pro-inflammatory responses, and immunopathology and 2) targeting specific 
epigenetic mechanisms that alter inflammatory DC responses may be pivotal for limiting long-
term RSV-driven disease pathologies. Thus, an early viral response may specifically "train" innate 
immune cells leading to long-term phenotypes. 
Previous studies have shown that epigenetic modulation directs the differentiation and 
maturation of immune cells. A key epigenetic gene modifier is H3K27 tri-methylation, which 
represses gene transcription, and removal of this mark by KDM6 demethylases leads to active gene 
transcription.  Studies have shown that KDM6B can enhance both pro-inflammatory and anti-
inflammatory responses by targeting distinct transcription factors, such as NF-kB137,220,221 in a 
context-dependent manner in gene promoters137. KDM6B can drive M2 polarization via STAT6 
activation222, Th1 cell differentiation via Tbet interaction223, and support EMT pathways via TGF-






experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis, with chemical 
inhibition leading to a tolerogenic DC phenotype and decreased Th1 and Th17 responses139.  
Importantly, the KDM6 family of enzymes has been shown to regulate not only H3K27me3 but 
also H3K4me deposition through stabilization of the MLL complex135,136, an H3K4 
methyltransferase that deposits activating methylation marks on the histone tail.   Studies have 
shown that the overexpression of KDM6B leads to increased H3K4me3 while leaving H3K27me 
relatively unchanged225 similar to our observations of H3K4me3 on CD80/86.  Overall our data 
expand on the inflammatory role for KDM6 in driving pathologic diseases, linking innate cytokine 
production by inflammatory DC and induction of Th2 cytokines leading to lung immunopathology 
in RSV infection. 
The myeloid/inflammatory DC has been linked to chronic disease that is enhanced and/or 
exacerbated by RSV29,89,226.  Our lab has previously observed an upregulation of KDM5B, an 
H3K4 demethylase, following RSV infection of DCs37 that contributes to a pathogenic T cell-
mediated immune response due to the regulation of critical innate cytokines, especially Type I 
IFN. While KDM6A/B are upregulated following RSV infection, PolyI:C, a double stranded RNA 
and TLR3 agonist did not induce KDM6 expression37.  Interestingly, KDM5B and KDM6 do not 
appear to regulate the same genes. To evaluate KDM6 targets, inhibition of KDM6 enzymatic 
activity was accomplished using GSK J4, which has previously been shown to be specific for 
KDM6 activity215.  While a study determined minor GSK J4 activity against KDM5 enzymes as 
well227, no increase in the level of H3K4me3 on the CD80/86 promoter regions was observed in 
our data, an expected enzymatic activity if KDM5, a H3K4 demethylase, was inhibited.  
Furthermore, RSV-infected BMDC with inhibited KDM6 enzymatic function led to decreased 






chemokines; whereas our previous studies with KDM5B inhibition showed an increase in IL-6 as 
well as IFN-β with no alteration of APC markers37.  Importantly, decreased infiltration of 
inflammatory DC/macrophages into the lung, as well as decreased activation of T cells were 
observed following inhibition of KDM6 during in vivo RSV infection. These latter studies 
demonstrated that inhibition of KDM6 demethylation led to a reduction of Th2 induced pathology, 
including development of mucus hypersecretion. These data indicate that the effect of KDM6 
activity alters both the innate as well as adaptive immune responses in a related but different 
mechanism from KDM5B, largely through alteration of APC function. Thus, there appears to be 
an epigenetic program that controls multiple chromatin modifying enzymes that alters the ability 
of the immune response to function appropriately during RSV infection.  
 These studies demonstrate a novel pathway whereby RSV infection leads to upregulation 
of epigenetic enzymes KDM6A and KDM6B that modify multiple DC functions. These include 
maturation of APC including costimulatory molecule expression as well as activation of defined 
chemokines and cytokines responsible for RSV-driven immunopathology (Figure 4-6).  Inhibition 
of this activity leads to protection from Th2-driven lung pathogenesis that has been linked both to 
the exacerbated response following RSV vaccination228–230 and the enhanced likelihood of asthma 
development later in life1,3,58,94. While these studies focused on DC-driven T cell adaptive 
responses due to their role in immunopathology, it is likely that the in vivo use of GSK J4 blocked 
multiple responses, including directly modifying macrophages and T cells. Thus, KDM6 may be 
a therapeutic target that could alter the progression of pathogenic immune responses in the lung 







Figure 4- 6. RSV infection leads to upregulation of epigenetic enzymes KDM6A and KDM6B to enhance 
immunopathology.  







Chapter 5:  Discussion and Future Directions 
5.1. Sex-Associated Long-term Local Alterations Following Early-life RSV-infection 
The studies presented in this dissertation provide novel evidence that correlates with 
clinical data indicating:  1) Boys are more susceptible to severe RSV than girls and 2) Boys are 
more likely to develop childhood allergy and asthma than girls.  In addition to these findings, we 
have shown novel results indicating that TSLP has a sex-associated role in RSV-driven allergic 
exacerbation in males.  This expands on data already suggesting that TSLP leads to asthma 
pathogenesis and correlates with GWAS studies indicating that specific SNPs in TSLP lead to 
different responses in males vs females; specifically SNP1837253 leads to protection from asthma 
in boys whereas SNP2289276 leads to enhanced likelihood of asthma development in girls157.  
Collectively, these data indicate clear sex differences in TSLP responses to asthma. 
We have shown that upon primary infection with RSV, neonatal female mice are able to 
clear RSV viral infection faster than males with a correlative increase in IFN-β expression.  We 
also show that males have protracted resolution of the immune response and evidence of persistent 
inflammation. These data suggest that not only are males more susceptible to the initial viral 
infection with difficulty clearing the virus but they may also be susceptible to severe disease later 
in life due to the persistent inflammatory response priming for Th2 responses later in life. 
Studies have previously shown that long-term alterations in the lung occur following RSV 
that include continued mucus expression and inflammatory cell infiltration into the lungs46,47.  Our 
data at 4 weeks post-early-life RSV-infection expand upon these findings, with visible mucus 






ILC2).  While we see no significant differences in the number of T cells within the lungs, 
we do observe strong increases in antigen presenting cells-CD11b+ and CD103+ dendritic cells 
(DC).  The sheer number of inflammatory CD11b+ DC have previously been indicated in leading 
to severe disease29,89 as well as exacerbation upon secondary exposures when transferred to the 
lungs of naïve animals prior to live RSV-infection37,89.  Additionally, CD103+ DC have been 
shown to produce strong Th2 responses during RSV and asthma89,231.  We also see increases in 
OX-40L+ DC as well as total OX-40L positive cells.  TSLP, which is persistently expressed in 
male mice at 4 weeks post-infection, is responsible for upregulation of OX-40L on DC populations 
that promote Th2 cell responses41,112,151.  Also, of note, ILC2 cells have been shown to upregulate 
OX-40L to interact with T cells to enhance the Th2 response232,233; however, IL-33 (also retained 
at 4 weeks post-infection) was shown to be the driver of this pathway.  Whether or not TSLP has 
the ability to drive this phenomenon is currently unknown.   
We determined that these long-term alterations in male mice leave them susceptible to 
exacerbated allergic responses later in life; characterized by an increased expression of mucus as 
well as Th2/Th17-skewing when given an early-life RSV infection followed by cockroach allergen 
(CRA) exposure at 4 weeks post-early-life RSV.  No difference in absolute numbers of T cells 
compared to female mice was observed, but there are differences in T cell responses as indicated 
by CRA re-stimulated lymph node cytokine production.  This may be due to specificity of the T 
cells in responding to CRA or it could be due to alterations of the antigen presenting cells as there 
are increases in the number of macrophages, monocytes and DC in the RSV-exacerbated CRA-
challenged male mice.  Correlating with the data described above at 4 weeks post-infection, we 
see that the main population affected is the ILC2 population.  These data support previous findings 






pathogenesis.  The specific role that ILC2 have in this response was not determined in these 
studies; therefore, further analysis of this population through knockdown or genetic 
reduction/deletion (ST2-/-, RORaflox/IL7RCre) studies may be necessary.  Of important note, we 
see a similar exacerbated response only in males when CRA challenge is initiated at 12-weeks 
post-infection (data not shown), indicating that this phenotype is long-lived and well-established.   
When TSLP signaling is knocked down, there is a significant reduction in the male 
exacerbation response.  These data correlate with previous findings showing that when TSLP is 
inhibited during an early-life RSV infection, exacerbation following a second RSV-infection later 
in life is abrogated118.  This study found that if TSLP was inhibited during the latter, secondary 
infection, exacerbation still occurred suggesting that it is the neonatal period that needs to be 
altered to prevent secondary exacerbations later in life.  In our studies, we saw that simply 
inhibiting TSLP during the allergen challenge phase of the study (without early-life RSV-
infection) was not sufficient to protect against allergy development, similar to these findings as 
well as others, including granuloma development during parasitic helminth responses161.   
As noted above, female mice are capable of upregulating IFN-β much quicker and to a 
greater extent than male mice, which indicates faster viral clearance and better resolution of the 
Th2 response.  However, this needs further exploration to determine 1) Why/how females produce 
more IFN-β than males and 2) Whether IFN-β is capable of inhibiting TSLP or vice versa.  
Interestingly, we also see that TSLPR-/- male mice show a similar phenotype to female mice 
following neonatal RSV-infection, producing higher levels of IFN-β and quicker viral clearance 
than do WT male mice (Appendix 4; Figure A4-1A,B).  These data support the idea that TSLP is 
regulating production of IFN-β in male mice; however, why TSLP is increased in males (i.e. 






findings. Since our RNAscope staining indicated that it is the airway epithelial cells that express 
increased TSLP in RSV-infected male mice, focus on this subset should be maintained for future 
experiments.   
5.2. Long-term Systemic Alterations of BMDC Following Early-life RSV-infection 
These studies determined that there are also persistent systemic alterations of BMDC 
following early-life RSV-infection linked to TSLP signaling.  While this is a novel finding, the 
concept of persistent systemic alterations has been eluded to for quite some time.  A vaccine trial 
in the 1960s with formalin-inactivated RSV led to enhanced disease, including 2 deaths, when 
vaccinated infants were exposed to live viral infection25–27.  The details of this phenomenon have 
been extensively studied and determined that this was largely due to lack of TLR signaling and 
improper initial response to viral antigen during the vaccination that led to alterations of the 
immune system and subsequent enhanced immune response upon live infection228,234,235.  This has 
been further studied in other models, such as exposures to LPS and C. albicans, and has since been 
termed trained innate immunity122,126,127. The studies detailed here show that 1) BMDC populations 
are persistently altered to remain in a more activated “DC2” state, possibly skewing the BMDC 
response towards inflammatory rather than tolerant responses upon exposure to allergen and 2) 
TSLP is at least partially responsible for the skewed activation state in male mice. 
BMDC isolated at 4 weeks post-infection from male mice infected neonatally at 7 days of 
age show significant signs of persistent activation, including upregulation of maturation markers, 
(CD80/86, OX-40L).  The presence of OX-40L is implicated in DC-driven Th2 responses and the 
concomitant expression of CD80/86 is necessary for optimal OX-40 responses41,175,236. The 
presence of these maturation markers suggest that DC are primed to lead to strong Th2 responses 






inflammatory cytokines/chemokines, even though antigenic stimulation is no longer present, 
suggesting a shift in transcriptional activation possibly through stabilization of histone or 
chromatin marks or the increased expression of upstream modifiers, such as transcription factors 
or histone/DNA modifiers as has been described during trained innate immunity122,126.  
Interestingly, our analysis shows that the epigenetic enzyme, KDM6B continues to be expressed 
in the BMDC isolated from early-life RSV-infected male mice.  KDM6B is a known enhancer of 
the inflammatory response134,213,213,220 and has been linked with M2 macrophage polarization134.  
Additionally, studies also show that KDM6 enzymatic activity is required for upregulation of 
maturation markers such as CD80/86 and plays a role in the expression of the same group of 
cytokines and chemokines.  These data suggest that the continued expression of KDM6B may be 
allowing for the activation status of these BMDC.  We also show increased expression of TSLP 
and its downstream target, CCL-17.  Importantly, it has been reported that CCL-17 is a direct target 
for KDM6 activity and that the removal of the H3K27me3 mark by KDM6B is required for 
activation of CCL-17 transcription237 suggesting a possible link between TSLP signaling, CCL-17 
and KDM6B.  Additional studies showed that KDM6B demethylase activity is required for the 
activation of IRF4 which then leads to the upregulation of CCL-17238. Of particular note, this same 
persistent activation does not occur in BMDC isolated from female mice following an early-life 
RSV-infection which further supports a sex-specific role for long-term alterations following early-
life RSV infection with a link to TSLP; however, male/female differences in the BMDC population 
should be further evaluated. 
 The presence of TSLP during differentiation of naïve WT BMDC in cell culture led to 
similar activation and cytokine/chemokine response as the BMDC isolated from early-life RSV 






enzymes.  Additional evaluation was performed using BMDC from TSLPR-/- mice infected during 
early-life and we observed abrogation of the “activated” phenotype; however, lack of a significant 
change in KDM6 expression was observed.  Therefore, while we’ve shown that TSLP induces 
Kdm6 expression, a lack of TSLP signaling is not sufficient to abolish its upregulation following 
RSV-infection, which is not surprising since multiple pathways, including NF-ΚB and JAK/STAT 
are known to lead to KDM6 activity137.   
ATAC-seq data show significant differences in chromatin landscape between TSLPR-/- 
and WT BMDC with inherent differences in regions near genes linked with type 1 immunity 
(Mid1, Spp1, Cxcl11) and Th2 responses (Cxcl1, Cxcl2, Irf4, Areg) that could lead to better viral 
control in TSLPR-/- mice while leading to enhanced Th2 disease in WT.   BART analysis of genes 
in differentially accessible regions (DARs) depicted transcription factors linked to Th2 and TSLP-
signaling (IRF4, RELA, STAT3)41,112,170,194–196 as being significant.  IRF4 was both a transcription 
factor linked to accessible genes in the DARs as well a gene itself within the DAR predictions 
suggested to have more accessible chromatin in WT BMDC.  TSLP is known to increase the 
expression of IRF4 and to regulate similar genes and Th2 responses170.  However, these data show 
a novel role for TSLP regulation of IRF4 at the chromatin level in BMDC which could be linked 
to KDM6B. IRF4 is a target gene of KDM6B238 and therefore, TSLP-driven expression of KDM6B 
may lead to the removal of methylation from H3K27 on IRF4 promoter regions leading to more 
accessible chromatin.  Together, this indicates more accessibility to IRF4 target genes as well as 
more IRF4 available to bind to these regions which could contribute to an accelerated and more 
pronounced Th2 response.   
Further characterization of Mid1 showed a very strong association for TSLP regulation of 






BMDC compared to WT BMDC and upon in vitro RSV-infection, TSLPR-/- BMDC have an 
accelerated type-1 response.  Co-culture studies showed that TSLPR-/- BMDC exposed to reactive 
T cells allow for stronger IFN-γ production than WT BMDC.  Together, these data indicate a more 
appropriate anti-viral response in the absence of TSLP signaling and further strengthen the 
argument for TSLP/IFN-β regulation. Knockdown experiments targeting Mid1 and Ifnb, especially 
in TSLPR-/- BMDC, will help to further elucidate this regulation.   
Planned RNA-seq experiments on WT and TSLPR-/- BMDC following in vitro RSV 
infection to evaluate initial RSV-infection will lead to further insights into TSLP-driven RSV 
responses. Additionally, the data here have shown a striking observation of the ability of TSLP to 
alter the genomic landscape of BMDC populations; however, it will be beneficial to further expand 
this knowledge to determine if this phenomenon occurs at the progenitor level.  Experiments are 
planned to perform ATAC-seq on the common myeloid progenitor (CMP) cells isolated from WT 
and TSLPR-/- mice following early-life RSV infection.   
5.3. Role of KDM6 Epigenetic Enzymes in RSV-driven Immunopathology 
The next set of findings show a novel role for the H3K27 demethylase, KDM6, in 
enhancing RSV-driven immunopathology. The KDM6 family of enzymes has previously been 
indicated as an epigenetic enzyme required for fine-tuning the inflammatory response137,213,220.  
Studies from our lab have specifically identified a role for the histone demethylase, KDM5B, in 
regulation of the immune response to RSV by inhibiting type-1 IFN.  To expand upon this 
knowledge, we further investigated histone demethylases, focusing on KDM6.  Findings from 
these studies determined that 1) KDM6 epigenetic enzymes are upregulated during RSV-infection 
2) Inhibition of their activity leads to protection from immunopathology and 3) Targeting DC 






above in the previous section, these studies show evidence of innate immune cell “training” 
following RSV-infection. 
In these groups of studies, we discovered that RSV infection led to upregulation of KDM6 
enzymes in the inflammatory CD11c+ DC population within the lungs as well as BMDC.  We 
utilized the KDM6 inhibitor GSK J4 to inhibit KDM6 enzymatic activity and show that inhibition 
of this activity leads to a similar phenotype as that observed in TSLPR-/- BMDC, with decreased 
maturation marker expression and pro-inflammatory cytokine/chemokine expression.  Evaluation 
of ChIP-PCR determined that the decrease in activation marker upregulation was directly linked 
with increased H3K27me3 (a repressive mark) as well as a decrease in H3K4me3 (an activating 
mark).  These results are supported by previous studies which indicate that KDM6 activity also 
alters H3K4 methylation239,240.  In fact, one study determined that the over expression of KDM6B 
led to very little change in H3K27me3 but significant increases in H3K4me3 that led to specific 
gene activation.  This is likely due to interactions of KDM6 with ASH2L, a component of the MLL 
complex which deposits the H3K4 methylation mark241 or its possible interactions with other 
epigenetic enzymes.   
Additional studies determined that alterations of the T cell response to RSV-infected 
BMDC are diminished when KDM6-inhbited BMDC are exposed to reactive T cells, including 
decreased production of IL-5, IL-17A and IFN-γ.  These data support a role for KDM6 in the 
overall inflammatory response and are correlated by data presented by Doñas et al139 that show 
that DC-specific inhibition by GSK J4 leads to a more tolerogenic DC phenotype with decreased 
IL-17A and IFN-γ production in a model of experimental autoimmune encephalomyelitis 
(EAE)139.   Inflammatory DC are able to lead to enhanced secondary responses when transferred 






as show that this enhanced response is decreased in KDM6-inhibited BMDC.  Specifically, we see 
significant decreases in inflammatory cell infiltration that correlates with decreased expression of 
chemokines as seen in KDM6-inhibited BMDC following in vitro RSV infection.  These data 
indicate that KDM6 activity plays a role in enhancing secondary RSV infection similar to that seen 
in vaccine-linked exacerbation25–27,228,235.   
Importantly, in vivo treatment with GSK J4 leads to decreased immunopathology and 
inflammatory cell infiltration into the lung, suggesting that KDM6 activity is crucial for RSV-
driven immunopathology.  A decrease in infiltration of activated APC into the lungs was observed 
with GSK J4 treatment, correlating with the above data of KDM6 alteration of APC function.  
However, the number of activated T cells are also decreased when KDM6 activity is inhibited 
indicating a role in the adaptive response, whether through APC function or directly related to 
KDM6 activity on T cells.  Studies have shown that KDM6 specifically targets T cells and is 
responsible for determining T cell differentiation in a tissue dependent manner242–245.  For example, 
it was determined that in the colon and lymph node, knockdown of KDM6B led to increased IFN-
γ producing Th1 cells but decreases in the small intestine and spleen, and IL-4 producing Th2 cells 
were increased in the small intestine and colon but unchanged in the spleen and lymph node in the 
absence of KDM6B243.  Finally, IL-17 producing Th17 cells were also increased in the small 
intestine and colon but unchanged in the lymph node243.  Furthermore, while our studies described 
here focused on the DC population, we also see alterations in monocytes and macrophages in in 
vivo studies; hence other innate cells may also be affected either through indirect alteration by DC 
or directly by KDM6 and may require further exploration.  
Collectively, these data suggest that KDM6 expression from BMDC leads to activation of 






lung that ultimately lead to activation of T cells that drive RSV-driven immunopathology.  It 
should be noted that the activation and pro-inflammatory response is necessary for proper viral 
clearance and activation of the immune response; however, the persistence of this response can be 
detrimental and lead to immunopathology7,246–250. Elucidation of these mechanisms and how they 
lead to persistent alterations will be crucial to balance the two and lead to protection from disease. 
It is interesting to note that the studies identifying long-term alterations of BMDC 
following early-life RSV-infection (Chapter 3) show a similar phenotype to that observed in the 
presence of KDM6 activity.  The long-term alterations following early-life RSV infection also 
include KDM6B expression; therefore, it is not unreasonable to conclude that these may be linked.  
TSLP and KDM6 both lead to BMDC phenotype linked to persistent activation and we have shown 
that TSLP leads to upregulation of KDM6A/B.  However, it is critical to point out that knockdown 
of TSLP signaling led to an increase in IFN-γ while inhibition of KDM6 activity led to a decrease.  
It is likely that they have overlapping as well as distinct roles in these responses; TSLP may be 
limiting the anti-viral response while KDM6 is concomitantly contributing to enhanced/persistent 
inflammation.  When considering treatment options, TSLP may be a better target during early 
infection but epigenetic targeting, such as KDM6, may need to be considered later in life, after 
immunopathology has been established. This scenario is supported by literature that indicates that 
targeting TSLP later in life, after an RSV-infection or during chronic allergy, has minimal 
protection against enhanced disease118,153, suggesting that the window for treatment with anti-
TSLP is narrow.  Additionally, targeting epigenetic enzymes such as KDM6 during strong 
persistent inflammatory responses has been suggested in other disease, such as cancer251–254. To 
test this hypothesis, we plan to perform time-course studies.  The use of anti-TSLP monoclonal 






infection, during peak RSV infection (4 days post-infection) at the time of immunopathology 
development (8 days post-infection) and prior to allergen challenge.  Similar studies will be 
performed using GSK J4 to inhibit KDM6 enzymatic activity in neonatal mice at the same time 
points.  This will help to elucidate when these key players are contributing to RSV disease and to 
offer insights to be adopted into the clinic.  
5.4. Conclusions and Future Studies 
Overall, the studies described in this dissertation have determined a novel role for TSLP in the 
neonatal response to RSV by altering transcriptional and epigenetic pathways of immune cell 
populations in a sex-dependent manner to persistently alter the immune system.  These studies 
have helped to elucidate why boys may be more susceptible to severe RSV-infection and have 
more incidences of childhood asthma than do girls and have identified TSLP as a possibly 
relevant clinical target, specifically in boys hospitalized due to severe RSV disease.  
Importantly, there is a monoclonal TSLP antibody currently being tested in clinical trials in adult 
asthmatics that could be used for this target.  Our data further suggest that the innate immune 
system can itself lead to strong immunological memory; indicating that targeting innate immune 
responses should be considered when determining treatment options as well as vaccine 
development.  While the field has made striking discoveries in RSV biology and mechanisms, 
much more is left to be discovered and studies beyond what have been presented here need to be 
considered. 
We show strong support for the role of TSLP in male-specific pathologies but it will be crucial 
to determine what is leading to persistent upregulation of TSLP. We have data to suggest that this 
may be due to decreased ability of males to produce IFN-β.  Without type-1 interferon to inhibit 






phenotype.  On the other hand, there may be a direct effect on TSLP expression itself through 
epigenetic mechanisms that lead to the persistent activation of TSLP, such as remodeling and 
stability of chromatin activation marks/accessibility or the persistence of epigenetic modifiers 
and/or transcription factors.  Finally, it may be a combination of both of these scenarios. 
How or why IFN-β is expressed to a greater extent in females than in males needs to be 
evaluated.  A previous study has shown that plasmacytoid DC (pDC) isolated from females 
produce more IFN-α than do pDC isolated from males164. A similar phenomenon has not yet been 
reported for IFN-β but there is support for this idea. TLR7 and IRAK-1, both found on the X 
chromosome, have the ability to escape X-inactivation255,256, and lead to high levels of IFN-β257–
260.  Furthermore, neonatal female infants have significantly higher levels of IRAK-1 in their cord 
blood compared to male infants256.  The TLR7/IRAK pathway has also been implicated in Th1-
driven autoimmune disease, which is more common in females than males260–263. Therefore, RSV 
stimulation through TLR7 may lead to a stronger IFN-β response in females.  Future studies to 
examine the role of TLR7 could be performed using TLR7 knockout mice.  There are multiple 
chemical inhibitors of the IRAK proteins, including IRAK-1, which could also be used to 
interrogate this pathway, specifically in female mice. While females are protected from allergic 
responses following early-life RSV infection, it would be intriguing to evaluate if there is a link 
between early-life RSV infection in females and increased incidences of autoimmunity.  Our 
studies here have focused on the expression of only IFN-β and cDC populations; interrogating the 
role of IFN-α and pDC may further enhance these findings and determine what specific IFN 
subtypes are involved in this model. 
Questions also remain about the role of hormones.  During childhood, the levels of female 






puberty264,265.  However, testosterone is known to peak and wane throughout childhood to develop 
male-specific characteristics and the first testosterone peak occurs between 2-4 months of age265.  
Interestingly, clinical data indicate that the infants with the highest likelihood to develop severe 
RSV disease resulting in hospitalization during peak RSV season are male AND 3-6 months of 
age266–269 correlating with this testosterone peak.  It might also be interesting to examine a cohort 
of males hospitalized with severe RSV disease and observe future viral/allergic exacerbations for 
correlations with testosterone peaks.  Additionally, it is known that TLR3/4 stimulation inhibits 
testosterone signaling and once testosterone dips to a low enough level, Tyro/Axl/Mer (TAM) 
proteins are produced to downregulate TLR3/4270,271.  Low level testosterone, as that observed in 
neonatal males, indicates that TLR3/4 would likely be shut down rapidly to inhibit this signaling 
and subsequently type-1 IFN.  Since RSV signals through TLR3/4, this pathway in males may be 
inhibiting production of IFN-β.  Interrogation of this pathway would be very difficult as it is likely 
dose-dependent as the incidence of allergy/asthma switches to more predominantly female after 
puberty.  High levels of androgen have been shown to decrease Th2 response272 while large spikes 
in estrogen/progesterone are known to lead to Th2 response as well as TSLP induction273–275 during 
puberty in females, which may explain this switch of predominance.   
Another pathway to consider is androgen/MID1.  Studies in castrate-resistant prostate cancer 
have determined that androgen is a strong inhibitor of MID1 and in the absence of testosterone, 
MID1 expression is highly increased276.  Testosterone in the male may be inhibiting the type-1 
pathway through inhibition of MID1.  We have observed significant differences in the expression 
of Mid1 in WT vs TSLPR-/- BMDC isolated from male mice with TSLPR-/- BMDC having higher 
expression of Mid1, suggesting that testosterone alone is not enough to inhibit MID1.  It is possible, 






testosterone upregulates HIF-1α277 and HIF-1α, which is induced during RSV-infection, leads to 
the expression of TSLP278,279.  Therefore, a reasonable scenario is that during RSV infection, HIF-
1α is expressed to a greater extent in male mice due to the presence of testosterone that leads to 
increased expression of TSLP and TSLP then targets MID1 for inhibition.  HIF-1α also has the 
ability to increase production of testosterone280, suggesting that this could lead to a continuous 
positive feedback loop. Additionally, HIF-1α targets KDM6B, which is also persistently expressed 
in BMDC from early-life RSV-infected male mice, further supporting a role for its involvement in 
these responses. HIF-1α inhibitors have been developed as well as HIF-1α flox/Cre mouse systems 
that could be used to elucidate this pathway which would have an impact on multiple fields of 
study.   
Our data described in these studies as well as the differences in TLR signaling between males 
and females suggest that sex of the infant should be considered when determining treatment 
options during RSV infection and vaccine development. For instance, knockdown of TSLP 
signaling had no additional protection in the early-life RSV-infected female mice when exposed 
to allergen; therefore, whether this treatment would be beneficial in treating females in not clear.  
Additionally, since the 1960s vaccine trial failure was attributed to improper TLR signaling 
following vaccination228,234,235, TLR-specific adjuvants should be considered for successful RSV 
vaccine development.  However, different TLR adjuvants may be needed dependent on sex of the 
infant; a TLR7 adjuvant may lead to increased likelihood of autoimmune disease in females while 
TLR3/4 adjuvant in males be unsuccessful due to increased inhibition by testosterone and/or 
deleterious effects on testosterone signaling. 
 In addition to the studies detailed in this dissertation, we have evidence that early-life RSV-






Airway remodeling, including fibrotic deposition, is a hallmark symptom of asthma281 and RSV-
infection has previously been suggested to lead to fibrosis and collagen deposition93.  ILC2 
production of amphiregulin (Areg), while necessary for lung repair following epithelial injury, 
may lead to lung fibrosis75,282,283 and  DC-specific AREG is linked to ILC2-driven 
inflammation/fibrotic responses284. Studies with TSLP have indicated that it is required for 
initiation/persistence of airway remodeling during chronic allergy285, that may or may not be 
directly immune-related. It is interesting to note that we see increased CD45+ cells in lungs 
isolated at 4 weeks post-infection from early-life RSV-infected male mice (Appendix 4; Figure 
4-2A-C) that correlates with increased DC and ILC2 shown in Figure 2-4, whereas TSLPR-/- 
mice appear more like naive (Appendix 4; Figure 4-2A-C).  Furthermore, Areg was a predicted 
DAR gene in WT BMDC suggesting a role for TSLP in this pathway that will be further evaluated.  
Remodeling is also directly linked to a decrease in lung function during pulmonary function tests 
(PFT)286,287. At 4 weeks post-early-life RSV-infection, we performed PFT and observed significant 
defects in measured parameters consistent with decreased lung function (Appendix 4; Figure A4-
3A-D).  These data correlate with clinical data as well as that which is seen during bleomycin 
treatment and the fibrotic response288–290.   
Airway simplification may also occur following RSV-infection and is another hallmark of 
childhood pulmonary pathologies291 that leads to either physically larger airways or less elasticity 
in the airways causing a “floppy” lung or a lung that is unable to inflate/deflate properly.  To 
evaluate airway simplification, we observed the distal airways in histological slides and found that 
early-life RSV-infected male lungs have a simplified appearance compared to naïve age-matched 
controls and TSLPR-/- mice (Appendix 4; Figure A4-4A).  The Wellik lab determined that 






and that knockout of these genes leads to lung simplification292.  Evaluation of HOX5 genes 
(Hox5a/b) showed that WT early-life RSV-infected male mice have slightly decreased HOX 
expression (~30%) compared to naïve and that lack of TSLP signaling rescues this expression 
(Appendix 4; Figure 4-4B).  While these are exciting preliminary findings, much more work 
needs to be done to verify these phenotypes and determine the mechanism of how RSV and TSLP 
could be altering lung development. 
In conclusion, the studies described in this dissertation have elucidated novel and exciting 
aspects of RSV-driven immunopathology and suggest that it is imperative to consider sex 
differences in neonates as well as the innate immune system during RSV disease. To our 
knowledge, this is the first time that a sex-specific role for TSLP has been shown as well as a link 
between TSLP regulation of IFN-β and MID1 pathway during RSV-infection (Figure 5-1). These 
studies have also led to unanswered questions that may be more thoroughly explored to further 
increase our knowledge and understanding of RSV.  Hopefully, together with other published 
literature, this will ultimately lead to better treatment options and the development of a successful 
vaccine candidate which will not only decrease RSV burden but will also limit the development 
of childhood asthma, the number one chronic childhood illness.   
 
Figure 5- 1. Proposed model of TSLP-driven immune alterations leading to enhanced allergic response in male mice 
following early-life RSV-infection.  






Appendix 1:  Chapter 2 Supplemental Figures 
 
 
Figure A1- 1. Naïve neonatal male and female mice have similar local lung environment.   
Tissues were collected from age-matched male and female uninfected mice at the time of 2 (9 days old), 8 (15 days old), and 14 
(21 days old) day post-infection analysis for infected mice. A,B. Lungs were embedded in paraffin and Periodic acid-Schiff stain 
(PAS) was performed.  Representative photos shown 
 
 
Figure A1- 2. Naïve male and female mice have similar local lung environment at 5 weeks of age.   
Tissues were collected from 5 week old male and female uninfected mice at the time of 4 week post-infection analysis for infected 
mice. A,B. Lungs were embedded in paraffin and Periodic acid-Schiff stain (PAS) was performed.  Representative photos shown 
C-E. Lungs were homogenized and mRNA extracted to determine relative gene expression compared to 18s housekeeping gene 







Figure A1- 3. No significant differences are observed in male and female WT or TSLPR-/- mice following CRA challenge 
alone.   
Male and Female WT and TSLPR-/- mice were exposed to CRA allergen challenge at 5 weeks of age (initiated at the time of 4 
weeks post-infection for RSV/CRA animals). A. Lungs were embedded in paraffin and Periodic acid-Schiff stain (PAS) was 
performed to visualize mucus (bright pink staining).  Representative photos shown B.  AHR was determined using full-body 
plethysmography and methacholine challenge (N ≥ 3) C, D. Lungs were homogenized and mRNA extracted to determine mucus 
and cytokine gene expression (N ≥ 3) E, F. Lungs were processed into single-cell suspension and stained for flow cytometry 
analysis. (N ≥ 7) G.  Lung draining lymph nodes in single cell suspension were re-stimulated with CRA in vitro for 48 hours to 








Appendix 2:  Chapter 3 Supplemental Figures and Tables 
 
Figure A2- 1. Lack of TSLP signaling in BMDC increases T cell production of IFN-γ.  
RSV-infected DC co-cultured with CD4+ T cells isolated from the lymph nodes of RSV-infected mice at 8 days post-infection.  












p.value FDR gene 
chr5 7.06 8.4E-118 2.0E-113 Crlf2 
chr5 4.95 3.11E-43 3.74E-39 Galnt9 
chr5 2.99 6.15E-42 4.94E-38 Arhgap24 
chr4 2.78 4.67E-16 9.38E-13 Zfp981 
chr5 2.47 6.51E-26 2.24E-22 Pitpnb 
chr5 2.09 9.04E-42 5.44E-38 Crlf2 
MG4310_MG4311_PATCH 2.05 3.35E-17 8.07E-14   
chr4 1.93 2.65E-10 2.90E-07 Zfp981 
chr1 1.67 2.74E-16 6.00E-13 Epha4 
chr5 1.64 2.17E-19 5.80E-16 Arhgap24 
chr6 1.6 1.33E-10 1.52E-07 Mir7661 
chr4 1.57 2.82E-13 4.24E-10 Zfp985 
chr5 1.39 2.99E-10 3.13E-07 Aff1 
chr4 1.34 4.94E-09 4.25E-06 Zfp985 
chr5 1.32 4.44E-13 5.94E-10 Cops4 
chr9 1.27 1.29E-07 7.39E-05 Rwdd2a 
chr5 1.26 1.02E-09 9.84E-07 Arhgap24 
chr15 1.22 3.27E-07 0.000144 Oxr1 
chr4 1.22 2.16E-06 0.000592 Ptprd 
chr9 1.19 1.33E-08 1.07E-05 Rwdd2a 
chr2 1.19 1.69E-07 9.06E-05 Olfr1258 
chr2 1.17 8.56E-07 0.000286 Kif16bos 
chr4 1.12 2.97E-06 0.000777 Zfp985 
chr17 1.11 1.52E-05 0.00265 Kcng3 






chr5 1.08 2.04E-06 0.000579 1700028D13Rik 
chr8 1.08 9.59E-06 0.00192 Gpat4 
chr9 1.08 1.53E-05 0.00265 Gm4668 
chr15 1.07 5.55E-08 3.61E-05 2610037D02Rik 
chr14 1.06 0.000114 0.00989 Tspan14 
chr5 1.04 9.99E-08 6.01E-05 Galnt9 
chr15 1.04 1.44E-05 0.00259 4930430F21Rik 
chrX 1.03 2.85E-09 2.64E-06 Tfe3 
chr6 1.03 8.56E-07 0.000286 Trpv6 
chr18 1.02 7.13E-07 0.00026 Mir1901 
chr15 1.02 5.19E-05 0.00585 Tmem74 
chr5 1.01 2.86E-06 0.000758 Cxcl1 
chr10 1 6.43E-09 5.34E-06 Frk 
chr6 1 1.48E-07 8.13E-05 4930511A08Rik 
chr5 1 2.28E-05 0.00355 Arhgap24 
chr2 0.99 8.00E-07 0.000275 Sdcbp2 
chrX 0.99 3.10E-06 0.000804 Tgif2lx2 
chrX 0.98 1.17E-13 1.88E-10 Tfe3 
chr3 0.98 4.60E-07 0.000182 Gm5148 
chr12 0.98 6.40E-07 0.000245 Vash1 
chr10 0.98 7.29E-07 0.000261 Rfpl4b 
chr3 0.97 4.99E-08 3.34E-05 Gm29811 
chr5 0.96 1.98E-06 0.000568 Tmem60 
chr5 0.96 6.52E-05 0.00686 Gm10354 
chr4 0.96 0.000142 0.0114 Zfp985 
chr1 0.94 2.83E-07 0.000131 Rdh10 
chr12 0.93 1.01E-05 0.00199 Galc 






chr5 0.93 0.000487 0.0236 Cpeb2 
chrX 0.92 3.80E-05 0.00485 Nap1l3 
chr5 0.91 4.21E-08 2.90E-05 Rasgef1b 
chr7 0.91 1.80E-06 0.000527 Tead1 
chr15 0.91 9.45E-05 0.00879 Khdrbs3 
chr5 0.91 0.000125 0.0105 Galnt11 
chr2 0.9 1.17E-06 0.000376 1700021F07Rik 
chr14 0.9 4.40E-06 0.00103 Blk 
chr18 0.89 2.19E-07 0.000108 4930426D05Rik 
chr2 0.89 2.65E-07 0.000125 Olfr1258 
chr8 0.89 9.25E-06 0.00189 AW046200 
chr6 0.89 1.70E-05 0.00284 Pdzrn3 
chr1 0.89 0.000558 0.0255 Rgs18 
chr14 0.88 1.02E-07 6.01E-05 Pcca 
chr10 0.88 3.40E-06 0.00086 Syt1 
chr16 0.88 4.82E-06 0.00107 Ltn1 
chr10 0.88 2.46E-05 0.00368 Cabcoco1 
chr18 0.88 6.53E-05 0.00686 Mir6356 
chr9 0.88 0.000216 0.0141 Gm32014 
chr18 0.87 1.48E-07 8.13E-05 Lyzl1 
chr5 0.87 3.68E-05 0.0048 Lin54 
chr4 0.87 0.000182 0.0131 Acot7 
chr1 0.87 0.000284 0.0168 Ercc5 
chr5 0.87 0.000857 0.0325 Igfbp7 
chr5 0.86 9.08E-06 0.00187 Cdc7 
chrX 0.86 9.52E-06 0.00192 Klhl34 
chr1 0.85 6.28E-07 0.000244 Brinp3 






chr12 0.85 6.42E-06 0.00136 Rapgef5 
chr2 0.85 7.07E-05 0.00724 Trp53rkb 
chr6 0.85 0.000187 0.0134 Eps8 
chr5 0.84 1.63E-06 0.000497 Gm7854 
chr2 0.84 3.46E-06 0.00086 Vapb 
chr14 0.84 4.70E-06 0.00106 Tbc1d4 
chr5 0.84 3.57E-05 0.00473 Rasl11b 
chrX 0.84 4.21E-05 0.00512 Ndp 
chr4 0.84 5.46E-05 0.00609 Usp24 
chr12 0.83 2.01E-07 0.000104 Etv1 
chr1 0.83 4.50E-07 0.000182 Lancl1 
chr18 0.83 1.71E-06 0.000514 Mir1901 
chr10 0.83 1.24E-05 0.00238 4921513I03Rik 
chr11 0.83 5.91E-05 0.0065 Itgb3 
chr3 0.83 6.39E-05 0.00684 Odf2l 
chr6 0.82 2.13E-07 0.000107 Bmt2 
chr5 0.82 6.55E-07 0.000246 9630001P10Rik 
chr10 0.82 2.62E-06 0.000702 Ccdc59 
chr4 0.82 3.69E-06 0.000907 Mpdz 
chr5 0.82 4.12E-06 0.000994 Bmp2k 
chr13 0.82 1.29E-05 0.00242 Edil3 
chr3 0.82 3.06E-05 0.00437 Veph1 
chr16 0.82 1.00E-04 0.00913 Myh15 
chr17 0.82 0.000325 0.0181 Rftn1 
chr13 0.82 0.000564 0.0256 Glrx 
chr19 0.81 7.01E-07 0.00026 Mir3970 
chr8 0.81 5.07E-06 0.00111 Rasd2 






chr2 0.81 8.06E-05 0.00783 Dut 
chr15 0.81 0.000147 0.0116 Dab2 
chr5 0.81 0.000206 0.0139 Areg 
chr5 0.81 6.00E-04 0.0267 Tmprss11a 
chr8 0.81 0.00153 0.0431 4930488L21Rik 
chr5 0.8 7.66E-08 4.86E-05 Antxr2 
chr2 0.8 1.09E-05 0.00212 Wipf1 
chr14 0.8 3.39E-05 0.00463 Tdrd3 
chr4 0.8 4.06E-05 0.005 Triqk 
chr9 0.8 0.000145 0.0115 Tmem108 
chr6 0.8 0.000276 0.0166 4930515G16Rik 
chr1 0.8 0.000428 0.0215 Mir5126 
chr6 0.8 0.00147 0.0426 Aebp2 
chr13 0.8 0.00154 0.0431 Mfsd14b 
chr7 0.79 1.43E-06 0.000447 Nucb2 
chr5 0.79 1.90E-06 0.000551 Dthd1 
chr3 0.79 0.000199 0.0137 Atp1a1 
chr11 0.79 0.00023 0.0148 4933427E13Rik 
chr2 0.79 0.000316 0.0178 Taf4 
chr6 0.79 0.000354 0.019 Suclg1 
chr12 0.79 0.000393 0.0204 Lrrn3 
chr17 0.79 0.000721 0.0292 2410021H03Rik 
chr18 0.79 0.00114 0.0371 Mbp 
chr16 0.78 2.13E-06 0.000589 Myh15 
chr1 0.78 2.25E-06 0.000609 Rcsd1 
chr3 0.78 3.43E-06 0.00086 Gyg 
chr4 0.78 3.49E-05 0.00469 Slc46a2 






chr16 0.78 0.000176 0.0129 D16Ertd519e 
chr9 0.78 0.00031 0.0177 Bmper 
chr4 0.78 0.0012 0.0382 Ttc39b 
chr15 0.77 9.81E-10 9.84E-07 Tnfrsf11b 
chr18 0.77 4.28E-06 0.00101 Fam69c 
chr2 0.77 4.68E-06 0.00106 Arhgap21 
chr2 0.77 1.36E-05 0.00249 Mir7002 
chr6 0.77 2.90E-05 0.00423 1700049E22Rik 
chr1 0.77 3.47E-05 0.00469 Aim2 
chr1 0.77 5.00E-05 0.00576 Diexf 
chr17 0.77 5.62E-05 0.00624 Cd2ap 
chr18 0.77 9.93E-05 0.00908 Zfp608 
chr9 0.77 0.000253 0.0158 Tmem108 
chr14 0.77 0.000281 0.0168 Cacna2d3 
chr2 0.77 0.000376 0.0198 Nmi 
chr13 0.76 9.92E-06 0.00196 Rala 
chr15 0.76 1.93E-05 0.00306 Mroh2b 
chr3 0.76 4.10E-05 0.00501 Gm29811 
chr17 0.76 7.85E-05 0.00769 Slc8a1 
chr9 0.76 9.49E-05 0.00879 Slc9a9 
chr2 0.76 0.000102 0.00916 4921531C22Rik 
chr8 0.76 0.000135 0.0111 Mir3108 
chr1 0.76 0.000145 0.0115 Efcab2 
chr6 0.76 0.000153 0.0118 St8sia1 
chr5 0.76 0.000165 0.0125 Scarb2 
chr17 0.76 0.000223 0.0145 Zfp36l2 
chr2 0.76 0.000349 0.0188 Ttc17 






chr10 0.76 0.00147 0.0426 Ipcef1 
chr4 0.76 0.00152 0.0431 A530072M11Rik 
chr10 0.76 0.00193 0.0479 Ncoa7 
chr12 0.75 1.78E-08 1.30E-05 Gm35725 
chr8 0.75 4.57E-07 0.000182 AW046200 
chr17 0.75 2.10E-06 0.000588 Rab5a 
chr7 0.75 5.82E-05 0.00643 AI987944 
chr18 0.75 6.27E-05 0.0068 Ppp2r2b 
chr18 0.75 9.25E-05 0.00864 Fzd8 
chr18 0.75 0.000131 0.0109 B4galt6 
chr2 0.75 0.000139 0.0112 Bcas1os2 
chr12 0.75 0.000271 0.0165 Etv1 
chr4 0.75 0.000273 0.0165 Osbpl9 
chr2 0.75 0.000376 0.0198 Stk39 
chr16 0.75 0.000378 0.0198 Tigit 
chr15 0.75 0.000412 0.0209 Rpl37 
chr3 0.75 0.00105 0.0358 Mir466q 
chr1 0.74 2.33E-07 0.000112 1810006J02Rik 
chr10 0.74 1.04E-06 0.000339 Esr1 
chr14 0.74 1.64E-05 0.0028 Abcc4 
chr2 0.74 2.37E-05 0.00361 Bcas1os2 
chr2 0.74 2.50E-05 0.00372 Cdh4 
chr16 0.74 3.51E-05 0.00469 St3gal6 
chr18 0.74 4.84E-05 0.00569 Chsy3 
chr2 0.74 5.04E-05 0.00576 Kif16b 
chr8 0.74 6.27E-05 0.0068 Efnb2 
chr18 0.74 0.000181 0.0131 Nr3c1 






chr12 0.74 0.000466 0.0227 Gpr65 
chr3 0.73 1.22E-06 0.000386 Agtr1b 
chr18 0.73 2.94E-05 0.00424 Mppe1 
chr14 0.73 5.00E-05 0.00576 Mir6390 
chr14 0.73 6.55E-05 0.00686 Klf5 
chr18 0.73 8.47E-05 0.00806 2210409D07Rik 
chr4 0.73 0.000102 0.00914 Dhrs3 
chr3 0.73 0.000125 0.0105 Col24a1 
chr10 0.73 0.000269 0.0165 Gm29685 
chr7 0.73 0.000292 0.017 Gm4971 
chr3 0.73 0.000324 0.0181 Il12a 
chr2 0.73 0.000748 0.0297 Slc24a3 
chr13 0.73 0.000895 0.033 Actn2 
chr7 0.73 0.000968 0.0344 Ptpre 
chr12 0.73 0.00126 0.0394 Fut8 
chr3 0.73 0.0015 0.0428 Selenof 
chr18 0.73 0.00159 0.044 Colec12 
chr1 0.73 0.00181 0.0469 Dock10 
chr18 0.72 4.62E-06 0.00106 Rab18 
chr2 0.72 6.06E-06 0.00129 Arhgap21 
chrX 0.72 1.27E-05 0.0024 Spin4 
chr1 0.72 1.29E-05 0.00242 Prg4 
chr6 0.72 1.51E-05 0.00265 Edem1 
chr12 0.72 1.57E-05 0.0027 Sp8 
chr1 0.72 3.96E-05 0.005 Irf6 
chr12 0.72 7.24E-05 0.00739 Lrfn5 
chr15 0.72 7.74E-05 0.00761 1700084J12Rik 






chr5 0.72 0.000108 0.00953 Cxcl13 
chr5 0.72 0.000115 0.00991 Arhgap24 
chr18 0.72 0.000125 0.0105 Mkx 
chr7 0.72 0.000185 0.0132 Fam196a 
chr3 0.72 0.00022 0.0143 Rxfp1 
chr5 0.72 0.000299 0.0172 Lrrc8d 
chr8 0.72 0.000326 0.0181 Naf1 
chr15 0.72 0.000332 0.0182 Trio 
chr18 0.72 0.000366 0.0194 Dmxl1 
chrY 0.72 0.000422 0.0213 Gm20871 
chr1 0.72 0.000703 0.029 Tnfrsf11a 
chr16 0.72 0.000735 0.0295 Mb21d2 
chr7 0.72 0.00123 0.0387 Slco3a1 
chr15 0.72 0.00169 0.0454 Gm20740 
chr7 0.71 1.57E-06 0.000486 Xylt1 
chr18 0.71 1.80E-05 0.00295 Setbp1 
chr5 0.71 2.45E-05 0.00368 Hsd17b13 
chr6 0.71 2.52E-05 0.00372 Hpgds 
chr14 0.71 3.69E-05 0.0048 1700100I10Rik 
chr12 0.71 3.72E-05 0.0048 Dhrs7 
chr9 0.71 3.74E-05 0.0048 Tpbg 
chr12 0.71 4.66E-05 0.00554 Eml1 
chr14 0.71 5.15E-05 0.00585 Ggact 
chr3 0.71 6.94E-05 0.00718 Cyr61 
chr2 0.71 7.34E-05 0.00741 Otor 
chr13 0.71 7.52E-05 0.00749 Irf4 
chr1 0.71 8.30E-05 0.00798 Khdc1b 






chr1 0.71 0.000117 0.01 Col19a1 
chr3 0.71 0.000138 0.0112 4930406D18Rik 
chr3 0.71 0.000287 0.0168 A830029E22Rik 
chr8 0.71 0.000314 0.0178 Mir21c 
chr2 0.71 0.000497 0.0238 Fermt1 
chr15 0.71 0.000501 0.0239 Npr3 
chr5 0.71 0.00059 0.0265 Clnk 
chrX 0.71 0.000631 0.0274 Cysltr1 
chr3 0.71 0.000806 0.0312 Platr4 
chr4 0.71 0.00108 0.0361 Adamtsl1 
chr5 0.71 0.00189 0.0477 Arhgap24 
chr18 0.7 8.47E-06 0.00176 Setbp1 
chr13 0.7 3.23E-05 0.0045 Gm3604 
chr12 0.7 3.75E-05 0.0048 Mir669c 
chr18 0.7 8.94E-05 0.00845 Chsy3 
chr5 0.7 0.000104 0.00929 Abcb1b 
chr16 0.7 0.00015 0.0117 Mir691 
chr15 0.7 0.000173 0.0128 Tnfrsf11b 
chr7 0.7 0.000205 0.0139 5830432E09Rik 
chr17 0.7 0.000215 0.0141 L3mbtl4 
chr14 0.7 0.00024 0.0152 Slc4a7 
chr1 0.7 0.000266 0.0164 Rgs18 
chr9 0.7 0.000285 0.0168 Tgfbr2 
chr17 0.7 0.000315 0.0178 Ston1 
chr7 0.7 0.000517 0.0243 Tlnrd1 
chr6 0.7 0.000544 0.0252 Ccser1 
chr11 0.7 0.000633 0.0274 F930015N05Rik 






chr1 0.69 2.02E-07 0.000104 Hhat 
chr6 0.69 3.25E-07 0.000144 Fam3c 
chr10 0.69 3.29E-07 0.000144 Nup37 
chr17 0.69 1.93E-05 0.00306 Xdh 
chr1 0.69 7.64E-05 0.00754 Nenf 
chr15 0.69 0.000157 0.012 Trio 
chr1 0.69 0.000158 0.012 Mir205 
chr5 0.69 0.000193 0.0135 Mir703 
chr6 0.69 0.000201 0.0138 Ergic2 
chr5 0.69 0.000214 0.0141 Tmprss11c 
chr18 0.69 0.000251 0.0158 Pcdh12 
chr18 0.69 0.000711 0.0292 AW554918 
chr1 0.69 0.00118 0.0379 9130227L01Rik 
chr17 0.69 0.00134 0.0405 Gm9805 
chr5 0.69 0.00149 0.0428 Speer8-ps1 
chr9 0.69 0.0015 0.0428 Zc3h12c 
chr9 0.69 0.00171 0.0456 Tgfbr2 
chr16 0.69 0.00192 0.0477 Gm15713 
chr18 0.68 7.37E-07 0.000261 Mir5127 
chr18 0.68 2.66E-05 0.00391 Ss18 
chr18 0.68 4.05E-05 0.005 4930445N18Rik 
chr16 0.68 4.37E-05 0.00529 Ncam2 
chr2 0.68 4.94E-05 0.00576 9130015L21Rik 
chr12 0.68 0.000114 0.00989 Wdr25 
chr2 0.68 0.000129 0.0108 Slc24a5 
chr8 0.68 0.000137 0.0112 Sall1 
chr17 0.68 0.000214 0.0141 Gm20491 






chr5 0.68 0.000328 0.0181 Cpeb2 
chr18 0.68 0.000388 0.0202 Megf10 
chr16 0.68 0.000445 0.0222 St3gal6 
chr14 0.68 0.000496 0.0238 Dpysl2 
chr13 0.68 0.000604 0.0267 Lhfpl2 
chrX 0.68 0.000685 0.0285 Phex 
chr7 0.68 0.000878 0.0329 Cfap161 
chr8 0.68 0.000993 0.0349 Sh2d4a 
chr7 0.68 0.00106 0.036 1700120G07Rik 
chr12 0.68 0.00126 0.0394 Mir680-3 
chr1 0.68 0.00129 0.0398 Rnf152 
chr13 0.68 0.0014 0.0414 Dapk1 
chr9 0.68 0.0019 0.0477 Zc3h12c 
chr17 0.67 3.98E-06 0.000968 Epb41l3 
chr6 0.67 4.21E-06 0.00101 A430035B10Rik 
chr18 0.67 6.67E-06 0.0014 Garem1 
chr14 0.67 1.52E-05 0.00265 Rap2a 
chr11 0.67 6.74E-05 0.00703 Mir744 
chr9 0.67 0.000105 0.00929 Pdcd6ip 
chr4 0.67 0.000116 0.00997 Dhrs3 
chr2 0.67 0.000119 0.0101 Rtf2 
chr9 0.67 0.000303 0.0173 Fat3 
chr19 0.67 0.000336 0.0184 Sgms1 
chr5 0.67 0.000343 0.0186 Sfswap 
chr6 0.67 0.000372 0.0196 Tcaf1 
chr7 0.67 0.000452 0.0223 Atp10a 
chr14 0.67 0.000598 0.0267 Ear2 






chr18 0.67 0.000677 0.0284 1700044K03Rik 
chr2 0.67 0.000722 0.0292 Ninl 
chr2 0.67 0.000913 0.0335 Ube2e3 
chr2 0.67 0.000959 0.0343 Gpd2 
chr13 0.67 0.0011 0.0365 Pfkp 
chr15 0.67 0.00112 0.0367 Wdr70 
chr6 0.67 0.00114 0.0371 Vopp1 
chr7 0.67 0.0015 0.0428 Sox6 
chr2 0.66 3.22E-06 0.000825 Upp2 
chr7 0.66 1.65E-05 0.0028 Gas2 
chr14 0.66 2.02E-05 0.00319 Ear10 
chr10 0.66 7.35E-05 0.00741 Ccdc6 
chr16 0.66 7.43E-05 0.00746 Tomm70a 
chr12 0.66 7.93E-05 0.00773 Tmem18 
chr12 0.66 9.11E-05 0.00857 Itgb8 
chr2 0.66 0.000152 0.0118 Sdcbp2 
chr13 0.66 0.000161 0.0122 A530046M15Rik 
chr6 0.66 0.000183 0.0132 Klra1 
chr4 0.66 0.000191 0.0134 Gm11413 
chr1 0.66 0.000228 0.0147 Nrp2 
chr12 0.66 0.000236 0.015 3200001D21Rik 
chr3 0.66 0.000256 0.016 Ptger3 
chr3 0.66 0.000375 0.0197 Ppp3ca 
chr13 0.66 0.000476 0.0231 A430090L17Rik 
chr9 0.66 0.000618 0.0272 Birc3 
chr5 0.66 0.00063 0.0274 Rasgef1b 
chr9 0.66 0.000735 0.0295 Cpne4 






chr3 0.66 0.000994 0.0349 Gipc2 
chr2 0.66 0.00116 0.0376 4933406D12Rik 
chr6 0.66 0.00129 0.0398 C1galt1 
chr14 0.66 0.0014 0.0414 Mir6390 
chr9 0.66 0.0016 0.0441 Stac 
chr1 0.65 4.09E-07 0.000173 B3galt2 
chr4 0.65 1.26E-05 0.0024 Tnc 
chr11 0.65 1.39E-05 0.00253 Map2k6 
chr13 0.65 3.23E-05 0.0045 Rnf180 
chr13 0.65 7.46E-05 0.00746 Cwc27 
chr9 0.65 0.000169 0.0127 Mei4 
chr13 0.65 0.000171 0.0128 1700029F12Rik 
chr3 0.65 0.000247 0.0156 Gipc2 
chr10 0.65 0.000262 0.0162 Gm36595 
chr2 0.65 0.000296 0.0172 Gm826 
chr18 0.65 0.000411 0.0209 Prrc1 
chr6 0.65 0.000638 0.0275 Sox5 
chr7 0.65 0.000667 0.0281 Syt9 
chr13 0.65 0.000858 0.0325 Sugct 
chr18 0.65 0.0013 0.0398 Tubb6 
chr1 0.64 9.75E-06 0.00194 Plxna2 
chr15 0.64 3.28E-05 0.00452 Cpq 
chr16 0.64 5.03E-05 0.00576 Samsn1 
chr4 0.64 6.53E-05 0.00686 Tle1 
chr13 0.64 6.54E-05 0.00686 Akr1e1 
chr13 0.64 8.40E-05 0.00803 1700024I08Rik 
chr3 0.64 0.000109 0.00955 Gm30173 






chr1 0.64 0.00017 0.0127 D1Ertd622e 
chr2 0.64 0.00019 0.0134 Sema6d 
chr2 0.64 0.000227 0.0147 Napb 
chr17 0.64 0.000301 0.0172 Srbd1 
chr11 0.64 0.00036 0.0192 Meis1 
chr16 0.64 0.00042 0.0213 Mir691 
chr4 0.64 0.000643 0.0276 Ttc39b 
chr13 0.64 0.000719 0.0292 Pik3r1 
chr6 0.64 0.000732 0.0295 Fxyd4 
chr2 0.64 0.000774 0.0306 Mindy3 
chr17 0.64 0.000809 0.0313 Crim1 
chr9 0.64 0.00089 0.0329 Bbs9 
chr6 0.64 0.000899 0.0331 Ppp1r17 
chr9 0.64 0.000996 0.0349 Grik4 
chr4 0.64 0.00105 0.0358 BC039966 
chr16 0.64 0.00113 0.037 App 
chr2 0.64 0.00117 0.0377 9630028H03Rik 
chr16 0.64 0.00123 0.0387 Filip1l 
chr7 0.64 0.00144 0.0424 Tjp1 
chr13 0.64 0.00168 0.0453 Pfkp 
chr17 0.64 0.00178 0.0466 Clip4 
chrX 0.64 0.00179 0.0466 Ap1s2 
chr3 0.64 0.00189 0.0477 Ctbs 
chr5 0.64 0.00194 0.0479 Cnot6l 
chr9 0.63 9.62E-07 0.000317 Cep162 
chr18 0.63 1.75E-05 0.00289 Zfp608 
chr1 0.63 4.56E-05 0.00547 Slc39a10 






chr10 0.63 9.95E-05 0.00908 Itgb2 
chr18 0.63 0.000201 0.0138 Ss18 
chr11 0.63 0.000216 0.0141 4933406G16Rik 
chr2 0.63 0.000236 0.015 Pfkfb3 
chr16 0.63 0.000271 0.0165 4930529L06Rik 
chr10 0.63 0.000295 0.0171 Adgrg6 
chr10 0.63 0.000335 0.0184 Cep85l 
chr5 0.63 0.000399 0.0206 Cpeb2 
chr1 0.63 0.00052 0.0244 Traf3ip3 
chr4 0.63 0.00056 0.0255 Slc24a2 
chr18 0.63 0.000719 0.0292 Sncaip 
chr18 0.63 0.000727 0.0293 Cyb5a 
chr15 0.63 0.000743 0.0297 Dennd3 
chr3 0.63 0.000766 0.0303 St6galnac5 
chr14 0.63 0.000844 0.0323 Gpr18 
chr13 0.63 0.000946 0.0342 Golm1 
chr14 0.63 0.001 0.0351 Mbnl2 
chr5 0.63 0.00107 0.0361 Slc15a4 
chr6 0.63 0.0011 0.0365 Chn2 
chr1 0.63 0.00115 0.0373 Gm4846 
chr3 0.63 0.00145 0.0424 Gpr149 
chr1 0.63 0.00146 0.0425 Rgs1 
chr17 0.63 0.0019 0.0477 Pabpc6 
chr13 0.63 0.00191 0.0477 Edil3 
chr3 0.62 1.44E-05 0.00259 Gm6260 
chr1 0.62 2.33E-05 0.00357 Gorab 
chr14 0.62 4.67E-05 0.00554 Dock5 






chr5 0.62 0.000204 0.0139 Arpc1a 
chr2 0.62 0.000235 0.015 Dhx35 
chr4 0.62 0.000259 0.0161 Kcnab2 
chr6 0.62 0.000342 0.0186 Uroc1 
chr2 0.62 0.000533 0.0248 Pfkfb3 
chr14 0.62 0.000811 0.0313 Flnb 
chr8 0.62 0.000887 0.0329 Irf2 
chr9 0.62 0.00101 0.0351 Herpud2 
chr4 0.62 0.00101 0.0352 Saxo1 
chr1 0.62 0.00132 0.0402 Sft2d2 
chr4 0.62 0.00133 0.0403 Ripk2 
chr4 0.62 0.0014 0.0414 Triqk 
chr15 0.62 0.00173 0.0459 Ext1 
chr17 0.62 0.002 0.0488 4930405O22Rik 
chr2 0.61 4.77E-06 0.00106 Zfp120 
chr15 0.61 2.33E-05 0.00357 Oxr1 
chr13 0.61 3.40E-05 0.00463 Cwc27 
chr14 0.61 6.36E-05 0.00684 Rnf219 
chr6 0.61 7.29E-05 0.00741 Tspan9 
chr15 0.61 0.000176 0.0129 Gm19276 
chr1 0.61 0.000188 0.0134 Htr5b 
chr2 0.61 0.000211 0.0141 P2rx3 
chr2 0.61 3.00E-04 0.0172 Ube2e3 
chr13 0.61 3.00E-04 0.0172 Ipo11 
chr10 0.61 0.00033 0.0182 Wisp3 
chr8 0.61 0.000361 0.0192 Efnb2 
chr19 0.61 0.000443 0.0221 Dkk1 






chr2 0.61 0.000701 0.029 Mafb 
chr14 0.61 0.000779 0.0306 Lmo7 
chr2 0.61 0.000798 0.031 Plxdc2 
chr18 0.61 0.000871 0.0328 Setbp1 
chr13 0.61 0.000896 0.033 Mir3961 
chr11 0.61 0.000964 0.0343 4933406G16Rik 
chr1 0.61 0.00102 0.0353 Map2 
chr1 0.61 0.00107 0.0361 Dnm3os 
chr5 0.61 0.00114 0.0372 1700016H13Rik 
chr17 0.61 0.00124 0.0387 Nudt12 
chr6 0.61 0.00128 0.0398 Tpk1 
chr14 0.61 0.00129 0.0398 Fndc3a 
chr4 0.61 0.00158 0.0439 Nsmaf 
chr13 0.61 0.00164 0.0447 Marveld2 
chr13 0.61 0.00164 0.0447 Dip2c 
chr1 0.61 0.00196 0.0484 Tnfsf18 
chr18 0.6 3.39E-07 0.000146 Prelid2 
chr5 0.6 1.35E-05 0.00249 Gm19619 
chr2 0.6 1.47E-05 0.00261 Pkp4 
chr3 0.6 7.61E-05 0.00754 Zc2hc1a 
chr1 0.6 8.87E-05 0.00842 Mir3962 
chr4 0.6 9.94E-05 0.00908 Zfp462 
chr17 0.6 0.000102 0.00914 Txndc2 
chr18 0.6 0.000135 0.0111 Ttc39c 
chr13 0.6 0.000138 0.0112 Adamts6 
chr18 0.6 0.00018 0.0131 Pabpc2 
chr2 0.6 0.000211 0.0141 Sdcbp2 






chr7 0.6 0.000272 0.0165 Swap70 
chr5 0.6 0.000283 0.0168 Wsb2 
chr13 0.6 0.000315 0.0178 Emb 
chr15 0.6 0.000343 0.0186 Ctnnd2 
chr15 0.6 0.000349 0.0188 Tmem74 
chr18 0.6 0.000359 0.0192 Gramd3 
chr12 0.6 0.00041 0.0209 Arl4a 
chr9 0.6 0.000443 0.0221 Filip1 
chr14 0.6 0.000471 0.023 Extl3 
chr13 0.6 0.000473 0.023 Nnt 
chr19 0.6 0.000492 0.0237 Psat1 
chr3 0.6 0.000552 0.0254 Dclk1 
chr18 0.6 0.000561 0.0255 Pabpc2 
chr16 0.6 0.000653 0.0278 Retnlb 
chr17 0.6 0.000786 0.0308 4930517M08Rik 
chr14 0.6 0.000857 0.0325 Rarb 
chr5 0.6 0.000915 0.0335 Rasgef1b 
chr6 0.6 0.000932 0.0339 Rpia 
chr9 0.6 0.00117 0.0377 Ky 
chr5 0.6 0.00117 0.0378 Rfc5 
chr17 0.6 0.00138 0.0412 Slc8a1 
chr4 0.6 0.00148 0.0427 Ripk2 
chr18 0.6 0.00149 0.0428 Gm10536 
chr18 0.6 0.0015 0.0428 Map3k8 
chr5 0.6 0.00152 0.0431 Cdk8 
chr19 0.6 0.00178 0.0465 Tmem2 
chr12 0.6 0.0018 0.0467 Immp2l 






chr14 0.6 0.00189 0.0477 Lcp1 
chr2 0.6 0.00198 0.0486 Itga4 
chr14 0.59 5.59E-06 0.00121 Slain1 
chr14 0.59 0.000109 0.00955 Stk24 
chr15 0.59 0.000139 0.0112 Fbxo4 
chr6 0.59 0.000148 0.0117 Adipor2 
chr7 0.59 0.000171 0.0128 Dbx1 
chr12 0.59 0.000215 0.0141 Scin 
chr7 0.59 0.000269 0.0165 4930543N07Rik 
chr1 0.59 0.000279 0.0167 Fam168b 
chr1 0.59 0.000464 0.0227 Tnr 
chr18 0.59 0.000509 0.024 Kctd16 
chr5 0.59 0.000601 0.0267 Adam22 
chr5 0.59 0.000633 0.0274 Hgf 
chr13 0.59 0.000665 0.0281 Mir3961 
chr15 0.59 0.000695 0.0288 Ndrg1 
chr17 0.59 0.000727 0.0293 Nudt12 
chr14 0.59 0.000822 0.0317 Ube2e1 
chr16 0.59 0.000885 0.0329 Bach1 
chr12 0.59 0.000928 0.0338 3200001D21Rik 
chr12 0.59 0.000929 0.0338 Stxbp6 
chr17 0.59 0.00095 0.0342 Tbc1d5 
chr9 0.59 0.00098 0.0346 Dopey1 
chr18 0.59 0.00105 0.0359 Mir122 
chr3 0.59 0.00108 0.0362 4933417G07Rik 
chr3 0.59 0.00111 0.0365 Adgrl2 
chr8 0.59 0.00133 0.0403 Cmtm4 






chrX 0.59 0.00171 0.0456 Rnf128 
chr15 0.59 0.00182 0.047 Slc1a3 
chr13 0.59 0.0019 0.0477 Iqgap2 
chr1 0.58 9.16E-05 0.00859 Farsb 
chr9 0.58 0.00015 0.0117 Vwa5a 
chr2 0.58 0.000233 0.015 3300002I08Rik 
chr2 0.58 0.000254 0.0158 Sdcbp2 
chr15 0.58 4.00E-04 0.0206 Samd12 
chr15 0.58 0.000637 0.0275 Ago2 
chr4 0.58 0.000666 0.0281 Plpp3 
chr14 0.58 0.00071 0.0292 Abcc4 
chr18 0.58 0.000854 0.0325 Mocos 
chr10 0.58 0.000858 0.0325 Ipcef1 
chr8 0.58 0.00095 0.0342 Lyl1 
chr7 0.58 0.00112 0.0367 Tspan32 
chr14 0.58 0.0015 0.0428 Msra 
chr2 0.58 0.00151 0.043 Secisbp2l 
chr7 0.58 0.00153 0.0431 Stk33 
chr19 0.58 0.00157 0.0437 Hells 
chr8 0.58 0.00164 0.0447 1-Mar 
chr3 0.58 0.00183 0.0471 Lmo4 
chr16 0.58 0.00187 0.0476 Fbxo40 
chr15 0.57 5.01E-05 0.00576 Irak4 
chr11 0.57 8.32E-05 0.00798 Sptbn1 
chr5 0.57 9.60E-05 0.00886 Medag 
chr4 0.57 0.000101 0.00914 Ror1 
chr17 0.57 0.000132 0.0109 Epb41l3 






chr11 0.57 0.000409 0.0209 Cacng1 
chr3 0.57 0.00049 0.0237 Mecom 
chr18 0.57 0.000547 0.0253 Zfp608 
chr3 0.57 0.000595 0.0266 Ctso 
chr13 0.57 0.00064 0.0275 Pfkp 
chr18 0.57 0.000677 0.0284 Adrb2 
chr8 0.57 0.000882 0.0329 Tma16 
chr6 0.57 0.000958 0.0343 Tex52 
chr7 0.57 0.00103 0.0353 Tead1 
chr10 0.57 0.00104 0.0357 Rnf217 
chr3 0.57 0.00108 0.0361 Trim55 
chr10 0.57 0.0011 0.0365 Sash1 
chr6 0.57 0.00123 0.0387 6820426E19Rik 
chr1 0.57 0.00146 0.0425 Prex2 
chr8 0.57 0.00185 0.0475 Maf 
chr3 0.57 0.00201 0.049 Gm48909 
chr5 0.56 1.72E-05 0.00287 Scarb2 
chr2 0.56 2.93E-05 0.00424 Gm14325 
chr3 0.56 3.29E-05 0.00452 Map9 
chr5 0.56 4.04E-05 0.005 Antxr2 
chr19 0.56 4.41E-05 0.00531 Pfpl 
chr3 0.56 5.27E-05 0.00591 Depdc1a 
chr5 0.56 0.000151 0.0117 Steap4 
chr12 0.56 0.000192 0.0134 Etv1 
chr8 0.56 0.000299 0.0172 Prag1 
chr18 0.56 0.00036 0.0192 Zfp608 
chr9 0.56 0.000387 0.0202 Rsl24d1 






chr17 0.56 0.000505 0.0239 Zfp677 
chr10 0.56 0.000524 0.0245 Gm36595 
chr12 0.56 0.000554 0.0255 Etv1 
chr6 0.56 0.000591 0.0265 Plxna4 
chr8 0.56 7.00E-04 0.029 Lncbate1 
chr12 0.56 0.000915 0.0335 Lrrn3 
chr1 0.56 0.000985 0.0347 Gm5523 
chr1 0.56 0.00112 0.0367 Ly96 
chr7 0.56 0.00114 0.0371 Klhl25 
chr10 0.56 0.00121 0.0384 Mmp19 
chr5 0.56 0.00173 0.0459 Aff1 
chr19 0.56 0.00176 0.0463 Pcgf5 
chr10 0.56 0.00177 0.0464 Gm18409 
chr13 0.56 0.00179 0.0466 Mir713 
chr18 0.56 0.00182 0.047 Mir122 
chr8 0.56 0.00206 0.0498 Mir21c 
chr18 0.55 5.91E-06 0.00127 Stard4 
chr17 0.55 6.94E-05 0.00718 Dreh 
chr1 0.55 0.000126 0.0105 Rgs1 
chr4 0.55 0.000185 0.0132 Trabd2b 
chr18 0.55 0.000269 0.0165 Pik3c3 
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chr16 0.55 0.000408 0.0209 Tiam1 
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chr9 0.55 0.000969 0.0344 Mir6386 
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chr5 0.55 0.00143 0.0421 Adgra3 
chr9 0.55 0.00165 0.0447 Smco4 
chrX 0.55 0.00166 0.0449 Gm6377 
chr15 0.55 0.00166 0.0449 4930447A16Rik 
chr3 0.55 0.00178 0.0466 P2ry14 
chr10 0.55 0.00192 0.0478 Tmem19 
chr4 0.55 0.00202 0.0492 A530072M11Rik 
chr5 0.55 0.00206 0.0498 Antxr2 
chr3 0.54 1.86E-05 0.00301 Fpgt 
chr1 0.54 0.000116 0.00997 Rnf152 
chr17 0.54 0.000142 0.0114 Slc8a1 
chr13 0.54 0.00015 0.0117 Spz1 
chr13 0.54 0.000184 0.0132 AW209491 
chr17 0.54 0.000311 0.0177 Capn13 
chr9 0.54 0.00045 0.0223 Glb1l2 
chr5 0.54 0.000503 0.0239 Mrpl1 
chr1 0.54 0.000562 0.0255 Ptgs2os2 
chr8 0.54 0.000575 0.0259 Msr1 
chr2 0.54 0.000579 0.0261 Mir5129 
chr2 0.54 0.000619 0.0272 Gm13315 
chr7 0.54 0.000654 0.0278 Gm15412 
chr18 0.54 0.000778 0.0306 Zfp608 






chr3 0.54 0.000831 0.0319 4930503B20Rik 
chr6 0.54 0.000873 0.0328 M6pr 
chr9 0.54 0.000874 0.0328 Eef1a1 
chrX 0.54 0.000961 0.0343 Rragb 
chr8 0.54 0.00101 0.0351 Ikbkb 
chr9 0.54 0.0011 0.0365 Pxylp1 
chr10 0.54 0.0011 0.0365 Lss 
chr17 0.54 0.00112 0.0367 Synj2 
chr5 0.54 0.00119 0.0379 Antxr2 
chr17 0.54 0.00123 0.0387 L3mbtl4 
chr2 0.54 0.00134 0.0403 Itgav 
chr4 0.54 0.00137 0.041 Rragc 
chr9 0.54 0.00139 0.0414 Azi2 
chr10 0.54 0.00145 0.0425 1110002J07Rik 
chr13 0.54 0.00148 0.0428 Klf6 
chr3 0.54 0.00153 0.0431 Etnppl 
chr6 0.54 0.0016 0.0441 Gm7457 
chr10 0.54 0.00185 0.0475 Ust 
chr11 0.54 0.00189 0.0477 Tex14 
chr14 0.54 0.00198 0.0486 Mbnl2 
chr18 0.54 0.00203 0.0494 Osbpl1a 
chr15 0.53 1.79E-06 0.000527 Alg10b 
chr18 0.53 1.91E-05 0.00306 Txnl1 
chr2 0.53 3.16E-05 0.00446 Ube2e3 
chr18 0.53 3.61E-05 0.00475 Snx24 
chr13 0.53 4.06E-05 0.005 Vcan 
chr3 0.53 7.06E-05 0.00724 Snx7 






chr14 0.53 0.000645 0.0277 Txndc16 
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chr3 0.53 0.000779 0.0306 Selenof 
chr4 0.53 0.000962 0.0343 Mknk1 
chr17 0.53 0.000979 0.0346 Foxn2 
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chr6 0.53 0.00187 0.0476 Bicd1 
chr4 0.53 0.0019 0.0477 Car8 
chr17 0.53 0.00192 0.0477 Agpat4 
chr6 0.53 0.00205 0.0495 4930515G16Rik 
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chr14 0.52 5.18E-05 0.00585 Erc2 
chr2 0.52 0.000141 0.0113 Bcas1 
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chr10 0.52 0.000282 0.0168 Zfp873 
chr13 0.52 0.000337 0.0184 4922502H24Rik 
chr2 0.52 4.00E-04 0.0206 Rbm45 
chr5 0.52 0.000452 0.0223 Phtf2 






chr18 0.52 0.00049 0.0237 Setbp1 
chr6 0.52 0.000617 0.0272 Smim10l1 
chr13 0.52 0.000716 0.0292 Lpcat1 
chr18 0.52 0.000751 0.0298 Abhd3 
chr14 0.52 0.000795 0.031 Stk24 
chr7 0.52 0.000796 0.031 Wdr11 
chr7 0.52 0.000858 0.0325 Mmp21 
chr18 0.52 0.000883 0.0329 Ldlrad4 
chr6 0.52 0.000896 0.033 Gng12 
chr16 0.52 0.000945 0.0342 Pla1a 
chr16 0.52 0.000947 0.0342 App 
chr6 0.52 0.000978 0.0346 Tulp3 
chr6 0.52 0.00105 0.0358 Il12rb2 
chr14 0.52 0.00117 0.0377 Rarb 
chr7 0.52 0.00123 0.0387 Atp10a 
chr9 0.52 0.00134 0.0403 5830418P13Rik 
chr5 0.52 0.0014 0.0414 Tec 
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chr1 0.52 0.00185 0.0474 Nrp2 
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chr16 0.52 0.00198 0.0486 Gpr15 
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chr4 0.51 6.34E-05 0.00684 9530080O11Rik 
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chr3 0.51 0.000194 0.0135 Rapgef2 
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chr10 0.51 0.000975 0.0345 Adgrg6 
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chr4 0.51 0.00101 0.0352 Zfp462 
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chr1 0.51 0.00105 0.0358 Fmo9 
chr3 0.51 0.00106 0.0359 Mir7008 
chr9 0.51 0.00116 0.0376 Rwdd2a 
chr10 0.51 0.00119 0.0381 Stxbp5 
chr14 0.51 0.00134 0.0403 Prss52 
chr19 0.51 0.00139 0.0414 Pfpl 
chr9 0.51 0.00151 0.043 Gm15511 
chr4 0.51 0.00153 0.0431 9530080O11Rik 
chr8 0.51 0.00155 0.0434 Kifc3 
chr2 0.51 0.00159 0.0439 Gm14326 
chr18 0.51 0.00161 0.0442 Pmaip1 
chr7 0.51 0.00205 0.0497 Slc17a6 
chr18 0.5 2.38E-05 0.00361 Commd10 






chr3 0.5 0.000323 0.0181 Gm1653 
chr2 0.5 0.000495 0.0238 Flrt3 
chr8 0.5 0.000504 0.0239 Cdyl2 
chr13 0.5 0.000569 0.0257 Ubqln1 
chr18 0.5 0.00101 0.0352 Mcc 
chr4 0.5 0.00115 0.0373 Virma 
chr17 0.5 0.00136 0.0409 Ldhal6b 
chr18 0.5 0.00137 0.041 Svil 
chr1 0.5 0.00153 0.0431 Pla2g4a 
chr17 0.5 0.00157 0.0437 Gm7072 
chr9 0.5 0.00186 0.0475 Tgfbr2 
chr15 0.5 0.00189 0.0477 Ext1 
chr9 0.5 0.00197 0.0486 Ttc21a 
chr5 0.49 0.000182 0.0131 Hgf 
chrX 0.49 0.00019 0.0134 Amer1 
chr17 0.49 0.000252 0.0158 Spaca6 
chr10 0.49 0.000364 0.0193 4930430F08Rik 
chr6 0.49 0.000407 0.0209 Asns 
chr1 0.49 0.000655 0.0278 Rpe 
chr7 0.49 0.000681 0.0285 Trim6 
chr9 0.49 0.000889 0.0329 1700057G04Rik 
chr18 0.49 0.00102 0.0352 Crem 
chr3 0.49 0.00112 0.0367 S1pr1 
chr6 0.49 0.00129 0.0398 Gm31520 
chr13 0.49 0.00132 0.0403 Cdk20 
chr1 0.49 0.00133 0.0403 Gm19705 
chr18 0.49 0.00133 0.0403 Ythdc2 






chr5 0.49 0.00147 0.0426 2900026A02Rik 
chr4 0.49 0.00149 0.0428 Ifna1 
chr10 0.49 0.00174 0.046 Themis 
chr8 0.49 0.00176 0.0463 AI429214 
chr18 0.49 0.00176 0.0463 Cyb5a 
chr15 0.49 0.0019 0.0477 Trps1 
chr3 0.49 0.00192 0.0478 Pde7a 
chr3 0.49 0.002 0.0488 Camk2d 
chr7 0.49 0.00207 0.0499 Ceacam16 
chr17 0.48 6.08E-05 0.00666 Fam98a 
chr12 0.48 0.000214 0.0141 Fam181a 
chr9 0.48 0.000547 0.0253 Pik3r4 
chr3 0.48 0.000624 0.0273 Dclk1 
chr7 0.48 0.000649 0.0277 Eef2k 
chr13 0.48 0.000747 0.0297 Vps41 
chr2 0.48 0.000957 0.0343 Slc38a11 
chr16 0.48 0.00097 0.0344 Cpox 
chr1 0.48 0.0011 0.0365 Wdfy1 
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chr11 0.48 0.00194 0.0479 Prkca 
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chr18 0.47 0.000286 0.0168 Hdhd2 
chr6 0.47 0.000682 0.0285 Eps8 
chr1 0.47 0.000747 0.0297 Aspm 
chr10 0.47 0.000829 0.0319 Washc3 
chr2 0.47 0.000868 0.0328 Dph6 
chr14 0.47 0.000872 0.0328 Mir6239 
chr18 0.47 0.000948 0.0342 Stard6 
chrX 0.47 0.00109 0.0364 Pdzd11 
chr1 0.47 0.00128 0.0398 Pfkfb2 
chr2 0.47 0.00154 0.0431 Cd93 
chr6 0.47 0.00161 0.0442 Aebp2 
chr1 0.47 0.00182 0.047 Aim2 
chr17 0.47 0.00191 0.0477 Akain1 
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chr14 0.46 0.00125 0.0391 5430440P10Rik 
chr9 0.46 0.00149 0.0428 Alkbh8 
chr13 0.46 0.00151 0.043 4833420G17Rik 






chr4 0.46 0.00161 0.0442 Cdh17 
chr2 0.46 0.00173 0.0459 B230118H07Rik 
chr2 0.46 0.0018 0.0468 Cdh26 
chr16 0.46 0.00184 0.0474 4930529L06Rik 
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chr13 0.46 0.00199 0.0488 Akr1e1 
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chr10 0.44 0.00124 0.0387 Ctgf 
chr10 0.44 0.00128 0.0398 2610008E11Rik 
chr3 0.44 0.00131 0.04 Tet2 






chr2 0.44 0.00162 0.0444 Depdc7 
chr8 0.44 0.00164 0.0447 Fbxo8 
chr2 0.44 0.00179 0.0466 Gata3 
chr1 0.44 0.0018 0.0468 Vamp4 
chr5 0.44 0.00182 0.047 Slc4a4 
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chr2 0.42 0.000531 0.0248 Ccdc34 
chr14 0.42 0.000788 0.0308 Ghitm 
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chr3 0.41 0.00158 0.0439 Cenpe 
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chr18 0.4 0.000524 0.0245 Dcp2 
chr17 0.4 0.000717 0.0292 Ppp2r1a 
chr4 0.4 0.000833 0.032 Wwp1 
chr13 0.4 0.000884 0.0329 Mfsd14b 
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chr10 0.4 0.00132 0.0402 E2f7 
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chr9 0.4 0.00133 0.0403 Plscr1 
chr3 0.4 0.00152 0.043 Wars2 
chr14 0.4 0.00154 0.0431 Stc1 
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chr10 0.4 0.00175 0.0461 Ipmk 
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chr8 0.38 0.000397 0.0206 Gm21119 
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chr17 0.38 0.000779 0.0306 Mut 
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chr8 0.38 0.0014 0.0414 1700029J07Rik 
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Appendix 3:  Chapter 4 Supplemental Figures 
 
 
Figure A3- 1. Chapter 4 Supplemental Figure 1. 
A, B. Male C57BL/6 or Balb/c mice were infected with RSV (2 x 105 pfu) and lungs collected 8 days post-infection and compared 
to naïve control animals.  Lungs were harvested and the CD11c+ cell population isolated using MACS bead separation, mRNA 
extracted and qPCR performed to determine RSV F gene expression (N ≥ 3). C. BMDC isolated from Balb/c mice were infected 
in vitro with RSV and cells collected at the indicated timepoints, mRNA extracted and qPCR performed to determine RSV F gene 
expression (N = 4). D. BMDC isolated from Balb/c mice were exposed in vitro to UV-inactivated RSV and cells collected at the 
indicated timepoints, mRNA extracted and qPCR performed to determine epigenetic enzyme expression (N = 3). Data represent 








Figure A3- 2. Chapter 4 Supplemental Figure 2. 
BMDC were isolated from Balb/c mice, cultured for 6 days in the presence of GM-CSF and infected with RSV in vitro for the 
indicated time points. A. mRNA was extracted and qPCR performed to determine cytokine/chemokine gene expression (N = 3). 
B. BMDC were exposed to GSK J5 or vehicle control during RSV-infection for 24 hours, mRNA was extracted and qPCR 
performed to determine cytokine/chemokine gene expression (N = 3). C,D. BMDC were exposed in vitro to UV-inactivated RSV 
and cells collected after 24 hours, mRNA extracted and qPCR performed to determine cytokine/chemokine gene expression (N = 
3). E. Kdm6b gene was knocked down in BMDC using siRNA (siKdm6b) (non-targeting control (siNC) used for control) for 48 
hours, followed by RSV-infection for 24 hours. Cells were collected, processed and stained for flow cytometry analysis of APC 
markers (N = 3).  Data represent Mean ± SEM (Representative of at least 2 individual experiments). * = p < 0.05; ** = p < 0.01; 








Appendix 4:  Chapter 5 Additional Results 
 
Figure A4- 1. Neonatal RSV infection of TSLPR-/- male mice leads to increased Ifnb and faster viral clearance.   
Male WT and TSLPR-/- mice were infected with RSV at 7 days of age and tissues collected at 4 days post-infection to evaluate 
primary response and clearance of RSV gene.  A, B.  Lungs were homogenized and mRNA extracted to determine interferon-β 
and RSV F gene expression, respectively (N ≥ 3) 
 
Figure A4- 2. Increased CD45+ cells in lungs of WT mice at 4 weeks post-early-life RSV-infection.   
Male WT and TSLPR-/- mice were infected neonatally with RSV at 7 days of age and CD45+ immunofluorescence staining 
(staining in blue) performed at 4 weeks post-infection. A. Naïve age-matched control B. WT early-life RSV. C. TSLPR-/- early-







Figure A4- 3. PFT analysis following early-life RSV-infection.   
Male WT and TSLPR-/- mice were infected neonatally with RSV at 7 days of age and analyzed for indications of lung 
remodeling at 4 weeks post-infection A-D. Pulmonary Function Test analysis. ± SEM (N ≥ 3). ** = p < 0.01; *** = p < 0.001. 
 
Figure A4- 4. Lung remodeling following early-life RSV-infection.   
Male WT and TSLPR-/- mice were infected neonatally with RSV at 7 days of age and analyzed for indications of lung 
remodeling at 4 weeks post-infection A. Lungs were embedded in paraffin and H&E staining was performed to visualize alveolar 
spaces.  Representative photos shown B.  Lungs were homogenized and mRNA extracted to determine HOX5 gene expression. ± 









1. Sigurs, N. et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first 
year of life. Thorax 65, 1045–1052 (2010). 
2. Nair, H. et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus 
in young children: a systematic review and meta-analysis. Lancet Lond. Engl. 375, 1545–1555 
(2010). 
3. Henderson, J. et al. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent 
asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr. Allergy Immunol. Off. Publ. 
Eur. Soc. Pediatr. Allergy Immunol. 16, 386–392 (2005). 
4. Chatzis, O. et al. Burden of severe RSV disease among immunocompromised children and adults: a 
10 year retrospective study. BMC Infect. Dis. 18, (2018). 
5. Walsh, E. E. Respiratory Syncytial Virus infection: an illness for all ages. Clin. Chest Med. 38, 29–36 
(2017). 
6. Griffiths, C., Drews, S. J. & Marchant, D. J. Respiratory Syncytial Virus: Infection, Detection, and New 
Options for Prevention and Treatment. Clin. Microbiol. Rev. 30, 277–319 (2017). 
7. Collins, P. L., Fearns, R. & Graham, B. S. Respiratory Syncytial Virus: Virology, Reverse Genetics, and 
Pathogenesis of Disease. Curr. Top. Microbiol. Immunol. 372, 3–38 (2013). 
8. Sullender, W. M. Respiratory Syncytial Virus Genetic and Antigenic Diversity. Clin. Microbiol. Rev. 13, 
1–15 (2000). 
9. McLellan, J. S., Ray, W. C. & Peeples, M. E. Structure and Function of RSV Surface Glycoproteins. 






10. Low, K.-W., Tan, T., Ng, K., Tan, B.-H. & Sugrue, R. J. The RSV F and G glycoproteins interact to form a 
complex on the surface of infected cells. Biochem. Biophys. Res. Commun. 366, 308–313 (2008). 
11. Collins, P. L. & Graham, B. S. Viral and Host Factors in Human Respiratory Syncytial Virus 
Pathogenesis. J. Virol. 82, 2040–2055 (2008). 
12. Lo, M. S., Brazas, R. M. & Holtzman, M. J. Respiratory Syncytial Virus Nonstructural Proteins NS1 and 
NS2 Mediate Inhibition of Stat2 Expression and Alpha/Beta Interferon Responsiveness. J. Virol. 79, 
9315–9319 (2005). 
13. Ling, Z., Tran, K. C. & Teng, M. N. Human Respiratory Syncytial Virus Nonstructural Protein NS2 
Antagonizes the Activation of Beta Interferon Transcription by Interacting with RIG-I. J. Virol. 83, 
3734–3742 (2009). 
14. Nice, T. J., Robinson, B. A. & Van Winkle, J. A. The role of interferon in persistent viral infection: 
insights from murine norovirus. Trends Microbiol. 26, 510–524 (2018). 
15. Stetson, D. B. & Medzhitov, R. Type I interferons in host defense. Immunity 25, 373–381 (2006). 
16. Teijaro, J. R. Type I interferons in viral control and immune regulation. Curr. Opin. Virol. 16, 31–40 
(2016). 
17. Munir, S. et al. Nonstructural Proteins 1 and 2 of Respiratory Syncytial Virus Suppress Maturation of 
Human Dendritic Cells. J. Virol. 82, 8780–8796 (2008). 
18. Munir, S. et al. Respiratory Syncytial Virus Interferon Antagonist NS1 Protein Suppresses and Skews 
the Human T Lymphocyte Response. PLoS Pathog. 7, (2011). 
19. Bukreyev, A. et al. The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus 
Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through 
Effects on Fc Receptor-Bearing Leukocytes. J. Virol. 82, 12191–12204 (2008). 
20. Lambert, L., Sagfors, A. M., Openshaw, P. J. M. & Culley, F. J. Immunity to RSV in Early-Life. Front. 






21. Lanari, M., Vandini, S., Capretti, M. G., Lazzarotto, T. & Faldella, G. Respiratory Syncytial Virus 
Infections in Infants Affected by Primary Immunodeficiency. J. Immunol. Res. 2014, (2014). 
22. Borchers, A. T., Chang, C., Gershwin, M. E. & Gershwin, L. J. Respiratory Syncytial Virus—A 
Comprehensive Review. Clin. Rev. Allergy Immunol. 45, 331–379 (2013). 
23. Zhang, X. et al. [Risk factors for acute respiratory syncytial virus infection of lower respiratory tract 
in hospitalized infants]. Zhonghua Er Ke Za Zhi Chin. J. Pediatr. 52, 373–377 (2014). 
24. Ruckwardt, T. J., Morabito, K. M. & Graham, B. S. Determinants of early life immune responses to 
RSV infection. Curr. Opin. Virol. 16, 151–157 (2016). 
25. Fulginiti, V. A. et al. Respiratory virus immunization. I. A field trial of two inactivated respiratory 
virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated 
respiratory syncytial virus vaccine. Am. J. Epidemiol. 89, 435–448 (1969). 
26. Kapikian, A. Z., Mitchell, R. H., Chanock, R. M., Shvedoff, R. A. & Stewart, C. E. An epidemiologic 
study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously 
vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89, 405–421 (1969). 
27. Kim, H. W. et al. Respiratory syncytial virus disease in infants despite prior administration of 
antigenic inactivated vaccine. Am. J. Epidemiol. 89, 422–434 (1969). 
28. Simoes, E. A. F. et al. Palivizumab Prophylaxis, Respiratory Syncytial Virus, and Subsequent 
Recurrent Wheezing. J. Pediatr. 151, 34-42.e1 (2007). 
29. McDermott, D. S., Weiss, K. A., Knudson, C. J. & Varga, S. M. Central role of dendritic cells in shaping 
the adaptive immune response during respiratory syncytial virus infection. Future Virol. 6, 963–973 
(2011). 
30. Meng, J., Stobart, C. C., Hotard, A. L. & Moore, M. L. An Overview of Respiratory Syncytial Virus. 






31. Mukherjee, S. et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and 
exacerbation of allergic disease. Am. J. Pathol. 179, 248–258 (2011). 
32. Stoppelenburg, A. J., de Roock, S., Hennus, M. P., Bont, L. & Boes, M. Elevated Th17 response in 
infants undergoing respiratory viral infection. Am. J. Pathol. 184, 1274–1279 (2014). 
33. Lukacs, N. W. et al. Respiratory virus-induced TLR7 activation controls IL-17-associated increased 
mucus via IL-23 regulation. J. Immunol. Baltim. Md 1950 185, 2231–2239 (2010). 
34. Hashimoto, K. et al. Respiratory syncytial virus infection in the absence of STAT 1 results in airway 
dysfunction, airway mucus, and augmented IL-17 levels. J. Allergy Clin. Immunol. 116, 550–557 
(2005). 
35. Lotz, M. T. & Peebles, R. S. Mechanisms of Respiratory Syncytial Virus Modulation of Airway 
Immune Responses. Curr. Allergy Asthma Rep. 12, 380–387 (2012). 
36. Becker, Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing 
the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-
-a review. Virus Genes 33, 235–252 (2006). 
37. Ptaschinski, C. et al. RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-
Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo. PLoS Pathog. 11, e1004978 
(2015). 
38. Nagata, D. E. de A. et al. Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase 
controls iTreg development and regulates pathogenic T-cell responses during pulmonary viral 
infection. Mucosal Immunol. 8, 1131–1143 (2015). 
39. Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293–301 (2015). 
40. Huang, Y. & Paul, W. E. Inflammatory group 2 innate lymphoid cells. Int. Immunol. 28, 23–28 (2016). 
41. Ito, T. et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response 






42. Wang, Q., Du, J., Zhu, J., Yang, X. & Zhou, B. Thymic stromal lymphopoietin signaling in CD4(+) T cells 
is required for TH2 memory. J. Allergy Clin. Immunol. 135, 781-791.e3 (2015). 
43. Roan, F., Obata-Ninomiya, K. & Ziegler, S. F. Epithelial cell-derived cytokines: more than just 
signaling the alarm. J. Clin. Invest. 129, 1441–1451 (2019). 
44. Freer, G. & Matteucci, D. Influence of dendritic cells on viral pathogenicity. PLoS Pathog. 5, 
e1000384 (2009). 
45. Swedan, S., Andrews, J., Majumdar, T., Musiyenko, A. & Barik, S. Multiple Functional Domains and 
Complexes of the Two Nonstructural Proteins of Human Respiratory Syncytial Virus Contribute to 
Interferon Suppression and Cellular Location▿. J. Virol. 85, 10090–10100 (2011). 
46. Cormier, S. A., You, D. & Honnegowda, S. The use of a neonatal mouse model to study respiratory 
syncytial virus infections. Expert Rev. Anti Infect. Ther. 8, 1371–1380 (2010). 
47. Saravia, J. et al. Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33. PLoS Pathog. 
11, e1005217 (2015). 
48. Miller, J. F. a. P. Events that led to the discovery of T-cell development and function – a personal 
recollection. Tissue Antigens 63, 509–517 (2004). 
49. Mitchell, G. F. & Miller, J. F. Cell to cell interaction in the immune response. II. The source of 
hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct 
lymphocytes. J. Exp. Med. 128, 821–837 (1968). 
50. Miller, J. F. & Mitchell, G. F. Cell to cell interaction in the immune response. I. Hemolysin-forming 
cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J. 
Exp. Med. 128, 801–820 (1968). 
51. Mahnke, Y. D., Brodie, T. M., Sallusto, F., Roederer, M. & Lugli, E. The who’s who of T-cell 






52. Mosmann, T. R. & Sad, S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. 
Today 17, 138–146 (1996). 
53. Zhu, J., Yamane, H. & Paul, W. E. Differentiation of Effector CD4 T Cell Populations. Annu. Rev. 
Immunol. 28, 445–489 (2010). 
54. Romagnani, S. Th1/Th2 cells. Inflamm. Bowel Dis. 5, 285–294 (1999). 
55. Swain, S. L., McKinstry, K. K. & Strutt, T. M. Expanding roles for CD4+ T cells in immunity to viruses. 
Nat. Rev. Immunol. 12, 136–148 (2012). 
56. Kang, S., Brown, H. M. & Hwang, S. Direct Antiviral Mechanisms of Interferon-Gamma. Immune 
Netw. 18, (2018). 
57. Guglani, L. & Khader, S. A. Th17 cytokines in mucosal immunity and inflammation. Curr. Opin. HIV 
AIDS 5, 120–127 (2010). 
58. Bacharier, L. B. et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J. 
Allergy Clin. Immunol. 130, 91-100.e3 (2012). 
59. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J. & Paul, W. E. The IL-4 receptor: signaling 
mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701–738 (1999). 
60. Luzina, I. G. et al. Regulation of inflammation by interleukin-4: a review of “alternatives”. J. Leukoc. 
Biol. 92, 753–764 (2012). 
61. Deo, S. S., Mistry, K. J., Kakade, A. M. & Niphadkar, P. V. Role played by Th2 type cytokines in IgE 
mediated allergy and asthma. Lung India Off. Organ Indian Chest Soc. 27, 66–71 (2010). 
62. LaPorte, S. L. et al. Molecular and structural basis of cytokine receptor pleiotropy in the Interleukin-
4/13 system. Cell 132, 259–272 (2008). 
63. Andrews, A.-L., Holloway, J. W., Holgate, S. T. & Davies, D. E. IL-4 Receptor α Is an Important 
Modulator of IL-4 and IL-13 Receptor Binding: Implications for the Development of Therapeutic 






64. Kelly-Welch, A. E., Hanson, E. M., Boothby, M. R. & Keegan, A. D. Interleukin-4 and interleukin-13 
signaling connections maps. Science 300, 1527–1528 (2003). 
65. Mueller, T. D., Zhang, J.-L., Sebald, W. & Duschl, A. Structure, binding, and antagonists in the IL-4/IL-
13 receptor system. Biochim. Biophys. Acta 1592, 237–250 (2002). 
66. Hilton, D. J. et al. Cloning and characterization of a binding subunit of the interleukin 13 receptor 
that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. U. S. A. 93, 497–501 
(1996). 
67. Aman, M. J. et al. cDNA cloning and characterization of the human interleukin 13 receptor alpha 
chain. J. Biol. Chem. 271, 29265–29270 (1996). 
68. Wills-Karp, M. & Finkelman, F. D. Untangling the Complex Web of IL-4– and IL-13–Mediated 
Signaling Pathways. Sci. Signal. 1, pe55 (2008). 
69. Takatsu, K. Interleukin-5 and IL-5 receptor in health and diseases. Proc. Jpn. Acad. Ser. B Phys. Biol. 
Sci. 87, 463–485 (2011). 
70. Possa, S. S., Leick, E. A., Prado, C. M., Martins, M. A. & Tibério, I. F. L. C. Eosinophilic Inflammation in 
Allergic Asthma. Front. Pharmacol. 4, (2013). 
71. Mould, A. W. et al. The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking 
and Degranulation and the Induction of Bronchial Hyperreactivity. J. Immunol. 164, 2142–2150 
(2000). 
72. Thai, P., Chen, Y., Dolganov, G. & Wu, R. Differential Regulation of MUC5AC/Muc5ac and hCLCA-
1/mGob-5 Expression in Airway Epithelium. Am. J. Respir. Cell Mol. Biol. 33, 523–530 (2005). 
73. Stier, M. T. et al. Respiratory syncytial virus infection activates IL-13-producing group 2 innate 







74. McKenzie, A. N. J. Type-2 Innate Lymphoid Cells in Asthma and Allergy. Ann. Am. Thorac. Soc. 11, 
S263–S270 (2014). 
75. Mindt, B. C., Fritz, J. H. & Duerr, C. U. Group 2 Innate Lymphoid Cells in Pulmonary Immunity and 
Tissue Homeostasis. Front. Immunol. 9, 840 (2018). 
76. Han, M. et al. The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 
Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice. J. 
Immunol. Baltim. Md 1950 199, 1308–1318 (2017). 
77. Rajput, C. et al. RORα-dependent type 2 innate lymphoid cells are required and sufficient for 
mucous metaplasia in immature mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 312, L983–L993 
(2017). 
78. Schuijs, M. J. & Halim, T. Y. F. Group 2 innate lymphocytes at the interface between innate and 
adaptive immunity. Ann. N. Y. Acad. Sci. 1417, 87–103 (2018). 
79. Halim, T. Y. et al. Group 2 innate lymphoid cells license dendritic cells to potentiate memory T 
helper 2 cell responses. Nat. Immunol. 17, 57–64 (2016). 
80. Halim, T. Y. F. et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 
cell-mediated allergic lung inflammation. Immunity 40, 425–435 (2014). 
81. Halwani, R., Al-Muhsen, S. & Hamid, Q. T helper 17 cells in airway diseases: from laboratory bench 
to bedside. Chest 143, 494–501 (2013). 
82. Flannigan, K. L. et al. IL-17A-mediated neutrophil recruitment limits expansion of segmented 
filamentous bacteria. Mucosal Immunol. 10, 673–684 (2017). 
83. Chen, Y. et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 
paracrine/autocrine loop. J. Biol. Chem. 278, 17036–17043 (2003). 
84. Xia, W. et al. Interleukin-17A Promotes MUC5AC Expression and Goblet Cell Hyperplasia in Nasal 






85. Hymowitz, S. G. et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-
17F, and implications for receptor binding. EMBO J. 20, 5332–5341 (2001). 
86. Kawaguchi, M., Adachi, M., Oda, N., Kokubu, F. & Huang, S.-K. IL-17 cytokine family. J. Allergy Clin. 
Immunol. 114, 1265–1273 (2004). 
87. Mildner, A. & Jung, S. Development and function of dendritic cell subsets. Immunity 40, 642–656 
(2014). 
88. Smit, J. J., Rudd, B. D. & Lukacs, N. W. Plasmacytoid dendritic cells inhibit pulmonary 
immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 203, 1153–
1159 (2006). 
89. Jang, S., Smit, J., Kallal, L. E. & Lukacs, N. W. Respiratory syncytial virus infection modifies and 
accelerates pulmonary disease via DC activation and migration. J. Leukoc. Biol. 94, 5–15 (2013). 
90. Tognarelli, E. I., Bueno, S. M. & González, P. A. Immune-Modulation by the Human Respiratory 
Syncytial Virus: Focus on Dendritic Cells. Front. Immunol. 10, (2019). 
91. Cormier, S. A. et al. Limited type I interferons and plasmacytoid dendritic cells during neonatal 
respiratory syncytial virus infection permit immunopathogenesis upon reinfection. J. Virol. 88, 
9350–9360 (2014). 
92. Kallal, L. E., Schaller, M. A., Lindell, D. M., Lira, S. A. & Lukacs, N. W. CCL20/CCR6 blockade enhances 
immunity to RSV by impairing recruitment of DC. Eur. J. Immunol. 40, 1042–1052 (2010). 
93. Tourdot, S. et al. Respiratory syncytial virus infection provokes airway remodelling in allergen-
exposed mice in absence of prior allergen sensitization. Clin. Exp. Allergy J. Br. Soc. Allergy Clin. 
Immunol. 38, 1016–1024 (2008). 
94. Larkin, E. K. & Hartert, T. V. Genes associated with RSV lower respiratory tract infection and asthma: 







95. Bacharier, L. B. et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J. 
Allergy Clin. Immunol. 130, 91-100.e3 (2012). 
96. Asher, I. & Pearce, N. Global burden of asthma among children. Int. J. Tuberc. Lung Dis. Off. J. Int. 
Union Tuberc. Lung Dis. 18, 1269–1278 (2014). 
97. Almqvist, C., Worm, M., Leynaert, B. & working group of GA2LEN WP 2.5 Gender. Impact of gender 
on asthma in childhood and adolescence: a GA2LEN review. Allergy 63, 47–57 (2008). 
98. Lu, S. et al. Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in 
early childhood. Pediatr. Pulmonol. 51, 1382–1392 (2016). 
99. Divekar, R. & Kita, H. Recent advances in epithelium-derived cytokines (IL-33, IL-25 and TSLP) and 
allergic inflammation. Curr. Opin. Allergy Clin. Immunol. 15, 98–103 (2015). 
100. Byers, D. E. Defining the Roles of IL-33, Thymic Stromal Lymphopoietin, and IL-25 in Human 
Asthma. Am. J. Respir. Crit. Care Med. 190, 715–716 (2014). 
101. Rhinovirus induced IL-25 in asthma exacerbation drives type-2 immunity and allergic pulmonary 
inflammation. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246061/. (Accessed: 
30th June 2018) 
102. Verma, M. et al. Experimental asthma persists in IL-33 receptor knockout mice because of the 
emergence of thymic stromal lymphopoietin-driven IL-9+ and IL-13+ type 2 innate lymphoid cell 
subpopulations. J. Allergy Clin. Immunol. (2017). doi:10.1016/j.jaci.2017.10.020 
103. Gauvreau, G. M. et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N. 
Engl. J. Med. 370, 2102–2110 (2014). 
104. Ying, S. et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and 
correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. Baltim. 






105. Torgerson, D. G. et al. Meta-analysis of Genome-wide Association Studies of Asthma In Ethnically 
Diverse North American Populations. Nat. Genet. 43, 887–892 (2011). 
106. Vicente, C. T., Revez, J. A. & Ferreira, M. A. R. Lessons from ten years of genome-wide association 
studies of asthma. Clin. Transl. Immunol. 6, e165 (2017). 
107. Levin, S. D. et al. Thymic stromal lymphopoietin: a cytokine that promotes the development of 
IgM+ B cells in vitro and signals via a novel mechanism. J. Immunol. Baltim. Md 1950 162, 677–683 
(1999). 
108. Ziegler, S. F. et al. The biology of thymic stromal lymphopoietin (TSLP). Adv. Pharmacol. San Diego 
Calif 66, 129–155 (2013). 
109. Chien, C. D., Nguyen, S. M., Qin, H., Jacoby, E. & Fry, T. J. CRLF2 /Tslpr Overexpressing Acute 
Lymphoblastic Leukemia Relapse Is Driven By Chemotherapy-Induced TSLP from Bone Marrow 
Stromal Cells. Blood 126, 1432–1432 (2015). 
110. Collison, A. et al. TRAIL regulates MID1, TSLP, inflammation and remodelling in experimental 
eosinophilic oesophagitis. J. Allergy Clin. Immunol. 136, 971–982 (2015). 
111. Takai, T. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol. Int. Off. J. 
Jpn. Soc. Allergol. 61, 3–17 (2012). 
112. Zhong, J. et al. TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling. 
Database J. Biol. Databases Curation 2014, bau007 (2014). 
113. Ito, T., Liu, Y.-J. & Arima, K. Cellular and Molecular Mechanisms of TSLP Function in Human Allergic 
Disorders - TSLP Programs the “Th2 code” in Dendritic Cells. Allergol. Int. Off. J. Jpn. Soc. Allergol. 
61, 35–43 (2012). 
114. Li, Y.-L. et al. Thymic stromal lymphopoietin promotes lung inflammation through activation of 






115. Elder, M. J., Webster, S. J., Williams, D. L., Gaston, J. S. H. & Goodall, J. C. TSLP production by 
dendritic cells is modulated by IL-1β and components of the endoplasmic reticulum stress 
response. Eur. J. Immunol. 46, 455–463 (2016). 
116. Kashyap, M., Rochman, Y., Spolski, R., Samsel, L. & Leonard, W. J. Thymic Stromal Lymphopoietin is 
Produced by Dendritic Cells. J. Immunol. Baltim. Md 1950 187, 1207–1211 (2011). 
117. Lee, H.-C. et al. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected 
airway epithelial cells and promotes a type 2 response to infection. J. Allergy Clin. Immunol. 130, 
1187-1196.e5 (2012). 
118. Han, J. et al. Responsiveness to respiratory syncytial virus in neonates is mediated through thymic 
stromal lymphopoietin and OX40 ligand. J. Allergy Clin. Immunol. 130, 1175-1186.e9 (2012). 
119. Bohmwald, K. et al. Contribution of Cytokines to Tissue Damage During Human Respiratory 
Syncytial Virus Infection. Front. Immunol. 10, 452 (2019). 
120. Miller, A. L., Bowlin, T. L. & Lukacs, N. W. Respiratory syncytial virus-induced chemokine 
production: linking viral replication to chemokine production in vitro and in vivo. J. Infect. Dis. 189, 
1419–1430 (2004). 
121. Lukacs, N. W. et al. Respiratory syncytial virus predisposes mice to augmented allergic airway 
responses via IL-13-mediated mechanisms. J. Immunol. Baltim. Md 1950 167, 1060–1065 (2001). 
122. Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. 
Science 352, aaf1098 (2016). 
123. Song, W. M. & Colonna, M. Immune Training Unlocks Innate Potential. Cell 172, 3–5 (2018). 
124. Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 
1–5 (2007). 
125. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-






126. Foster, S. L., Hargreaves, D. C. & Medzhitov, R. Gene-specific control of inflammation by TLR-
induced chromatin modifications. Nature 447, 972–978 (2007). 
127. Quintin, J. et al. Candida albicans Infection Affords Protection against Reinfection via Functional 
Reprogramming of Monocytes. Cell Host Microbe 12, (2012). 
128. Ramirez-Carrozzi, V. R. et al. Selective and antagonistic functions of SWI/SNF and Mi-2beta 
nucleosome remodeling complexes during an inflammatory response. Genes Dev. 20, 282–296 
(2006). 
129. Ramirez-Carrozzi, V. R. et al. A unifying model for the selective regulation of inducible transcription 
by CpG islands and nucleosome remodeling. Cell 138, 114–128 (2009). 
130. Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 
823–837 (2007). 
131. Lee, G. R., Kim, S. T., Spilianakis, C. G., Fields, P. E. & Flavell, R. A. T helper cell differentiation: 
regulation by cis elements and epigenetics. Immunity 24, 369–379 (2006). 
132. Wei, G. et al. Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in 
Lineage Fate Determination of Differentiating CD4+ T Cells. Immunity 30, 155–167 (2009). 
133. Wen, H., Dou, Y., Hogaboam, C. M. & Kunkel, S. L. Epigenetic regulation of dendritic cell-derived 
interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood 111, 
1797–1804 (2008). 
134. De Santa, F. et al. Jmjd3 contributes to the control of gene expression in LPS-activated 
macrophages. EMBO J. 28, 3341–3352 (2009). 
135. Lee, M. G. et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. 
Science 318, 447–450 (2007). 
136. Arcipowski, K. M., Martinez, C. A. & Ntziachristos, P. Histone demethylases in physiology and 






137. Salminen, A., Kaarniranta, K., Hiltunen, M. & Kauppinen, A. Histone demethylase Jumonji D3 
(JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process. J. 
Mol. Med. Berl. Ger. 92, 1035–1043 (2014). 
138. Estarás, C., Fueyo, R., Akizu, N., Beltrán, S. & Martínez-Balbás, M. A. RNA polymerase II progression 
through H3K27me3-enriched gene bodies requires JMJD3 histone demethylase. Mol. Biol. Cell 24, 
351–360 (2013). 
139. Doñas, C. et al. The histone demethylase inhibitor GSK-J4 limits inflammation through the 
induction of a tolerogenic phenotype on DCs. J. Autoimmun. 75, 105–117 (2016). 
140. Licona-Limón, P., Kim, L. K., Palm, N. W. & Flavell, R. A. TH2, allergy and group 2 innate lymphoid 
cells. Nat. Immunol. 14, 536–542 (2013). 
141. Zhou, B. et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in 
mice. Nat. Immunol. 6, 1047–1053 (2005). 
142. Salter, B. M. A. et al. Human Bronchial Epithelial Cell-Derived Factors from Severe Asthmatic 
Subjects Stimulate Eosinophil Differentiation. Am. J. Respir. Cell Mol. Biol. (2017). 
doi:10.1165/rcmb.2016-0262OC 
143. Mitchell, P. D. & O’Byrne, P. M. Epithelial-Derived Cytokines in Asthma. Chest 151, 1338–1344 
(2017). 
144. Chauhan, A., Singh, M., Agarwal, A. & Paul, N. Correlation of TSLP, IL-33, and 
CD4 + CD25 + FOXP3 + T regulatory (Treg) in pediatric asthma. J. Asthma Off. J. Assoc. Care Asthma 
52, 868–872 (2015). 
145. Moore, M. L. et al. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein 







146. Campbell, E. M. et al. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced 
bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. J. Immunol. Baltim. 
Md 1950 163, 2160–2167 (1999). 
147. Jang, S., Smit, J., Kallal, L. E. & Lukacs, N. W. Respiratory syncytial virus infection modifies and 
accelerates pulmonary disease via DC activation and migration. J. Leukoc. Biol. 94, 5–15 (2013). 
148. Wang, F. et al. RNAscope: A Novel in Situ RNA Analysis Platform for Formalin-Fixed, Paraffin-
Embedded Tissues. J. Mol. Diagn. 14, 22–29 (2012). 
149. Saenz, S. A., Taylor, B. C. & Artis, D. Welcome to the neighborhood: epithelial cell-derived 
cytokines license innate and adaptive immune responses at mucosal sites. Immunol. Rev. 226, 
172–190 (2008). 
150. Hammad, H. & Lambrecht, B. N. Barrier Epithelial Cells and the Control of Type 2 Immunity. 
Immunity 43, 29–40 (2015). 
151. Feng, S. et al. Role of the TSLP-DC-OX40L pathway in asthma pathogenesis and airway 
inflammation in mice. Biochem. Cell Biol. Biochim. Biol. Cell. 96, 306–316 (2018). 
152. Liu, Y.-J. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-
mediated allergic inflammation. J. Allergy Clin. Immunol. 120, 238–244; quiz 245–246 (2007). 
153. Jang, S., Morris, S. & Lukacs, N. W. TSLP Promotes Induction of Th2 Differentiation but Is Not 
Necessary during Established Allergen-Induced Pulmonary Disease. PLOS ONE 8, e56433 (2013). 
154. Sigurs, N. et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at 
age 13. Am. J. Respir. Crit. Care Med. 171, 137–141 (2005). 
155. Osman, M. et al. Changing trends in sex specific prevalence rates for childhood asthma, eczema, 
and hay fever. Pediatr. Pulmonol. 42, 60–65 
156. Hui, C. C. K. et al. Thymic stromal lymphopoietin (TSLP) secretion from human nasal epithelium is a 






157. Hunninghake, G. M. et al. TSLP polymorphisms are associated with asthma in a sex-specific 
fashion. Allergy 65, 1566–1575 (2010). 
158. Bunyavanich, S. et al. Thymic stromal lymphopoietin (TSLP) is associated with allergic rhinitis in 
children with asthma. Clin. Mol. Allergy CMA 9, 1 (2011). 
159. Camelo, A. et al. IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human 
type 2 innate lymphoid cells. Blood Adv. 1, 577–589 (2017). 
160. Halim, T. Y. F. Group 2 innate lymphoid cells in disease. Int. Immunol. 28, 13–22 (2016). 
161. Ramalingam, T. R. et al. Regulation of Helminth-Induced Th2 Responses by Thymic Stromal 
Lymphopoietin. J. Immunol. Baltim. Md 1950 182, 6452–6459 (2009). 
162. Huber, J. P. & Farrar, J. D. Regulation of effector and memory T-cell functions by type I interferon. 
Immunology 132, 466–474 (2011). 
163. Guo, B., Chang, E. Y. & Cheng, G. The type I IFN induction pathway constrains Th17-mediated 
autoimmune inflammation in mice. J. Clin. Invest. 118, 1680–1690 (2008). 
164. Ziegler, S. M. et al. Human pDCs display sex-specific differences in type I interferon subtypes and 
interferon α/β receptor expression. Eur. J. Immunol. 47, 251–256 (2017). 
165. Ye, L. et al. Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic 
stromal lymphopoietin. Nat. Immunol. 20, 593 (2019). 
166. Uller, L. et al. Double-stranded RNA induces disproportionate expression of thymic stromal 
lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma. Thorax 
65, 626–632 (2010). 
167. Robinson, R. F. Impact of respiratory syncytial virus in the United States. Am. J. Health. Syst. 
Pharm. 65, S3–S6 (2008). 
168. Lotz, M. T. & Peebles, R. S. Mechanisms of respiratory syncytial virus modulation of airway immune 






169. Malinczak, C.-A. et al. Sex-associated TSLP-induced immune alterations following early-life RSV 
infection leads to enhanced allergic disease. Mucosal Immunol. 12, 969–979 (2019). 
170. Williams, J. W. et al. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. 
Nat. Commun. 4, 1–12 (2013). 
171. Froidure, A. et al. Myeloid dendritic cells are primed in allergic asthma for thymic stromal 
lymphopoietin-mediated induction of Th2 and Th9 responses. Allergy 69, 1068–1076 (2014). 
172. Mohapatra, A. et al. Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate 
epithelial cell maintenance of lung homeostasis. Mucosal Immunol. 9, 275–286 (2016). 
173. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native 
chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and 
nucleosome position. Nat. Methods 10, 1213–1218 (2013). 
174. Amaral, M. L., Erikson, G. A. & Shokhirev, M. N. BART: bioinformatics array research tool. BMC 
Bioinformatics 19, 296 (2018). 
175. Jenkins, S. J., Perona-Wright, G., Worsley, A. G. F., Ishii, N. & MacDonald, A. S. Dendritic cell 
expression of OX40 ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming 
and memory induction in vivo. J. Immunol. Baltim. Md 1950 179, 3515–3523 (2007). 
176. Reed, M. et al. Autophagy-inducing protein beclin-1 in dendritic cells regulates CD4 T cell 
responses and disease severity during respiratory syncytial virus infection. J. Immunol. Baltim. Md 
1950 191, 2526–2537 (2013). 
177. Barnden, M. J., Allison, J., Heath, W. R. & Carbone, F. R. Defective TCR expression in transgenic 
mice constructed using cDNA-based alpha- and beta-chain genes under the control of 
heterologous regulatory elements. Immunol. Cell Biol. 76, 34–40 (1998). 
178. Robertson, J. M., Jensen, P. E. & Evavold, B. D. DO11.10 and OT-II T Cells Recognize a C-Terminal 






179. Kaneko, Y. et al. The search for common pathways underlying asthma and COPD. Int. J. Chron. 
Obstruct. Pulmon. Dis. 8, 65–78 (2013). 
180. Gabay, C., Lamacchia, C. & Palmer, G. IL-1 pathways in inflammation and human diseases. Nat. 
Rev. Rheumatol. 6, 232–241 (2010). 
181. Dinarello, C. A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 
117, 3720–3732 (2011). 
182. Molteni, M., Gemma, S. & Rossetti, C. The Role of Toll-Like Receptor 4 in Infectious and 
Noninfectious Inflammation. Mediators Inflamm. 2016, (2016). 
183. Miller, S. I., Ernst, R. K. & Bader, M. W. LPS, TLR4 and infectious disease diversity. Nat. Rev. 
Microbiol. 3, 36–46 (2005). 
184. van Tol, S., Hage, A., Giraldo, M. I., Bharaj, P. & Rajsbaum, R. The TRIMendous Role of TRIMs in 
Virus–Host Interactions. Vaccines 5, (2017). 
185. van Gent, M., Sparrer, K. M. J. & Gack, M. U. TRIM Proteins and Their Roles in Antiviral Host 
Defenses. Annu. Rev. Virol. 5, 385–405 (2018). 
186. Rajsbaum, R., García-Sastre, A. & Versteeg, G. A. TRIMmunity: The roles of the TRIM E3-ubiquitin 
ligase family in innate antiviral immunity. J. Mol. Biol. 426, 1265–1284 (2014). 
187. Patil, G. & Li, S. Tripartite motif proteins: an emerging antiviral protein family. Future Virol. 14, 
107–122 (2019). 
188. Cantor, H. & Shinohara, M. L. Regulation of T-helper-cell lineage development by osteopontin. Nat. 
Rev. Immunol. 9, 137–141 (2009). 
189. Ashkar, S. et al. Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity. 






190. Antonelli, A. et al. Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: 
modulation by peroxisome proliferator-activated receptor γ agonists. Immunobiology 218, 690–
695 (2013). 
191. Noah, T. L. et al. Chemokines and inflammation in the nasal passages of infants with respiratory 
syncytial virus bronchiolitis. Clin. Immunol. Orlando Fla 104, 86–95 (2002). 
192. Haeberle, H. A. et al. Inducible Expression of Inflammatory Chemokines in Respiratory Syncytial 
Virus-Infected Mice: Role of MIP-1α in Lung Pathology. J. Virol. 75, 878–890 (2001). 
193. Monick, M. M. et al. Activation of the Epidermal Growth Factor Receptor by Respiratory Syncytial 
Virus Results in Increased Inflammation and Delayed Apoptosis. J. Biol. Chem. 280, 2147–2158 
(2005). 
194. Gao, Y. et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. 
Immunity 39, 722–732 (2013). 
195. Stritesky, G. L. et al. The transcription factor STAT3 is required for T helper 2 cell development. 
Immunity 34, 39–49 (2011). 
196. Cao, L. et al. TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in 
human lung fibroblast. Exp. Lung Res. 44, 288–301 (2018). 
197. Liu, J. & Ma, X. Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation 
with interferon regulatory factor-1, NF-kappaB, and PU.1. J. Biol. Chem. 281, 19188–19195 (2006). 
198. Yamamoto, M. et al. Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in 
Myeloid Cell Development. PLOS ONE 6, e25812 (2011). 
199. Ozato, K., Shin, D.-M., Chang, T.-H. & Morse, H. C. TRIM family proteins and their emerging roles in 
innate immunity. Nat. Rev. Immunol. 8, 849–860 (2008). 
200. Tait Wojno, E. D., Hunter, C. A. & Stumhofer, J. S. The Immunobiology of the Interleukin-12 Family: 






201. Yamaguchi, T., Takizawa, F., Fischer, U. & Dijkstra, J. M. Along the Axis between Type 1 and Type 2 
Immunity; Principles Conserved in Evolution from Fish to Mammals. Biology 4, 814–859 (2015). 
202. Liu, Y.-J. TSLP in epithelial cell and dendritic cell cross talk. Adv. Immunol. 101, 1–25 (2009). 
203. Mitchell, C., Provost, K., Niu, N., Homer, R. & Cohn, L. Interferon-gamma acts on the airway 
epithelium to inhibit local and systemic pathology in allergic airway disease. J. Immunol. Baltim. 
Md 1950 187, 3815–3820 (2011). 
204. Han, M. et al. IFN-γ Blocks Development of an Asthma Phenotype in Rhinovirus-Infected Baby Mice 
by Inhibiting Type 2 Innate Lymphoid Cells. Am. J. Respir. Cell Mol. Biol. 56, 242–251 (2016). 
205. Ban, J. et al. Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I 
Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling. Viruses 10, 716 (2018). 
206. Du, H. et al. MID1 Catalyzes the Ubiquitination of Protein Phosphatase 2A and Mutations within Its 
Bbox1 Domain Disrupt Polyubiquitination of Alpha4 but Not of PP2Ac. PLOS ONE 9, e107428 
(2014). 
207. Zhang, L. et al. MID1-PP2A complex functions as new insights in human lung adenocarcinoma. J. 
Cancer Res. Clin. Oncol. 144, 855–864 (2018). 
208. Guergnon, J. et al. PP2A targeting by viral proteins: A widespread biological strategy from 
DNA/RNA tumor viruses to HIV-1. Biochim. Biophys. Acta BBA - Mol. Basis Dis. 1812, 1498–1507 
(2011). 
209. Kouzarides, T. Chromatin Modifications and Their Function. Cell 128, 693–705 (2007). 
210. Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487–
500 (2016). 
211. Fischle, W. et al. Molecular basis for the discrimination of repressive methyl-lysine marks  in 






212. Zhang, Y. & Reinberg, D. Transcription regulation by histone methylation: interplay between 
different covalent modifications of the core histone tails. Genes Dev. 15, 2343–2360 (2001). 
213. De Santa, F. et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of 
polycomb-mediated gene silencing. Cell 130, 1083–1094 (2007). 
214. Tekkanat, K. K. et al. RANTES (CCL5) production during primary respiratory syncytial virus infection 
exacerbates airway disease. Eur. J. Immunol. 32, 3276–3284 (2002). 
215. Kruidenier, L. et al. A selective jumonji H3K27 demethylase inhibitor modulates the 
proinflammatory macrophage response. Nature 488, 404–408 (2012). 
216. Bermick, J. R. et al. Neonatal monocytes exhibit a unique histone modification landscape. Clin. 
Epigenetics 8, 99 (2016). 
217. Bayarsaihan, D. Epigenetic Mechanisms in Inflammation. J. Dent. Res. 90, 9–17 (2011). 
218. Morandini, A. C., Santos, C. F. & Yilmaz, Ö. Role of epigenetics in modulation of immune response 
at the junction of host–pathogen interaction and danger molecule signaling. Pathog. Dis. 74, 
(2016). 
219. Shanmugam, M. K. & Sethi, G. Role of epigenetics in inflammation-associated diseases. Subcell. 
Biochem. 61, 627–657 (2013). 
220. Das, N. D. et al. Gene networking and inflammatory pathway analysis in a JMJD3 knockdown 
human monocytic cell line. Cell Biochem. Funct. 30, 224–232 (2012). 
221. Das, A. et al. Proteomic changes induced by histone demethylase JMJD3 in TNF alpha-treated 
human monocytic (THP-1) cells. Mol. Immunol. 56, 113–122 (2013). 
222. Ishii, M. et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 
114, 3244–3254 (2009). 
223. Pham, D. et al. Opposing roles of STAT4 and Dnmt3a in Th1 gene regulation. J. Immunol. Baltim. 






224. Estarás, C. et al. Genome-wide analysis reveals that Smad3 and JMJD3 HDM co-activate the neural 
developmental program. Dev. Camb. Engl. 139, 2681–2691 (2012). 
225. Wei, Y. et al. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis 
in mice. Blood Adv. 2, 2491–2504 (2018). 
226. Worgall, S. Editorial: RSV, dendritic cells, and allergens—a bad combination. J. Leukoc. Biol. 94, 1–3 
(2013). 
227. Heinemann, B. et al. Inhibition of demethylases by GSK-J1/J4. Nature 514, E1–E2 (2014). 
228. Acosta, P. L., Caballero, M. T. & Polack, F. P. Brief History and Characterization of Enhanced 
Respiratory Syncytial Virus Disease. Clin. Vaccine Immunol. CVI 23, 189–195 (2016). 
229. Connors, M. et al. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge 
of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. 
Virol. 66, 7444–7451 (1992). 
230. Connors, M. et al. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) 
challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of 
interleukin-4 (IL-4) and IL-10. J. Virol. 68, 5321–5325 (1994). 
231. Blanchet, M.-R., Gold, M., Bennett, J. & McNagny, K. CD103 in the development of experimental 
asthma. Allergy Asthma Clin. Immunol. Off. J. Can. Soc. Allergy Clin. Immunol. 6, P11 (2010). 
232. Halim, T. Y. F. et al. Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of 
the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells. Immunity 48, 1195-1207.e6 
(2018). 
233. Wu, J. et al. Critical role of OX40/OX40L in ILC2-mediated activation of CD4+T cells during 
respiratory syncytial virus infection in mice. Int. Immunopharmacol. 76, 105784 (2019). 







235. Delgado, M. F. et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation 
leads to enhanced respiratory syncytial virus disease. Nat. Med. 15, 34–41 (2009). 
236. Barrios, C. et al. The costimulatory molecules CD80, CD86 and OX40L are up-regulated in 
Aspergillus fumigatus sensitized mice. Clin. Exp. Immunol. 142, 242–250 (2005). 
237. Achuthan, A. et al. Granulocyte macrophage colony-stimulating factor induces CCL17 production 
via IRF4 to mediate inflammation. J. Clin. Invest. 126, 3453–3466 (2016). 
238. Hsu, A. T. et al. Epigenetic and transcriptional regulation of IL4-induced CCL17 production in 
human monocytes and murine macrophages. J. Biol. Chem. 293, 11415–11423 (2018). 
239. Wang, S.-P. et al. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes 
Active Enhancer Landscapes for Eliciting Transcription. Mol. Cell 67, 308-321.e6 (2017). 
240. Cho, Y.-W. et al. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 
methyltransferase complex. J. Biol. Chem. 282, 20395–20406 (2007). 
241. Van der Meulen, J., Speleman, F. & Van Vlierberghe, P. The H3K27me3 demethylase UTX in normal 
development and disease. Epigenetics 9, 658–668 (2014). 
242. Li, Q. et al. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell 
differentiation. Nat. Commun. 5, 5780 (2014). 
243. Liu, Z. et al. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation 
of Th17 cell differentiation. J. Mol. Cell Biol. 7, 505–516 (2015). 
244. LaMere, S. A. et al. H3K27 Methylation Dynamics during CD4 T Cell Activation: Regulation of 
JAK/STAT and IL12RB2 Expression by JMJD3. J. Immunol. Baltim. Md 1950 199, 3158–3175 (2017). 
245. Manna, S. et al. Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell 
differentiation. Nat. Commun. 6, (2015). 
246. Schmidt, M. E. et al. Memory CD8 T cells mediate severe immunopathology following respiratory 






247. Openshaw, P. J. & Chiu, C. Protective and dysregulated T cell immunity in RSV infection. Curr. Opin. 
Virol. 3, 468–474 (2013). 
248. Rosenberg, H. F. & Domachowske, J. B. Inflammatory responses to Respiratory Syncytial Virus 
(RSV) infection and the development of immunomodulatory pharmacotherapeutics. Curr. Med. 
Chem. 19, 1424–1431 (2012). 
249. Openshaw, P. J. M. & Tregoning, J. S. Immune Responses and Disease Enhancement during 
Respiratory Syncytial Virus Infection. Clin. Microbiol. Rev. 18, 541–555 (2005). 
250. Bueno, S. M. et al. Host immunity during RSV pathogenesis. Int. Immunopharmacol. 8, 1320–1329 
(2008). 
251. Li, Y. et al. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for 
acute myeloid leukemia. J. Cancer Res. Clin. Oncol. 144, 1065–1077 (2018). 
252. Pawlyn, C. et al. Histone Demethylase Inhibition As a Novel Therapeutic Strategy in Myeloma. 
Blood 124, 2087–2087 (2014). 
253. Thinnes, C. C. et al. Targeting histone lysine demethylases — Progress, challenges, and the future. 
Biochim. Biophys. Acta 1839, 1416–1432 (2014). 
254. Boila, L. D., Chatterjee, S. S., Banerjee, D. & Sengupta, A. KDM6 and KDM4 histone lysine 
demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia. Exp. 
Hematol. 58, 44-51.e7 (2018). 
255. Souyris, M. et al. TLR7 escapes X chromosome inactivation in immune cells. Sci. Immunol. 3, 
(2018). 
256. O’Driscoll, D. et al. Expression of X chromosome-linked TLR4 signalling molecules in female versus 
male neonatal cord blood. Eur. Respir. J. 48, PA3968 (2016). 







258. Yang, K. et al. Human TLR-7-, -8-, and -9-Mediated Induction of IFN-α/β and -λ Is IRAK-4 Dependent 
and Redundant for Protective Immunity to Viruses. Immunity 23, 465–478 (2005). 
259. Smith, N. et al. Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 
engagement—A new target for lupus treatment. Sci. Adv. 5, eaav9019 (2019). 
260. Jacob, C. O. et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of 
systemic lupus erythematosus. Proc. Natl. Acad. Sci. 106, 6256–6261 (2009). 
261. Souyris, M., Mejía, J. E., Chaumeil, J. & Guéry, J.-C. Female predisposition to TLR7-driven 
autoimmunity: gene dosage and the escape from X chromosome inactivation. Semin. 
Immunopathol. 41, 153–164 (2019). 
262. Farrugia, M. & Baron, B. The Role of Toll-Like Receptors in Autoimmune Diseases through Failure 
of the Self-Recognition Mechanism. Int. J. Inflamm. 2017, (2017). 
263. Singer, J. W. et al. Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic 
strategy. Oncotarget 9, 33416–33439 (2018). 
264. Quigley, C. A. The Postnatal Gonadotropin and Sex Steroid Surge—Insights from the Androgen 
Insensitivity Syndrome. J. Clin. Endocrinol. Metab. 87, 24–28 (2002). 
265. Bouvattier, C. et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR 
gene. J. Clin. Endocrinol. Metab. 87, 29–32 (2002). 
266. Robledo-Aceves, M. et al. Risk factors for severe bronchiolitis caused by respiratory virus infections 
among Mexican children in an emergency department. Medicine (Baltimore) 97, (2018). 
267. Buchwald, A. G. et al. Epidemiology, Risk Factors, and Outcomes of Respiratory Syncytial Virus 
Infections in Newborns in Bamako, Mali. Clin. Infect. Dis. doi:10.1093/cid/ciz157 
268. Jepsen, M. T. et al. Incidence and seasonality of respiratory syncytial virus hospitalisations in young 






269. Lanari, M. et al. Risk factors for bronchiolitis hospitalization during the first year of life in a 
multicenter Italian birth cohort. Ital. J. Pediatr. 41, 40 (2015). 
270. Shang, T. et al. Toll-Like Receptor-Initiated Testicular Innate Immune Responses in Mouse Leydig 
Cells. Endocrinology 152, 2827–2836 (2011). 
271. Sun, B. et al. Sertoli cell-initiated testicular innate immune response through toll-like receptor-3 
activation is negatively regulated by Tyro3, Axl, and mer receptors. Endocrinology 151, 2886–2897 
(2010). 
272. Cephus, J. et al. Testosterone attenuates group 2 innate lymphoid cell-mediated airway 
inflammation. Cell Rep. 21, 2487–2499 (2017). 
273. Keselman, A. & Heller, N. Estrogen Signaling Modulates Allergic Inflammation and Contributes to 
Sex Differences in Asthma. Front. Immunol. 6, (2015). 
274. Chang, K.-K. et al. TSLP induced by estrogen stimulates secretion of MCP-1 and IL-8 and growth of 
human endometrial stromal cells through JNK and NF-κB signal pathways. Int. J. Clin. Exp. Pathol. 
7, 1889–1899 (2014). 
275. Wu, H.-X., Guo, P.-F., Jin, L.-P., Liang, S.-S. & Li, D.-J. Functional regulation of thymic stromal 
lymphopoietin on proliferation and invasion of trophoblasts in human first-trimester pregnancy. 
Hum. Reprod. 25, 1146–1152 (2010). 
276. Köhler, A. et al. A hormone-dependent feedback-loop controls androgen receptor levels by limiting 
MID1, a novel translation enhancer and promoter of oncogenic signaling. Mol. Cancer 13, 146 
(2014). 
277. Mabjeesh, N. J., Willard, M. T., Frederickson, C. E., Zhong, H. & Simons, J. W. Androgens stimulate 
hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase 
receptor/phosphatidylinositol 3’-kinase/protein kinase B in prostate cancer cells. Clin. Cancer Res. 






278. Haeberle, H. A. et al. Oxygen-Independent Stabilization of Hypoxia Inducible Factor (HIF)-1 during 
RSV Infection. PLoS ONE 3, (2008). 
279. Jang, Y. et al. UVB Induces HIF-1α-Dependent TSLP Expression via the JNK and ERK Pathways. J. 
Invest. Dermatol. 133, 2601–2608 (2013). 
280. Mitani, T. et al. Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-
inducible factor-1α in a low androgen environment. J. Steroid Biochem. Mol. Biol. 123, 58–64 
(2011). 
281. Sumi, Y. & Hamid, Q. Airway remodeling in asthma. Allergol. Int. Off. J. Jpn. Soc. Allergol. 56, 341–
348 (2007). 
282. Zaiss, D. M. W., Gause, W. C., Osborne, L. C. & Artis, D. Emerging functions of amphiregulin in 
orchestrating immunity, inflammation and tissue repair. Immunity 42, 216–226 (2015). 
283. Monticelli, L. A. et al. Innate lymphoid cells promote lung tissue homeostasis following acute 
influenza virus infection. Nat. Immunol. 12, 1045–1054 (2011). 
284. Liu, T., Ding, L., Wu, Z., Santos, F. G. D. L. & Phan, S. Role of dendritic cell-derived amphiregulin in 
pulmonary fibrosis (CCR5P.203). J. Immunol. 194, 186.5-186.5 (2015). 
285. Chen, Z.-G. et al. Neutralization of TSLP inhibits airway remodeling in a murine model of allergic 
asthma induced by chronic exposure to house dust mite. PloS One 8, e51268 (2013). 
286. Fehrenbach, H., Wagner, C. & Wegmann, M. Airway remodeling in asthma: what really matters. 
Cell Tissue Res. 367, 551–569 (2017). 
287. Malmström, K. et al. Lung function, airway remodelling and inflammation in symptomatic infants: 
outcome at 3 years. Thorax 66, 157–162 (2011). 
288. Williams, P. V. Lung Function, Airway Remodeling, and Inflammation in Infants: Outcome at 8 






289. Roncolato, F. T. et al. The effect of pulmonary function testing on bleomycin dosing in germ cell 
tumours. Intern. Med. J. 46, 893–898 (2016). 
290. Sleijfer, S., van der Mark, T. W., Schraffordt Koops, H. & Mulder, N. H. Decrease in pulmonary 
function during bleomycin-containing combination chemotherapy for testicular cancer: not only a 
bleomycin effect. Br. J. Cancer 71, 120–123 (1995). 
291. Dishop, M. K. Diagnostic Pathology of Diffuse Lung Disease in Children. Pediatr. Allergy Immunol. 
Pulmonol. 23, 69–85 (2010). 
292. Hrycaj, S. M. et al. Hox5 genes direct elastin network formation during alveologenesis by regulating 
myofibroblast adhesion. Proc. Natl. Acad. Sci. U. S. Am. Wash. 115, E10605 (2018). 
 
